<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2025-11-03 09:16:55 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3. Blocking mitochondrial complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in vivo in an animal disease model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>109</td>
          <td>31</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>66</td>
          <td>74</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="CNS infection by HIV-1 contributes to neuroinflammation, cognitive impairments, and the establishment of viral reservoirs. Although HIV-1 is known to enter the brain early in infection via “Trojan horse” leukocytes, including infected monocytes and CD4⁺ T cells, the specific cellular phenotypes facilitating this process during acute infection remain incompletely characterized. This study aims to characterize the roles of brain lymphocytes during acute infection and primary CD4 + T cell phenotypes seeding the SIV to the CNS. scRNA-seq was performed on brain and blood cells of three acutely SIV-infected rhesus macaques. The transcriptomic data were analyzed using bioinformatics approaches and validated through in vitro co-culture assays and re-analysis of a publicly available scRNA-seq dataset. scRNA-seq of brain and blood immune cells from acutely SIV-infected rhesus macaques revealed an expansion of proliferating CD4⁺ cytotoxic T lymphocytes (CTLs) in the blood, characterized by high CD4, CCR5, and adhesion molecule expression, indicating strong potential for CNS infiltration. In the brain, CD4⁺ CTLs, tissue-resident memory cells, and a unique Myeloid–T cell cluster were enriched for SIV⁺ cells. Integration of brain and blood data revealed transcriptomic maturation of CD4⁺ CTLs upon brain entry. To validate the biological relevance of the Myeloid–T cluster, we used a macrophage–T cell co-culture system, which reproduced similar dual-marker expression and identified chemokines (e.g., CCL3, CCL4) as potential markers of T cell–myeloid cell interaction. Our findings suggest that CD4⁺ cytotoxic-like T cells represent a key lymphocyte subset responsible for initiating SIV entry into the brain and triggering neuroinflammatory processes. Furthermore, interactions between infiltrating lymphocytes and brain-resident myeloid cells, potentially through chemokine signaling, may facilitate viral propagation within the CNS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/72fbfac68579326979ef04a1dc07549f993cb4aa" target='_blank'>
              T cell-mediated SIV dissemination into the CNS: a single-cell transcriptomic analysis
              </a>
            </td>
          <td>
            Xiaoke Xu, Meng Niu, Benjamin G. Lamberty, Kathleen M. Emanuel, L. D. Estrella, Howard S. Fox
          </td>
          <td>2025-10-08</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="The recent COVID-19 pandemic left behind the lingering question as whether new variants of concern might cause further waves of infection. Thus, it is important to investigate the long-term protection gained via vaccination or exposure to the SARS-CoV-2 virus. Here we compare the evolution of memory T-cell responses following primary infection with subsequent antigen exposures. Single-cell TCR analysis of three dominant SARS-CoV-2 spike-specific CD4+ T-cell responses identifies the dominant public TCRα clonotypes pairing with diverse TCRβ clonotypes that associated with mild disease at primary infection. These clonotypes are found at higher frequencies in pre-pandemic repertoires compared to other epitope-specific clonotypes. Longitudinal transcriptomics and TCR analysis, combined with functional evaluation, reveals that the clonotypes persisting 3–4 years post initial infection exhibit distinct functionality compared to those that were lost. Furthermore, spike-specific CD4+ T cells at this time point show decreased Th1 signatures and enhanced GZMA-driven cytotoxic transcriptomic profiles that were independent of TCR clonotype and associated with viral suppression. In summary, we identify common public TCRs used by immunodominant spike-specific memory CD4+ T-cells, associated with mild disease outcome, which likely play important protective roles to subsequent viral infection events.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1990a5c85f154fc42126796dea994523a0bcd1cc" target='_blank'>
              Long-persisting SARS-CoV-2 spike-specific CD4+ T cells associated with mild disease and increased cytotoxicity post COVID-19
              </a>
            </td>
          <td>
            Guihai Liu, E. Antoun, A. Fries, Xuan Yao, Zixi Yin, D. Dong, Wenbo Wang, P. Wing, Wanwisa Dejnirattisa, P. Supasa, Chang Liu, Timothy Rostron, C. Waugh, Kevin Clark, Paul Sopp, J. Fry, I. Vendrell, Jane A. McKeating, J. Mongkolsapaya, G. Screaton, Benedikt M. Kessler, R. Fisher, G. Ogg, A. Mentzer, J. Knight, Yanchun Peng, Tao Dong
          </td>
          <td>2025-10-01</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>68</td>
        </tr>

        <tr id="ABSTRACT High morbidity and mortality associated with human β-coronavirus (CoV) infection highlight the need to determine host responses to infection and develop anti-viral therapies. Gap junction intercellular communication (GJIC), particularly involving Connexin43 (Cx43), is vital for maintaining central nervous system (CNS) homeostasis, and disruption of GJIC is a well-documented pathogenic mechanism among β-coronaviruses. Specifically, murine β-coronavirus, mouse hepatitis virus (MHV-A59) inoculation in the mouse brain causes acute-stage CNS viral spread and chronic neuroinflammatory demyelination while causing pronounced downregulation of Cx43 at the acute stage, reflecting a critical role in CNS pathology. To pharmacologically target Cx43, 4-phenylbutyric acid (4-PBA) has been widely used, since it enhances the expression of ER-resident thioredoxin family protein (ERp29), a molecular chaperone of Cx43. 4-PBA has been shown to have anti-viral effects against MHV-A59 in vitro; however, the in vivo efficacy of 4-PBA is unknown. This study investigates the effect of 4-PBA administration on the pathology of MHV-A59 infection in vivo. We demonstrate that 4-PBA treatment reduced acute MHV-A59 infectivity and viral spread in the brain while modulating the glial cell response and mounting host immunity. MHV-A59 infection downregulated the expression of ERp29 in the CNS, which was rescued by 4-PBA treatment. Furthermore, treatment with 4-PBA effectively preserved the expression of Cx43 and Cx47 in infected CNS cells, counteracting their infection-induced downregulation. 4-PBA treatment not only limits acute viral replication and spread throughout the brain but also protects against severe chronic virus-induced neuroinflammatory demyelination in vivo. These findings highlight 4-PBA’s significant anti-viral potential against murine β-CoV and therapeutic potential in mitigating virus-induced neuroinflammatory demyelination. IMPORTANCE Past outbreaks and the emergence of novel coronaviruses pose a serious global health threat, warranting studies on the disease mechanism of these viruses and the development of new anti-viral strategies. In the current study, we demonstrated the antiviral potential of 4-phenylbutyric acid (4-PBA) against a neurotropic murine β-coronavirus, mouse hepatitis virus (MHV-A59). MHV-A59 inoculation in the brain causes virus infection and disruption of gap junction (GJ) communication by the downregulation of GJ proteins connexin 43 (Cx43) and connexin 47 (Cx47), crucial for maintaining CNS homeostasis. We demonstrate that 4-PBA restricts viral spread and infectivity in the mouse brain and improves the reduced levels of ERp29 and, thus, Cx43 and Cx47 in the infected CNS. Furthermore, 4-PBA mitigated virus-induced chronic neuroinflammatory demyelination, the characteristic feature of multiple sclerosis (MS). These findings demonstrate that 4-PBA holds significant therapeutic potential for restricting β-CoV spread and virus-induced neuroinflammatory demyelination.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a2f2c9613b272fb16c992d1cc504fcdbd23f22e8" target='_blank'>
              Phenylbutyrate restricts murine β-coronavirus infectivity and limits virus-induced demyelination in vivo
              </a>
            </td>
          <td>
            Grishma Kasle, Madhav Sharma, Saurav Kumar, Pranati Das, Subhajit Das Sarma, Michael Koval, Lawrence C. Kenyon, J. Das Sarma
          </td>
          <td>2025-09-08</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Background Growing evidence indicates that Epstein-Barr virus (EBV), a gammaherpesvirus, plays a central role in the pathogenesis of multiple sclerosis (MS). The presence of EBV-infected cells in the central nervous system (CNS) of MS patients, but not in neurologically healthy individuals, suggests that viral persistence in the CNS may drive MS. However, why there is such a long interval between initial infection and the development of disease is unknown. Methods To model the effects of EBV infection on the brain, we intracerebrally infected mice with murine gammaherpesvirus-68 (MHV68), a virus genetically related to EBV that causes transient pathology strikingly similar to that seen in humans after acute EBV infection. One month following MHV68 infection, we administered myelin oligodendrocyte glycoprotein (MOG) peptide to evaluate the effects of prior MHV68 infection on the response to an additional inflammatory stimulus of the CNS. Virus persistence, microglial activation and immune cell infiltration were evaluated over time using flow cytometry. Results Intracerebral MHV68 infection induced mild brain demyelination and ataxia, a common symptom of MS, that both quickly resolved. However, administration of MOG peptide one month later led to more severe brain demyelination and more sustained ataxia, suggesting that prior MHV68 infection sensitized the mice to a newly introduced immune stimulus. Further investigation revealed that following CNS infection, MHV68 persisted in microglia, where it induced a primed phenotype marked by elevated MHC-II expression and heightened immune reactivity for at least six months. Primed microglia displayed increases in the labile iron pool, and iron chelation reduced microglial priming. Early antiviral treatment during MHV68 infection completely prevented subsequent MOG-induced demyelinating disease. Conclusions These findings support a two-step mechanism by which CNS infection with a gammaherpesvirus closely related to EBV sensitizes the host to a second unrelated immune stimulus that triggers MS-like disease manifestations. Chronic priming of microglia resulting from the initial infection contributes to this process, and prevention of such priming with early antiviral treatment also prevents neuropathology following the second stimulus. EBV infection may similarly sensitize humans to a second stimulus and, if so, treatment of acute EBV infection may avert subsequent MS development. Supplementary Information The online version contains supplementary material available at 10.1186/s12974-025-03547-8.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bc50305e75ba829510074041add280a2e4049038" target='_blank'>
              Early antiviral treatment following gammaherpesvirus-68 infection of the central nervous system prevents subsequent multiple sclerosis-like disease
              </a>
            </td>
          <td>
            Alexander Muselman, Sameera Kongara, Nathan Hsu, Asha Aggarwal, Joanna Yu, Jayakumar Rajadas, Edgar G Engleman
          </td>
          <td>2025-10-08</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a3b0406a502b6207a22c486cd8a1349eb32f77e5" target='_blank'>
              Microglia from patients with multiple sclerosis display a cell-autonomous immune activation state
              </a>
            </td>
          <td>
            Tanja Hyvärinen, Johanna Lotila, Luca Giudice, Iisa Tujula, M. Nylund, S. Ohtonen, Flavia Scoyni, Henna Jäntti, Sara Pihlava, H. Skottman, Susanna Narkilahti, L. Airas, T. Malm, S. Hagman
          </td>
          <td>2024-12-11</td>
          <td>bioRxiv</td>
          <td>2</td>
          <td>47</td>
        </tr>

        <tr id="In multiple sclerosis (MS), chronic compartmentalized inflammation is thought to drive relentless clinical deterioration. Here, we investigate the link between unresolved parenchymal inflammation and cellular senescence in MS progression. Single-cell transcriptomic analysis of human brain tissue reveals an accumulation of senescent-like glial cells in diseased white matter, especially in chronic active lesions, and to a lesser extent in the cortex. Spatial transcriptomics show gradients of senescence-like signatures extending from lesion cores to periplaque regions, alongside rewired cellular networks. Experimental induction of senescence in MS hiPSC-derived neural organoids demonstrates that microglia are especially vulnerable to inflammation-induced senescence, which can be partially rescued by CNS-penetrant anti-inflammatory drugs. At the patient level (n = 466), increased 3T MRI-estimated brain-age is observed, especially in individuals with more than four chronic active lesions. These findings suggest that chronic inflammation might accelerate senescence-like processes, potentially contributing to disease progression, and that its modulation might help limit further propagation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b77d9523c82f1187be87e3bd2154d78aa2798954" target='_blank'>
              Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids
              </a>
            </td>
          <td>
            Francesca Fagiani, Edoardo Pedrini, Maria Sofia Martire, Gaia Gastoldi, Colin Vanden Bulcke, Jing-Ping Lin, Dragan Maric, Elena Brambilla, F. Ruffini, Carolina Peri, P. Calabresi, Pietro Maggi, Paola Panina-Bordignon, Gianvito Martino, D. Reich, Martina Absinta
          </td>
          <td>2025-09-26</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d46811852497c54872a7282800dcab64fa68610f" target='_blank'>
              A multimodal atlas of COVID-19 severity identifies hallmarks of dysregulated immunity
              </a>
            </td>
          <td>
            K. Slowikowski, P. Sen, C. Cosgriff, J. Tantivit, T. Eisenhaure, T. J. LaSalle, K. Manakongtreecheep, A. Tirard, B. Y. Arnold, A. Pacheco-Navarro, E. Y. Yang, M. Reyes, A. Gonye, I. Gushterova, B. Russo, M. Rojas-Lopez, N. Sharma, M. F. Thomas, T. Sharova, D. Frederick, K. Lavin-Parsons, B. Lilley, B. Mckaig, C. Lodenstein, H. Khanna, K. Kays, N. Charland, N. Smith, S. Ramesh, T. Delorey, D. Phillips, L. Amir-Zilberstein, E. M. Brown, M. Benson, S.-M. Park, B. Tusi, V. Pokatayev, C. Hecht, N. Pishesha, A. E. Woolley, L. Cosimi, Rozenblatt-Ro
          </td>
          <td>2025-09-21</td>
          <td>None</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d74835f8e845ea18beb20340e5bd3f281ac019ce" target='_blank'>
              Tonic type I interferon signaling optimizes the antiviral function of plasmacytoid dendritic cells.
              </a>
            </td>
          <td>
            Joseph N. Pucella, Raul A Maqueda-Alfaro, Hai Ni, Fernando Bandeira Sulczewski, Anna Eichinger, E. Esteva, Ai C Ra, Annesa Das, Oriana A. Perez, Jue Feng, Marlon Stoeckius, Peter Smibert, Alireza Khodadadi-Jamayran, Igor Dolgalev, E. Ivanova, Stela Sota, Ken Cadwell, S. Koralov, Judy Zhong, Chetna Soni, Daniel B. Stetson, Stuart P Weisberg, Donna L. Farber, Juliana Idoyaga, Boris Reizis
          </td>
          <td>2025-10-14</td>
          <td>Nature immunology</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/05a71100671b244cc8f79397a31cb08b678438b9" target='_blank'>
              Patient-derived lymphocytes drive smoldering lesion pathology in a chimeric multiple sclerosis mouse model
              </a>
            </td>
          <td>
            O. Perrot, M. Nordbeck, C. Bachelin, A. Luong, D. Roussel, D. Akbar, N. Sarrazin, A. Tenenhaus, C. Louapre, V. Zujovic
          </td>
          <td>2025-09-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="A 48-year-old patient underwent lung transplantation because of severe COVID-19, which aggravated his underlying interstitial lung disease, despite the presence of detectable SARS-CoV-2. Subsequently, the graft is re-infected early in the post-procedural phase, leading to viral persistence for more than five months. By analyzing viral evolution and effector immune response within the transplanted organ, we observe three main findings. First, virus evolution differs in the transplanted organ compared to that in the upper respiratory tract and is affected by monoclonal SARS-CoV-2-specific antibodies and molnupiravir. Second, we show the potential clinical relevance of T cell HLA restriction that may facilitate viral clearance in the upper respiratory tract compared to the ongoing viral replication in the HLA mismatch organ. Third, close monitoring and modulation of immunosuppressive and antiviral therapy enables viral clearance in a lung transplantation setting despite incomplete SARS-CoV-2 clearance prior to transplantation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/569199782c3445155a7ccd2d640593b92abe836a" target='_blank'>
              SARS-CoV-2 infection dynamics in a MHCI-mismatched lung transplant recipient
              </a>
            </td>
          <td>
            Jonas Fuchs, V. Karl, Ina Hettich, Jaime Alvarado, Daniel Eckert, Lena Jaki, Ann-Kathrin Kohl, Anastasia Kremser, Anastasija Maks, C. Terschluse, P. Agarwal, F. Emmerich, Sebastian Fähndrich, Annabelle Flügler, D. Hornuss, Johannes Kalbhenn, N. Kneidinger, Inga Lau, A. Lother, I. Moneke, David Schibilsky, Elisabeth Schygulla, N. Venhoff, Gernot Zissel, M. Czerny, D. Huzly, Georg Kochs, Christoph Neumann-Haefelin, Bernward Passlick, Daiana Stolz, R. Thimme, M. Panning, M. Hofmann, Björn C. Frye
          </td>
          <td>2025-09-16</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c2ac7be7fefad26395dcc651024f1fe069018455" target='_blank'>
              Atlas of innate immune responses to experimental cholera and IL22 treatment demonstrates protection by mucus-secreting cells
              </a>
            </td>
          <td>
            Masataka Suzuki, Yuko Hasegawa, Hailong Zhang, M. Waldor
          </td>
          <td>2025-09-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>93</td>
        </tr>

        <tr id="Objective Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a significant global health burden, characterized by complex host–pathogen interactions that drive heterogeneous clinical outcomes. While pulmonary epithelial cells are increasingly recognized as active participants in innate immunity during Mtb infection, how host defense are altered when the epithelial barrier is compromised remains unclear. Methods In this study, we developed a murine model combining naphthalene-induced pulmonary epithelial injury with Mtb infection and mapped the pulmonary cells landscape through single-cell RNA sequencing (scRNA-seq), followed by in vitro stimulation assays to validate macrophage functional changes. Results Notably, we found a pronounced impairment in pulmonary bacterial clearance. Transcriptomic analysis revealed a widespread suppression of epithelial immune functions and showed that macrophages transitioned from an antimicrobial to an antigen-presenting phenotype, indicating waning pulmonary innate defenses and heightened adaptive immune activation. In vitro experiments further suggested that this macrophage transition may be linked to epithelial cell alterations. Conclusions These findings indicate that pulmonary epithelial integrity may influence early host immune responses to Mycobacterium tuberculosis and provide a transcriptomic framework for exploring epithelial–immune crosstalk as a potential therapeutic target. Supplementary Information The online version contains supplementary material available at 10.1007/s00011-025-02106-4.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e41984afd63dd846e210a4451e9fc159cd48e46" target='_blank'>
              Lung epithelial injury impairs early host immune responses to Mycobacterium tuberculosis
              </a>
            </td>
          <td>
            Xuan Miao, Xue Li, Zuokuan He, Guiying Xu, Yu Li, Youwei Wang, Junping Wu, Qi Wu, Huaiyong Chen
          </td>
          <td>2025-10-03</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7926169db8376b81cfe85e7301b1ef3978ec2753" target='_blank'>
              Innate immune responses to Plasmodium falciparum disrupt the blood-brain barrier
              </a>
            </td>
          <td>
            Alina Batzilla, Pia Dernick, Jon Bezney, A. Gschwind, Fumio Nakaki, Mireia Altadill, Hannah Fleckenstein, Livia Piatti, Silvia Sanz Sender, Manuel Fiegl, O. Oyerinde, Borja Lopez Gutierrez, M. López-Botet, James Sharpe, Lars M. Steinmetz, G. Moncunill, Maria Bernabeu
          </td>
          <td>2025-10-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Abstract Background Intracerebral haemorrhage (ICH) progresses rapidly with complex pathology and limited treatment options, making it a severe subtype of stroke. The extravasation of blood into the brain parenchyma triggers a cascade of inflammatory responses, contributing to secondary injury. Single‐nucleus RNA sequencing (snRNA‐seq) data have enabled more profound insights into the cellular heterogeneity and dynamic interactions within the haemorrhagic brain. Immune cells play a crucial role in shaping neuroinflammation. However, the lack of comprehensive longitudinal studies limits our understanding of the temporal evolution of these inflammatory processes, posing a challenge to the development of targeted therapeutic strategies. Methods We used snRNA‐seq in collagenase‐induced ICH mouse models at Days 1, 3, 7, 14 and 28 post‐injury, alongside naive controls, to profile the dynamics of gene expression over time. Results We obtained 281 577 high‐quality transcriptional profiles representing 21 distinct cell types. Co‐expression network analysis revealed a prominent ‘inflammation module’ that remained active throughout ICH. Integrative single‐cell transcriptomic and immunofluorescence staining suggested that the various Mif‐expressing cells may contribute to local inflammation, potentially engaging macrophages via receptor–ligand pairs such as Cd44 and Cd74. Over time, microglia appeared to serve as key recipients of pro‐inflammatory signals increasingly. During the resolution phase, oligodendrocytes exhibited transcriptional signatures consistent with enhanced maturation and remyelination, which T cell‐mediated interactions may have facilitated. Conclusions These findings offer a systems‐level perspective on cell‐type–specific responses and immune‐mediated interactions during ICH progression and resolution. Key points Establish intracerebral haemorrhage (ICH) mouse models at various time points (Days 1, 3, 7, 14, 28) and construct a high‐quality single‐nucleus RNA sequencing (snRNA‐seq) atlas. Computational analyses suggest that macrophage recruitment in the early stage of ICH potentially involves migration inhibitory factor (MIF) signalling pathways. T cells may interact with myelin‐forming oligodendrocytes during the resolution phase, potentially contributing to remyelination after ICH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/93fbc9517918c734a8d8739f3255c47b54244947" target='_blank'>
              Single‐nucleus transcriptomic profiling reveals temporal dynamics of neuroinflammation and myelin repair after intracerebral haemorrhage
              </a>
            </td>
          <td>
            Zhan Chen, Qinglin Wang, Rong Xiang, Ruoqi Ding, Jin Tao, Qinfeng Peng, Shao-Long Wang, Nannan Cheng, Mengke Zhao, Jiaxin Li, Qidi Xue, Chuanyu Liu, Xuemei Chen, Longqi Liu, Junmin Wang, Jian Wang, Mingyue Wang
          </td>
          <td>2025-09-28</td>
          <td>Clinical and Translational Medicine</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Guillain-Barré syndrome (GBS) is an autoimmune disorder that causes weakness, sensory loss, autonomic dysfunction, and chronic neuropathic pain. The mediators responsible for driving early autoimmune injury in the most common GBS variant, acute inflammatory demyelinating polyradiculoneuropathy (AIDP), remain incompletely understood. We performed bulk and single-cell RNA sequencing on peripheral blood mononuclear cells collected from early untreated AIDP-variant GBS patients and healthy controls to comprehensively deduce leukocyte transcriptome alterations and predict disease-driving interactions between pathogenic leukocytes and peripheral nervous system cells. Bulk transcriptomics showed interferon- and JAK/STAT-driven proinflammatory signatures in myeloid cells. CD8+ T-cells were highly proliferative and expressed axon guidance genes. Single-cell transcriptomics revealed dysregulation of CD4+FOXP3+ regulatory and CD4+ effector memory T-cells indicative of poorly controlled type 1 and type 17 immune responses. Highly activated intermediate monocytes upregulated genes related to angiogenesis and oncostatin M. Interactome analysis between GBS leukocytes, Schwann cells, and sensory neurons predicted increased engagement of ligand-receptor pairs with nerve integrity and pain functions, including epiregulin, interferon-beta, adrenomedullin, clusterin, IL-6, IL-15, and CCL4. Functional validation demonstrated that CCL4 sensitizes human sensory neurons in vitro. These results unearth molecular interactions by which specific leukocyte populations in AIDP-variant GBS may induce peripheral nerve injury and drive neuropathic pain.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f32750fba6dd394e7dec1bcd5d3da578effc6cef" target='_blank'>
              Peripheral nerve-targeting and pain-promoting transcriptomic signatures in early Guillain-Barré syndrome
              </a>
            </td>
          <td>
            Jayden A O'Brien, Joseph B. Lesnak, Ishwarya Sankaranarayanan, A. Arendt-Tranholm, Nikhil Inturi, Spoorthi Sadasivuni, Hemanth Mydugolam, Katelyn E. Sadler, Theodore J. Price, E. Ubogu
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2d51f8ffabe038649dc0dfff6cbb98cd892aa0a7" target='_blank'>
              Sphingosine kinase 2 suppresses neutrophil responses to promote viral persistence while attenuating immune pathology
              </a>
            </td>
          <td>
            Vijayamahantesh Vijayamahantesh, Ying He, Lei Jiang, Hailey Huerter, Kwang Il Jung, Savannah McKenna, Caleb J. Studstill, Lee-Ann H. Allen, Ravi Nistala, Dong Xu, B. Hahm
          </td>
          <td>2025-09-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ec883431c99591b4cd41d48f53e730f5880a5601" target='_blank'>
              MIF-induced CD74+ microglia/macrophages are clinically relevant disease-associated subpopulations in brain metastasis and other CNS disorders
              </a>
            </td>
          <td>
            Laura Alvaro-Espinosa, Ángel Márquez-Galera, N. Priego, Virginia García-Calvo, M. Perea-García, C. Hernandez-Oliver, Diana Retana, Oliva Sanchez, Ana de Pablos-Aragoneses, P. García-Gómez, Osvaldo Graña-Castro, Óscar Lapuente-Santana, Fátima Al-Shahrour, Ana Cayuela, Isabel Peset, D. Megías, Mihaela Ola, D. Varešlija, Leonie Young, Yolanda Martí-Mateos, J. A. Enríquez, Elena Hernández-Encinas, C. Blanco-Aparicio, Marisol Soengas, J. Bernhagen, A. Antón-Fernández, Jesús Ávila, Miguel A Marchena, Maximiliano Torres, Fernando de Castro, Mar Márquez-Ropero, Amanda Sierra, J. López-Atalaya, M. Valiente
          </td>
          <td>2025-09-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="SARS-CoV-2 variants have demonstrated distinct epidemiological patterns and clinical presentations throughout the COVID-19 pandemic. Understanding variant-specific differences at the respiratory epithelium is crucial for understanding their pathogenesis. Here, we utilized human nasal organoid air–liquid interface (HNO-ALI) cell cultures to compare the viral replication kinetics, innate immune response, and epithelial damage of six different strains of SARS-CoV-2 (B.1.2, WA, Alpha, Beta, Delta, and Omicron). All variants replicated efficiently in HNO-ALIs, but with distinct replication kinetic patterns. The Delta variant exhibited delayed replication kinetics, achieving a steady state at 6 days post-infection compared to 3 days for other variants. Cytokine analysis revealed robust pro-inflammatory and chemoattractant responses (IL-6, IL-8, IP-10, CXCL9, and CXCL11) in WA1, Alpha, Beta, and Omicron infections, while Delta significantly dampened the innate immune response, with no significant induction of IL-6, IP-10, CXCL9, or CXCL11. Immunofluorescence and H&E analysis showed that all variants caused significant ciliary damage, though WA1 and Delta demonstrated less destruction at early time points (3 days post-infection). Together, these data show that, in our HNO-ALI model, the Delta variant employs a distinct “stealth” strategy characterized by delayed replication kinetics and epithelial cell innate immune evasion when compared to other variants of SARS-CoV-2, potentially explaining a mechanism that the Delta variant can use for its enhanced transmissibility and virulence observed clinically. Our findings demonstrate that variant-specific differences at the respiratory epithelium could explain some of the distinct clinical presentations and highlight the utility of the HNO-ALI system for the rapid assessment of emerging variants.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2a66e6213ba7653ae3a1d826608bc43258345cb7" target='_blank'>
              Strain-Specific Variability in Viral Kinetics, Cytokine Response, and Cellular Damage in Air–Liquid Cultures of Human Nasal Organoids After Infection with SARS-CoV-2
              </a>
            </td>
          <td>
            G. Aloisio, Trevor McBride, Letisha Aideyan, Emily M. Schultz, Ashley M. Murray, Anubama Rajan, Erin G Nicholson, D. Henke, Laura Ferlic-Stark, Amal Kambal, Hannah L. Johnson, Elina A. Mosa, F. Stossi, S. Blutt, Pedro A. Piedra, V. Avadhanula
          </td>
          <td>2025-10-06</td>
          <td>Viruses</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d5f10f87444a0f37cbb7e1a59b90a9d489996af9" target='_blank'>
              Activation of transposable elements is linked to a region- and cell-type-specific interferon response in Parkinson’s disease
              </a>
            </td>
          <td>
            R. Garza, Anita Adami, Arun Thiruvalluvan, Sasvi S Wijesinghe, Annabel J. Curle, Oliver H. Tam, Talitha Forcier, Danai A Lagka, Nina-Lydia Kazakou, Diahann A. M. Atacho, Yogita Sharma, M. Jönsson, V. Horváth, Sara Bermudez, Jenny G. Johansson, Daniel B. Rainbow, Laura Castilla-Vallmanya, Joanne L. Jones, Annelies Quaegebeur, M. Hammell, A. Kirkeby, Roger A. Barker, Johan Jakobsson
          </td>
          <td>2025-09-07</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/30aa8b2f312de5ab72260d6f2d42db13d4d73388" target='_blank'>
              Immunoregulatory effect of metformin in monocytes exposed to SARS-CoV-2 spike protein subunit 1
              </a>
            </td>
          <td>
            R. M. Maurmann, K. Davis, Negin Mosalmanzadeh, Brenda Landvoigt Schmitt, B. Pence
          </td>
          <td>2025-09-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="
 Tuberculosis (TB) remains a global public health challenge, with the current BCG vaccine providing limited efficacy in adults, and available treatments being lengthy and debilitating. To overcome these challenges, we have previously developed a recombinant BCG strain expressing the detoxified
 E. coli
 Heat-Labile Toxin (LTAK63), providing increased protection in mouse models and reduced lung pathology. Here, using systems biology and RNA sequencing of lung tissues in a murine model, we uncover the molecular mechanisms underlying rBCG-LTAK63’s increased protection. Immunization triggered early activation of cAMP-related pathways, leading to hypoxia, autophagy, and circadian rhythm gene regulation. These processes were associated with an enhanced innate immunity and promoted long-lasting Th1/Th17 adaptive responses. Upon challenge, mice immunized with rBCG-LTAK63 exhibited an earlier onset of interferon-gamma response, reduced bacterial burden, and improved lung histopathology. Notably, circadian rhythm regulation was directly linked to a controlled inflammatory response and reduced migration of infection-susceptible cells, resulting in decreased immunopathology. Our findings demonstrate that rBCG-LTAK63 orchestrates protection through the integration of metabolic and temporal immune pathways. This work provides mechanistic insights into how rational vaccine design can reprogram host immunity to enhance protection and reduce pathology, supporting rBCG-LTAK63 as a promising next-generation TB vaccine candidate.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a2a1c920c02189ea2ce616d05d66a9ab9edfc010" target='_blank'>
              rBCG-LTAK63 enhances protection against tuberculosis by inducing autophagy and circadian gene regulation
              </a>
            </td>
          <td>
            Lázaro M Marques-Neto, M. Trentini, , S. F. Eto, , , M. S. Amaral, , , A. Chudzinski-Tavassi, A. I. Kanno, A. Tagliabue, Diana Boraschi, Sergio Verjovski-Almeida, , L. P. Farias, Pablo I. P. Ramos, Luciana C. C. Leite
          </td>
          <td>2025-10-24</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="ABSTRACT Extracellular vesicles (EVs) are released from all cells of the body. They are considered to mirror the state of the cells from which they are released and circulate in the blood, suggesting a possible use of EV analysis for diagnostic purposes. Here, we report that the analysis of single EVs by flow cytometry can detect infection of cells with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by identifying expression of the SARS-CoV-2 spike (S) protein on the surface of EVs and the cellular origin of EVs by detecting cell-type-specific markers such as troponin (cTNT1) for cardiomyocytes. In coronavirus-associated disease 19 (COVID-19) patients, we detected a direct correlation of the frequencies of circulating S-expressing EVs, but not of cTNT/S-co-expressing EVs, with the subsequent development of a severe disease course. Detection of circulating S-expressing EVs indicates widespread SARS-CoV-2 infection in the body, which may contribute to the immune pathogenesis that triggers tissue and organ damage in COVID-19. Our findings suggest that detecting circulating viral antigen-expressing EVs may provide crucial predictive information on infection-associated disease courses in situations of a future viral pandemic. IMPORTANCE The ability to predict which patients infected with the SARS-CoV-2 virus will develop severe disease remains a significant clinical challenge. The present study demonstrates that EVs in the peripheral blood, carrying the SARS-CoV-2 spike protein, can be detected by flow cytometry and serve as early biomarkers of disease progression. In contradistinction to PCR or serology, this method provides insight into systemic viral spread and potential organ involvement. The early identification of spike-positive EVs at the time of hospital admission has the potential to facilitate the timely identification of high-risk patients, thereby enhancing the efficacy of triage and subsequent care. This approach may also be of value in terms of facilitating a more rapid and precise response to future virus pandemics. The ability to predict which patients infected with the SARS-CoV-2 virus will develop severe disease remains a significant clinical challenge. The present study demonstrates that EVs in the peripheral blood, carrying the SARS-CoV-2 spike protein, can be detected by flow cytometry and serve as early biomarkers of disease progression. In contradistinction to PCR or serology, this method provides insight into systemic viral spread and potential organ involvement. The early identification of spike-positive EVs at the time of hospital admission has the potential to facilitate the timely identification of high-risk patients, thereby enhancing the efficacy of triage and subsequent care. This approach may also be of value in terms of facilitating a more rapid and precise response to future virus pandemics.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2d3bf4cbba6828542814999291764b0f493b9010" target='_blank'>
              Prediction of COVID-19 disease progression by multiparametric analysis of circulating extracellular vesicles with flow cytometry
              </a>
            </td>
          <td>
            Evelyn Hammer, Charlotte Flynn, Johannes Rößler, Johanna Erder, Rudolf Napieralski, Lisa Fricke, Birgit Campbell, M. Feuerherd, Felix Esslinger, Albrecht von Brunn, Timm Weber, Siobhan King, Sisareuth Tan, Alain R Brisson, Ulrike Protzer, Gabriele Schricker, Kathrin Gärtner, Gregor Ebert, Allessandra Moretti, Florian Klein, Kèvin Knoops, Ron Heeren, Wolfgang Hammerschmidt, Reinhard Zeidler, Olaf Wilhelm, Percy A. Knolle, B. Höchst
          </td>
          <td>2025-09-23</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Zika virus (ZIKV) is a mosquito-borne orthoflavivirus of global concern due to its ability to cause congenital neurological defects in infants. Natural killer (NK) cells are innate lymphocytes that can directly kill virus-infected cells. It is thought that NK cells are protective against ZIKV, although the mechanisms by which NK cells detect and respond to ZIKV are not well understood. Here, we evaluated NK cell receptor expression on isolated NK cells from a Panamanian cohort of ZIKV-infected participants, and corresponding NK receptor ligand expression on participant PBMCs and ZIKV-infected cells in vitro using mass cytometry. We found that during acute ZIKV infection, NK cells express high levels of activation markers, proliferative markers, and cytotoxic effector proteins, indicating that NK cells are mounting a response to ZIKV. Interestingly, many markers elevated during acute infection remain elevated post-acute infection, suggesting ZIKV infection may have potential long-term effects on NK cell function. Analysis of NK receptor ligand expression on ZIKV-infected participant PBMCs and ZIKV-infected cells in vitro did not identify a cellular source of NK cell activation, suggesting that either soluble or tissue-specific factors are responsible for modulating NK cell activity during ZIKV infection. Comparison of the NK cell receptor expression with a previously characterized cohort of dengue-infected participants revealed both common and virus-specific changes in NK cell phenotype during acute infection. This work improves our understanding of the NK cell response to orthoflavivirus infection, which will aid in the development of vaccines and therapeutics.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0f2462c567178bcf5b22a0a48aa2a04f8f20430d" target='_blank'>
              Zika virus induces persistent phenotypic changes in natural killer cells distinct from dengue virus infection
              </a>
            </td>
          <td>
            Trisha R Barnard, Noah G. Cruz, Michelle Nguyen, Davis Beltrán, Kassandra Pinedo, Soneida DeLine-Caballero, Uma M. Mangalanathan, Dimelza Araúz, Adriana Weeden, José A. Suarez, S. López-Vergès, Catherine A Blish
          </td>
          <td>2025-09-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b1d0d64915e039a05df492a9420be5b6930184b1" target='_blank'>
              Early cell autonomous and niche-mediated alveolar epithelial response to influenza infection in primary lung organoids
              </a>
            </td>
          <td>
            Amber Elitz, Sharlene Fernandes, K. Cook, H. Warheit-Niemi, Barbara Zhao, Andrea Toth, Amanda L. Zacharias, William J. Zacharias
          </td>
          <td>2025-10-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="COVID-19 causes a wide range of complications in the central nervous system, including encephalitis and other neurological symptoms such as memory problems, psychological disorders, depression, and anxiety. We present comprehensive data on the changes in gene expression levels in astrocytes infected with the Delta or Omicron variants of SARS-CoV-2. In RNA-seq data, we found 346 genes that were significantly evoked (197 up- and 149 down-regulated) in astrocytes challenged with the Omicron variant, compared to 341 evoked genes (215 up- and 126 down-regulated) in the Delta variant. A surprisingly large number of genes were exclusively evoked by Delta (82 up- and 48 downregulated) and Omicron variants (65 up and 60 downregulated). Numerous pathways, including those pertaining to the neuronal system, metabolism, response to viral infection, signal transduction, cytokine signaling, and homeostasis, were dysregulated in infected astrocytes. In this report we have dissected major pathways that are related to pathogen recognition, integrity of the BBB and glia limitans, and neurological disorders that could lead to neurological symptoms listed above. Our findings also reveal dysregulation of a large number of non-coding RNAs. The data presented here may help us better understand the role of astrocytes in the neurological disorders seen in COVID-19 patients. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-025-20851-8.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c339992734ddc6d228d9b0178084b42909087023" target='_blank'>
              Comprehensive mapping of the signaling events evoked by SARS-CoV-2 variants delta and omicron in human astrocytes
              </a>
            </td>
          <td>
            K. Bhide, M. Sláviková, Lea Talpašová, Katarína Kucková, Boris Klempa, Punit Tyagi, Mangesh Bhide
          </td>
          <td>2025-10-22</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2affd9966e7d74eae7ebff40360fcc4663c6bf18" target='_blank'>
              Clonal expansion of cytotoxic CD8âº T cells in lecanemab-associated ARIA
              </a>
            </td>
          <td>
            Lance A. Johnson, Kai Saito, Akhil Pallerla, Jessica L Funnell, Ashley R. Ezzo, Chelsea L. Song, Douglas A Harrison, Noah J. Norton, Lauren C. Moore, L. Eldik, D. Fardo, Greg E. Cooper, Josh M Morganti
          </td>
          <td>2025-09-21</td>
          <td>None</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="Interferon alpha-inducible protein 27 like 2A (Ifi27l2a) was initially identified as an interferon-stimulated gene (Isg) involved in host-dependent mechanisms during viral invasion. We have recently shown that the Ifi27l2a protein also plays a critical role in microglia and the spreading of neuroinflammation. However, the detailed mechanisms of action of intracellular and extracellular Ifi27l2a in glial cells, particularly in inflammatory and neurodegenerative diseases, are not yet defined. We now report that systemic inflammation leads to an elevated level of circulating Ifi27l2a in the plasma of lipopolysaccharide (LPS)-treated mice, which is associated with elevated Il1b mRNA expression in the brain. Elevated IFI27L2 (human isoform) was also found in plasma of human stroke patients. To test whether extracellular (e.g. secreted) Ifi27l2a can contribute as an autocrine or paracrine inducer of microglial activation and inflammation, we treated microglial cells with recombinant Ifi27l2a (rIfi27l2a). Treatment with rIfi27l2a led to increased expression of proinflammatory cytokines and elevated reactive oxygen species (ROS) levels in microglial cells. These effects resulted from alterations in mitochondrial function and a metabolic shift from oxidative phosphorylation toward glycolysis for ATP synthesis. Additionally, Ifi27l2a led to increased caspase-1 activity, demonstrating that Ifi27l2a causes Nlrp3 inflammasome activation. RNA sequencing revealed that Ifi27l2a mediates transcriptional changes reflecting activated microglia. These data support an extracellular role of Ifi27l2a as a novel cytokine, in which it promotes a phenotypic shift in microglia toward a proinflammatory phenotype. Targeting Ifi27l2a may therefore provide an additional strategy to reduce microglia-mediated inflammation in the brain.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd2010c6e0038f96da5055e23679983e49ae84e2" target='_blank'>
              Ifi27l2a acts as a cytokine that promotes a pro-inflammatory phenotype in microglia and enhances neuroinflammation
              </a>
            </td>
          <td>
            Sodam Kim, Haven Burrous, Elisabeth Harmon, Lauren Vance, Ting Wu, Alexander Andersohn, Andrea Doan, Darby Wolocko, Zachary Wise, Yuki Kitamura, Joo Eun Jung, G. Colpo, Lucy Couture, Frank Blixt, Louise McCullough, Sean P. Marrelli, G. Kim
          </td>
          <td>2025-09-24</td>
          <td>Research Square</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="The blood–brain barrier (BBB) is critical for central nervous system homeostasis, yet it is highly vulnerable to viral insults. While acute coronavirus infections are known to impair BBB integrity, the long-term impact of persistent infection on brain endothelial cells remains poorly understood. Using an in vitro BBB model, we examined the effects of a 12-week infection with the neurotropic murine coronavirus MHV-JHM. Structural and functional changes were assessed via fluorescein isothiocyanate (FITC)-dextran permeability assay, confocal imaging of mitochondria, actin cytoskeleton, reactive oxygen species (ROS), scanning electron microscopy (SEM) and RT-qPCR for viral RNA level. Long-term infection induced progressive mitochondrial fragmentation and sustained ROS overproduction. Permeability to 70 kDa dextran increased significantly at 48 h post-infection and exceeded control levels threefold by 168 h. SEM revealed gradual endothelial surface roughening, blebbing, and eventual monolayer collapse with extensive intercellular gaps by week 12. Our study demonstrates that long-term MHV-JHM infection profoundly alters brain endothelial cell structure and function, triggering a cascade of changes that culminate in the disintegration of the BBB model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6ab1a64108138024202350f1901cc8262b24aa07" target='_blank'>
              The Effect of Long-Term Betacoronavirus Infection on the Permeability of the Blood–Brain Barrier—In Vitro Model Studies
              </a>
            </td>
          <td>
            W. D. Krahel, Marcin Chodkowski, M. Bartak, Agnieszka Ostrowska, Michał M Godlewski, Maksymilian Adamczyk, Małgorzata Krzyżowska, Joanna Cymerys
          </td>
          <td>2025-09-24</td>
          <td>Cells</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Background Traumatic spinal cord injury (SCI) is a severe clinical challenge, often leading to long-term sensory, motor, and autonomic dysfunction. The SCI cascade involves a primary physical damage phase, followed by a secondary phase of inflammatory signalling driven by microglia and other infiltrating immune cells. Immunomodulatory therapies may help promote healing and restrict secondary damage. We have previously demonstrated that interleukin (IL)-13 delivery improves functional and histopathological recovery after SCI in murine models, primarily by polarising macrophages towards an alternatively activated pro-reparative M2-like phenotype and reducing axonal contacts. Although microglia respond robustly to IL-13 in vitro, polarisation of microglia in vivo is more difficult. To better understand what conditions may restrict microglial responses to IL-13 in vivo, we sought to examine the effect of cellular context or microenvironment on IL-13 efficacy in forcing microglia polarisation in vitro. Methods BV2 and murine induced pluripotent stem cell (miPSC)-derived microglia were treated with IL-13 alone or in combination with lipopolysaccharide (LPS), acidic media, extracellular matrix components, high glutamate or high potassium concentrations. Following this phenotypic changes including morphology, gene/protein expression (TNFα, IL-1β, iNOS, Arg-1, CD206, F4-80) and cytokine release (TNFα) were measured using high-content screening, RT-qPCR, immunohistochemistry, and ELISA. Results IL-13 leads to increased expression of the anti-inflammatory marker Arg-1 while lowering expression and secretion of the pro-inflammatory markers IL-1β, iNOS, and TNFα, and expression of the microglia activation marker F4-80, signifying effective polarisation of microglia. Concomitant administration of LPS with IL-13 reduces IL-13 polarisation efficacy in microglia. Forced polarisation of microglia is also compromised by high glutamate tone, acidosis, hyperkalemia, and extracellular fibronectin, suggesting microenvironmental contexts seen in neurotrauma directly act on microglia to limit polarisation potential. Conclusions Our study demonstrates that the post-SCI environment dampens IL-13 efficacy on microglia. Taken together these data caution against simple immunomodulatory strategies and suggest that effective polarisation of microglia in vivo will require multimodal approaches.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e5c9d5c1c52800333c93ab18452901901064a33b" target='_blank'>
              Forced polarisation of microglia by IL-13 is modified by inflammatory and microenvironmental context
              </a>
            </td>
          <td>
            E. D. Aiyegbusi, James P. Reynolds, Ross O'Carroll, Ruth Colbert, Christopher Carew, D. Dooley
          </td>
          <td>2025-09-16</td>
          <td>Inflammation Research</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b7db095a53d3537670668dae17c6ccb821695327" target='_blank'>
              Dissecting the epigenome dynamics in human immune cells upon viral and chemical exposure by multimodal single-cell profiling
              </a>
            </td>
          <td>
            Irem B Gündüz, Bei Wei, Derek C Chen, Wenliang Wang, Manoj Hariharan, Todd Norell, Timothy J. Broderick, M. T. McClain, Lisa L. Satterwhite, Thomas W. Burke, Elizabeth A. Petzold, Xiling Shen, Christopher W. Woods, Vance G. Fowler, F. Ruffin, Parinya Panuwet, Dana B. Barr, Aaron J. Wilk, Madeline J. Lee, Catherine Blish, Flora Castellino, Anna Maria Walley, Thomas G Evans, Joseph R Ecker, Fabian Müller, W.J. Greenleaf
          </td>
          <td>2025-09-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cb35136a04f424f94b3b76aae60083a4a527e70d" target='_blank'>
              Endothelial cell-intrinsic NOD2 signaling regulates the intestinal immune response through the generation of effector and memory T cells
              </a>
            </td>
          <td>
            B. Tsankov, Madison Denney, Charles Carr, J. S. Ahn, D. Tsang, G. Bayer, L. Baerg, A. Luchak, N. Nathan, T. Mukherjee, Elaine Tam, Bana Samman, J. Gommerman, S. Girardin, Dana P Philpott
          </td>
          <td>2025-09-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="The central nervous system (CNS) represents a uniquely immune-privileged environment, with inflammatory responses involving several resident CNS-specific cell types. While stereotyped cellular and transcriptional responses recur across varied diseases, relevant signaling pathways and regulatory networks are not fully understood. Here, we investigate multi-modal inflammatory gene networks at large scale by developing a high-throughput RNA-seq screening and analysis workflow. As proof-of-concept, we investigate genetically heterogeneous mice from a large-scale chemical mutagenesis screen to identify novel functionally relevant variants in six genes previously linked to human CNS disorders: Nrros, Ctsd, Smpd1, Idua, Nlrp1a, and Inpp5d. We leverage the readily interpretable data from our large-scale study to demarcate distinct inflammatory states arising from each mutation. In all, our work provides a validated analysis framework for identifying discrete gene expression modules that are engaged divergently across disease contexts, which can be used to discover novel regulators of CNS neuroimmune homeostasis. Supplementary Information The online version contains supplementary material available at 10.1186/s12974-025-03556-7.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a51f54829abe0e8b61931cb5f83b202b5c060ee" target='_blank'>
              Modular inflammation network discovery from large-scale phenotypic screening in genetically heterogeneous mouse brains
              </a>
            </td>
          <td>
            Monica Xiong, L. Miosge, Carolina Correa-Ospina, Claudia M. Y. Yan, Tiffany Cripps, Stefan Bauernfried, Yuanyuan Wang, Maggie Crow, Lucy X Morris, T. D. Andrews, Andrew Trujillo, Mitchell G. Rezzonico, Yuxin Liang, Qixin Bei, Z. Modrusan, Kimberly L Stark, Tracy J Yuen, Brad A Friedman, Jesse E Hanson, Edward M Bertram, Christopher J Bohlen
          </td>
          <td>2025-09-29</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>95</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/23d1526f5a77ff12eace732146acf8b49367f516" target='_blank'>
              Pigs lacking Natural Killer T cells have altered cellular responses to influenza
              </a>
            </td>
          <td>
            T. Kwon, Weihong Gu, Igor Morozov, Mariano Carossino, Eu-Lim Lyoo, Chester D. McDowell, Yonghai Li, U. Balasuriya, Yi Huang, Kiho Lee, Juergen A. Richt, John P Driver
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Long COVID (LC), also known as post-acute sequelae of COVID-19 infection (PASC), is a heterogeneous and debilitating chronic disease that currently affects 10 to 20 million people in the U.S. and over 420 million people globally. With no approved treatments, the long-term global health and economic impact of chronic LC remains high and growing. LC affects children, adolescents, and healthy adults and is characterized by over 200 diverse symptoms that persist for months to years after the acute COVID-19 infection is resolved. These symptoms target twelve major organ systems, causing dyspnea, vascular damage, cognitive impairments (“brain fog”), physical and mental fatigue, anxiety, and depression. This heterogeneity of LC symptoms, along with the lack of specific biomarkers and diagnostic tests, presents a significant challenge to the development of LC treatments. While several biological abnormalities have emerged as potential drivers of LC, a causative factor in a large subset of patients with LC, involves reservoirs of virus and/or viral RNA (vRNA) that persist months to years in multiple organs driving chronic inflammation, respiratory, muscular, cognitive, and cardiovascular damages, and provide continuous viral antigenic stimuli that overstimulate and exhaust CD4+ and CD8+ T cells. In this review, we (i) shed light on persisting virus and vRNA reservoirs detected, either directly (from biopsy, blood, stool, and autopsy samples) or indirectly through virus-specific B and T cell responses, in patients with LC and their association with the chronic symptomatology of LC; (ii) explore potential mechanisms of inflammation, immune evasion, and immune overstimulation in LC; (iii) review animal models of virus reservoirs in LC; (iv) discuss potential T cell immunotherapeutic strategies to reduce or eliminate persistent virus reservoirs, which would mitigate chronic inflammation and alleviate symptom severity in patients with LC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3796710d45738cf5a8e99e8ba1c550198cbdf88b" target='_blank'>
              Insights into Persistent SARS-CoV-2 Reservoirs in Chronic Long COVID
              </a>
            </td>
          <td>
            Swayam Prakash, Sweta Karan, Yassir Lekbach, D. Tifrea, Cesar J. Figueroa, Jeffrey B. Ulmer, James F. Young, Greg Glenn, Daniel Gil, Trevor M. Jones, Robert R. Redfield, L. BenMohamed
          </td>
          <td>2025-09-27</td>
          <td>Viruses</td>
          <td>0</td>
          <td>50</td>
        </tr>

        <tr id="ABSTRACT A limited number of studies on human subjects with type-A hepatitis have found a positive correlation between activated natural killer (NK) cell frequencies in blood and the severity of liver injury. However, without knowledge of differences in viral burdens, it remains unclear whether NK cells are elevated due to hepatitis A virus (HAV) replication and ongoing associated injury, or if NK cell responses directly cause pathogenesis. To gain insight into how NK cells respond during the early stages of hepatitis A virus infection, we generated mice that are permissive for HAV infection in the liver but are otherwise immunocompetent. HAV readily infected the liver of these hepatocyte-specific type-I interferon receptor knockout mice (Ifnar1ΔHep), resulting in fecal virus shedding, elevated serum alanine aminotransferase levels, and immune cell infiltrates in the liver. Single-cell RNA sequencing analyses of liver leukocytes from infected Ifnar1ΔHep mice revealed a rapid accumulation of activated NK cells in the liver within 2 days. HAV infection and liver inflammation were brief and substantially reduced in magnitude in these mice compared to global Ifnar1-/- knockout mice that failed to induce substantial antiviral NK cell responses. NK cells were the principal source of interferon (IFN)-γ in Ifnar1ΔHep mice. Ifnar1ΔHep mice that were experimentally depleted of NK cells or IFN-γ showed greatly increased viral replication and liver damage. Moreover, IFN-γ alone was sufficient to suppress HAV replication in primary mouse hepatocytes. Collectively, these findings establish a critical role for type-I IFN induction of NK cells, their expression of IFN-γ, and protection against hepatitis A. IMPORTANCE Hepatitis A virus remains a leading cause of foodborne illness among unvaccinated individuals. Infection can result in severe liver injury that can progress to fatal fulminant viral hepatitis. Despite its clinical significance, the molecular, genetic, and cellular factors influencing infection severity remain poorly understood. Previous studies of patient blood have suggested that natural killer (NK) cells cause liver injury during infection. In this study, we used mouse models of infection to characterize early cellular defenses to infection and identified a critical role for NK cells and interferon-γ in conferring rapid immune protection rather than pathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a1d931c631c3918d6d10533d13ffd0bbf83e1d0c" target='_blank'>
              Natural killer cells and IFN-γ protect against liver injury during HAV infection in mice
              </a>
            </td>
          <td>
            I. Misumi, You Li, Takayoshi Shirasaki, Lixin Yang, Maryna Kapustina, Stanley M. Lemon, J. Whitmire
          </td>
          <td>2025-09-19</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>50</td>
        </tr>

        <tr id="Long-duration spaceflight imposes significant physiological stress on astronauts, including profound alterations in immune function. This study investigated epigenetic changes in immune cells following prolonged orbital spaceflight by analysing histone modifications in CD4+ and CD8+ T-cells from astronauts before, immediately after, and during recovery from spaceflight. Using Cleavage Under Targets and Tagmentation (Cut&Tag) to assess H3K27ac modifications, we identified significant alterations in chromatin accessibility, predominantly involving immune response pathways, gene regulation, and cellular adaptation mechanisms. While some epigenetic changes were transient, others persisted beyond 50 days post-return, suggesting long-term effects. These findings enhance our understanding of immune adaptation to spaceflight and have implications for mitigating spaceflight-associated health risks. Furthermore, they provide valuable insights into immune system regulation under high-stress conditions, potentially informing research on immunodeficiency disorders, cancer epigenetics, and aging-related immune decline on Earth. This study underscores the critical role of epigenetics in long-term space missions and terrestrial health applications. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-025-17930-1.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/780844a1fbbba164d7db3cc05f2ab99cc5e6866c" target='_blank'>
              Epigenomic profiling of immune cell subtypes reveals H3K27ac-marked stress signatures after long-duration spaceflight
              </a>
            </td>
          <td>
            Tabea L Fullstone, Lukas F J Fischer, Maria Bohmeier, Petra Frings-Meuthen, Brian E. Crucian, Philipp Rathert
          </td>
          <td>2025-09-12</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="

 Acute rejection is a significant cause of impaired graft survival in the early post-transplantation period, and the early-stage immune cell dynamics with local intercellular communication during this process require further elucidation.



 We performed single-cell RNA sequencing (scRNA-seq) on CD45+ immune cells isolated from rat renal allografts during the early phase of acute rejection (days 0, 1, 3, and 7). Using unsupervised clustering, functional enrichment analysis, cellular trajectory inference, and intercellular communication network mapping, we delineated the immune cell dynamics and local communication networks at single-cell resolution. Our findings were subsequently validated through multiplex immunofluorescence and therapeutic intervention experiments.



 Macrophages constituted the dominant immune population during acute rejection. Sub-clustering analysis revealed a rapid expansion of the Isg15+Mac subset by post-transplant day 1, which persisted at elevated levels thereafter. Functional enrichment and trajectory inference demonstrated the pro-inflammatory properties of Isg15+Mac, implicating this subset in acute rejection. Cell-cell communication analysis identified Ccl3-Ccr5 ligand-receptor interactions between Isg15+Mac and T cells. Multiplex immunofluorescence confirmed abundance of Isg15+Mac within the allografts. Moreover, the acute rejection after kidney transplantation was alleviated by the FDA-approved Ccr5 blocker Maraviroc.



 Our study establishes an in-depth, early-stage immune landscape of renal transplantation, revealed that the Isg15+Mac subset activates T cells via the Ccl3–Ccr5 axis and thereby serves as a critical driver of acute rejection. And indicating that Maraviroc may potentially be a therapeutic candidate for transplant rejection.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0e9d767fb56923b15a4ac52a99263c253eebc577" target='_blank'>
              Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic target
              </a>
            </td>
          <td>
            Fanchao Wei, Zhaoxiang Wang, Ruochen Qi, Jingliang Zhang, Shichao Han, Changhong Shi, Tong Lu, Zhite Zhao, Zhengxuan Li, Lang Li, Weijun Qin, Shuaijun Ma, Lijun Yang
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="CD4+ T follicular helper (TFH) cells support tailored B cell responses against multiple classes of pathogens. To reveal how diverse TFH phenotypes are established, we profiled mouse TFH cells in response to viral, helminth and bacterial infection. We identified a core TFH signature that is distinct from CD4+ T follicular regulatory and effector cells and identified pathogen-specific transcriptional modules that shape TFH function. Cytokine-transcriptional TFH programming demonstrated that type I interferon and TGFβ signaling direct individual TFH phenotypes to instruct B cell output. Cytokine-directed TFH transcriptional phenotypes are shared within human germinal centers, but distinct TFH phenotypes dominate between donors and following immune challenge or in antibody-mediated disease. Finally, we identified new cell surface markers that align with distinct TFH phenotypes. Thus, we provide a comprehensive resource of TFH diversity in humans and mice to enable immune monitoring during infection and disease and to inform the development of context-specific vaccines.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a2b3b04af4219bd8ace503d4285d2c597f534c2b" target='_blank'>
              Divergent cytokine and transcriptional signatures control functional T follicular helper cell heterogeneity
              </a>
            </td>
          <td>
            Lennard Dalit, Chin Wee Tan, Amania A Sheikh, R. Munnings, Lauren J. Howson, Carolina Alvarado, Tabinda Hussain, Aidil Zaini, Lucy Cooper, Alana Kirn, Lauren Hailes, Angela Nguyen, Bailey E Williams, Ming Z M Zheng, C. E. van de Sandt, Laura K. Mackay, Katie L. Flanagan, K. Kedzierska, N.L. Harris, J. Juno, C. Zaph, Nicole L La Gruta, Melissa J Davis, S. Nutt, K. Good-Jacobson, Vanessa L. Bryant, J. Groom
          </td>
          <td>2025-09-09</td>
          <td>Nature Immunology</td>
          <td>2</td>
          <td>97</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/65799dca4a24e6fbcd774c66d4741d26a7a006c5" target='_blank'>
              Targeting a macrophage stemness factor to mitigate diseases post respiratory viral infection
              </a>
            </td>
          <td>
            Mohd Arish, A. Chaudhuri, Janli Tang, H. Narasimhan, An Fang, Jinyi Tang, Xiaoqin Wei, Chaofan Li, I. Cheon, Wei Qian, Farha Naz, Gislane Almeida-Santos, Samuel Young, T. Parimon, Y. Shim, Robert Vassallo, Peter Chen, Jie Sun
          </td>
          <td>2025-10-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/929f5e64525cee92d0f3fab0ebf61c85bfdd0623" target='_blank'>
              The spatial landscape of infectious mononucleosis tonsils
              </a>
            </td>
          <td>
            Ciara I Leahy, Matthew Pugh, Aoife Hennessy, Nadezhda Nikulina, Stefan Dojcinov, Gerald Niedobitek, Graham S. Taylor, Paul G Murray, É. Fennell
          </td>
          <td>2025-10-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/251bfd5a2d1d023592577c6a5e0b4f67420d1e06" target='_blank'>
              RIG-I-like receptor-dependent type I Interferon regulates antigen dose and activation in yellow fever vaccine 17D-infected antigen presenting cells
              </a>
            </td>
          <td>
            M. Zaucha, Elena Winheim, Antonio Santos-Peral, Apurva Dhavale, Paul Schwarzlmueller, Frank Dahlstroem, Giulia Spielmann, Magdalena K. Scheck, Linus Rinke, Yiqi Huang, Varvara Arzhakova, Katharina Eisenächer, Hadi Karimzadeh, M. Pritsch, Julia Spanier, U. Kalinke, Julia Thorn-Seshold, G. Barba-Spaeth, S. Rothenfusser, Anne B. Krug
          </td>
          <td>2025-10-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Sindbis virus (SINV) is a mosquito-borne alphavirus capable of causing neurological and immunological symptoms in humans, yet its effects on neural/immune systems remain insufficiently characterized. This study aimed to examine SINV replication, UV-C light inactivation, apoptosis induction, and immune gene modulation in human SH-SY5Y neuroblastoma cells. Following viral adaptation and infectious dose determination, SINV replication and inactivation were assessed using RT-qPCR and dsRNA immunofluorescence. Apoptotic markers (caspase-3, Bax, Bcl-2) were analyzed by immunofluorescence and immune genes expression kinetics (TLR3/7, RIGI, MDA5, IL-1β, IL-6, TNFα, IL-10, IFNβ and β-catenin) were measured at defined time points post-infection by RT-qPCR. SH-SY5Y cells supported productive SINV infection, with viral RNA detectable as early as 3 hpi and marked cytopathic effects by 24 hpi. A custom-built UV-C chamber achieved complete viral inactivation following 3 × 30 s exposures. We observed SINV time-course replication and UV-C inactivation with conspicuous morphological alterations in SH-SY5Y cells. Furthermore, SINV triggered caspase-dependent apoptosis and robust transcriptional upregulation of innate immune genes, peaking between 12–16 hpi and declining by 30 hpi. These findings elucidate the temporal dynamics of SINV replication, cell death mechanisms, and immune activation in a neuronal context, contributing to a better understanding of SINV neuropathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/83e2cc5a51197d9fec1538c92303d5084a961763" target='_blank'>
              Sindbis Virus–Host Interactions in Human Neuroblastoma Cells: Implications for Viral Pathogenesis and Replication
              </a>
            </td>
          <td>
            Kornélia Bodó, Zoltán Kopasz, Viktória Nyári, Krisztina Leiner, Péter Engelmann, Brigitta Zana, R. Hetényi, Dániel Hanna, Krisztián Bányai, M. Madai, Gréta Varga, A. Kuczmog
          </td>
          <td>2025-10-07</td>
          <td>Viruses</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0f99bb18019cd4b39bd05d6d11bec440e5d21593" target='_blank'>
              B cell transcriptomics reveals lasting dysregulation and rapid decline of protective immune memory after chronic hepatitis C cure
              </a>
            </td>
          <td>
            Fang Chen, E. Giang, Padmaja Natarajan, Tony S. Mondala, Steven R. Head, Sing Chau Lau, Aishwarya Sundaresan, Liudmila Kulakova, Xiaohe Lin, Jasneet Aneja, R. Andrabi, Yun Zhang, Richard H. Scheuermann, Eric A. Toth, Thomas R. Fuerst, Lia Lewis-Ximenez, Arthur Y Kim, Paul Pockros, Georg M Lauer, M. Law
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d02c6ef788d3f06d122c2a526528f66cd2e89e08" target='_blank'>
              Pre-Omicron Immunity Generates IgG⁺ but Not IgA⁺ Memory B Cells Reactive to Omicron Spike Protein
              </a>
            </td>
          <td>
            T. Tsoleridis, I. Singh, D. Onion, JG Chappell, A. Kelly, J. Nightingale, AM Valdes, B. Ollivere, Kenneth B. Hoehn, RA Urbanowicz, JK Ball
          </td>
          <td>2025-09-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Microglia and CNS-associated macrophages (CAMs) are the primary targets of human immunodeficiency virus (HIV-1) in humans and simian immunodeficiency virus (SIV) infection in nonhuman primates, contributing to HIV-associated neurocognitive disorders and establishment of a persistent viral reservoir in the central nervous system (CNS). Despite antiretroviral therapy (ART), neurocognitive and other neurological disorders persist in people with HIV (PWH). Opioid users can suffer exacerbated disease progression and neurological complications. However, the impact of ART-treated infection and opioids on brain myeloid cells, the main targets for HIV/SIV in the brain, remains poorly understood. Using an SIV-infected rhesus macaque model and single-cell multi-omic sequencing, we show that ART promotes the restoration of homeostatic microglial states, while morphine exerts immunosuppressive effects on brain myeloid cells. Consistent with this immunosuppression, in morphine-treated, SIV-infected ART-suppressed macaques we found that myeloid cells exhibited reduced antiviral gene expression, including downregulation of MHC class II and interferon-stimulated genes, as well as decreased activity of AP-1 and ETS transcription factors. Furthermore, through the integration of single-cell data from PWH, we found that homeostatic microglial signatures were also evident in ART-treated PWH, although the microglia from PWH exhibited more activated/inflammatory phenotypes than those from the macaque model. These findings reveal distinct effects of ART and morphine on brain myeloid cell dynamics during SIV infection, indicating potential mechanisms underlying worsened neurocognitive outcomes in opioid-using PWH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dbf3e359f11b660c49cf0e6f0056e5add76f6a24" target='_blank'>
              Opioid-induced immunosuppression of brain myeloid cells in SIV-infected rhesus macaques
              </a>
            </td>
          <td>
            Howard S. Fox, Xiaoke Xu, Meng Niu, Benjamin G. Lamberty, Kathleen M. Emanuel, Shannon E. Callen, Shilpa Buch, Arpan Acharya, S. Byrareddy
          </td>
          <td>2025-09-18</td>
          <td>Research Square</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e04af21df289e3bf6b7df85957ae65de21226d43" target='_blank'>
              Transcriptomic Profiling of Bronchial Epithelium Reveals Dysregulated Interferon and Inflammatory Responses to Rhinovirus in Exacerbation-Prone Pediatric Asthma
              </a>
            </td>
          <td>
            N. Jayavelu, Basilin Benson, P.C. Dela Cruz, Weston T. Powell, Lucille M. Rich, Elizabeth R. Vanderwall, C. Gates, Andrew J Nagel, M. White, N. Samanas, Kourtnie Whitfield, T. Hallstrand, Steven F. Ziegler, Matthew C. Altman, J. Debley
          </td>
          <td>2025-10-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>44</td>
        </tr>

        <tr id="Respiratory viral infections are a major cause of morbidity and mortality worldwide. The COVID-19 pandemic has evidenced the need for broad-spectrum antivirals and improved preclinical models that more accurately recapitulate human respiratory disease. These new strategies should also involve the search for drug targets in the infected cell that hamper the development of resistance and of potential efficacy against diverse viruses. Since many viruses reprogram cellular metabolism to support viral replication, we performed a comparative analysis of inhibitors targeting the PI3K/AKT/mTOR pathway, central to virus-induced metabolic adaptations, using MRC5 lung fibroblasts and Huh7 hepatoma cells. HCoV-229E infection in MRC5 cells caused the expected shift in the energy metabolism but the inhibitors had markedly different effects on the metabolic profile and antiviral activity in these two cell lines. Dichloroacetate (DCA), a clinically approved inhibitor of aerobic glycolysis, showed antiviral activity against HCoV-229E in MRC5 cells, but not in Huh7 cells, underscoring that the screening model is more critical than previously assumed. We further tested DCA in polarized human small airway epithelial cells cultured in air–liquid interface, a 3D model that mimics the human respiratory tract. DCA reduced the viral progeny of HCoV-229E, SARS-CoV-2, and respiratory syncytial virus by 2–3 orders of magnitude, even when administered after infection was established. Our work reinforces the need for advanced human preclinical screening models to identify antivirals that target host metabolic pathways frequently hijacked by respiratory viruses, and establishes DCA as a proof-of-concept candidate.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a93cce8e64ee2f98d68ef58672f98497642aac47" target='_blank'>
              Human Small Airway Epithelia Reveal Dichloroacetate as a Broad-Spectrum Antiviral Against Respiratory Viruses
              </a>
            </td>
          <td>
            Paula Martínez de Iturrate, Bruno Hernáez, Patricia de los Santos, Yolanda Sierra-Palomares, Alba García-Gómez, A. Sánchez-Cruz, Catalina Hernández-Sánchez, Luis Rivas, Margarita del Val, Eduardo Rial
          </td>
          <td>2025-10-10</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Background Severe influenza virus infection often triggers acute lung injury, and the efficacy of respiratory functional recovery critically depends on timely alveolar regeneration. However, the cellular dynamics and regulatory mechanisms underlying post-infectious alveolar repair remain incompletely understood. Methods Utilizing Sftpc-CreER; Rosa26-mTmG lineage-tracing model, we determine the main stem cell population responsible for alveolar regeneration following influenza-induced injury. Through integrated single-cell RNA sequencing (scRNA-seq), immunofluorescence, and electron microscopy approaches, we mapped cellular transcriptional landscapes and spatial interactions. Key macrophage-epithelial crosstalk was further investigated via in vitro co-culture systems and in vivo conditional depletion models using diphtheria toxin receptor-transgenic mice. Putative regulatory factors were predicted through ligand-receptor interaction analysis and functionally validated in ex vivo organoid models. Results In this study, we revealed that the severely damaged alveolar barrier after influenza virus infection was rebuilt by the proliferation and differentiation of residual type II alveolar epithelial (AT2) cells in an inflammatory niche. In particular, monocyte-derived macrophage (Mo-Macs) expand, displaying intimate spatial proximity with AT2 cells. In addition, the cellular transcriptional status determined by scRNA-seq revealed that Mo-Macs regulate epithelial cell proliferation. Mo-Macs promoted the formation of AT2 spheres in vitro. Moreover, Mo-Mac depletion resulted in delayed repair of the alveolar epithelial structure in vivo. In addition, the mechanism by which Mo-Macs regulate alveolar epithelial repair involves the secretion of oncostatin M (OSM), which stimulates p-STAT3 activation and promotes AT2 cell proliferation. Conclusions Our findings revealed that residual AT2 cells act as stem cells in the alveolus and are regulated by Mo-Macs through OSM secretion. These findings increase our understanding of the role of inflammatory signals in regulating tissue repair after severe injury, which may provide a potential avenue for therapeutic intervention in recovered patients. Graphical abstract Supplementary Information The online version contains supplementary material available at 10.1186/s12931-025-03359-7.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c77e7cb9a0802132b1fb5c49fb2be2fef756fe89" target='_blank'>
              Monocyte-derived macrophages support alveolar regeneration via oncostatin M post-H1N1 infection during the recovery phase
              </a>
            </td>
          <td>
            Xiaoan Shang, J. Jia, Jiapei Yu, Shumei Zou, Zeyi Wang, Jiuyang Xu, Hui Li, Bin Cao
          </td>
          <td>2025-10-08</td>
          <td>Respiratory Research</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="ABSTRACT Airborne RNA viruses of the Paramyxoviridae family are major human pathogens. These include measles virus (MeV) and Nipah virus (NiV), the latter being on the World Health Organization’s blueprint list due to its high case-fatality rate and critical risk of emergence. Although an effective vaccine is available for MeV, this is not the case for NiV. Moreover, there is no cure for MeV- or NiV-infected patients that prevents the acute respiratory syndrome or lethal encephalitis. To identify new host factors to target for inhibiting viral growth, a library of metabolic modulators was screened for activity against MeV using an in vitro infection model. Results showed that Molidustat, a pharmacological inhibitor of Prolyl-Hydroxylase Domain (PHD) enzymes, inhibits MeV infection in a Hypoxia-Inducible Factor (HIF)-dependent manner. We then tested the antiviral effect of Molidustat in organotypic cultures of hamster cerebellum. Molidustat induced the hypoxia-response pathway in this ex vivo model as assessed by transcriptomic analysis, and inhibited MeV infection. A similar antiviral effect was observed with Roxadustat and Daprodustat, two PHD enzyme inhibitors chemically unrelated to Molidustat. Finally, we showed that Molidustat inhibits NiV infection in organotypic cultures of hamster cerebellum and lung, thereby validating its effect in the two organs mainly targeted during infection. Taken together, our results provide evidence that pharmacological activation of the hypoxia-response pathway restricts MeV and NiV infections, highlighting HIF-inducing drugs as promising candidates to consider in the development of treatments.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b50108fb91308044942c325fe87c938a3eec629c" target='_blank'>
              In Vitro and Ex Vivo evidence that pharmacological induction of the hypoxia response pathway efficiently restricts measles and Nipah virus infections
              </a>
            </td>
          <td>
            Lola Canus, Clémence Jacquemin, Walid El Orch, Eva Ogire, Marion Ferren, Elodie Moissonnier, Alexandre Lalande, Amélie Bourgeais, Garance Ducret, Jules Bouget, Zofia Haftek, Florentine Jacolin, Anne Aublin-Gex, Didier Décimo, Marie Moroso, S. Mély, Aurore Rozières, Mathias Faure, Olivier Diaz, Denis Gerlier, M. Si-Tahar, V. Lotteau, L. Perrin-Cocon, Cyrille Mathieu, P.O. Vidalain
          </td>
          <td>2025-09-17</td>
          <td>Emerging Microbes & Infections</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="ABSTRACT The nucleocapsid (N) protein of SARS‐CoV‐2 is critical for viral replication and genome packaging. However, whether it induces inflammation through endothelial cell and monocyte activation remains controversial. One aspect that has been overlooked is the consideration of residual endotoxins in recombinant proteins when conducting immune response studies. We aimed to assess whether N‐protein induces an inflammatory response in mouse and human microvascular endothelial cells (MEC and HMEC) and THP‐1 cells, independent of endotoxin contamination. MEC, HMEC, and THP‐1 cells were treated with vehicle, lipopolysaccharide (LPS), or recombinant N‐protein in the presence or absence of the LPS‐neutralizing agent polymyxin B. The inflammatory response was assessed through quantification of mRNA and protein levels of inflammatory markers and monocyte adhesion to endothelial cells. In MEC, treatment with N‐protein resulted in at least a 15‐fold increase in inflammatory marker levels. Similarly, in THP‐1 cells, N‐protein caused a significant increase in mRNA inflammatory marker levels, which were brought back to control levels with polymyxin B. LPS or N‐protein alone resulted in a tripling of monocyte adhesion to MEC, and this was reduced to control levels with polymyxin B. In addition, in HMEC, endotoxin‐depleted N‐protein did not cause a significant increase in inflammatory marker levels. In conclusion, our data show that N‐protein does not induce inflammation in endothelial cells or monocytes. Some of its observed inflammatory effects may be due to endotoxin contamination, suggesting that it does not directly induce inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/092d82591b24f35578b8fb78c9b6f81f7b0f0b51" target='_blank'>
              SARS‐CoV‐2 Nucleocapsid Protein Does Not Induce Inflammation in Endothelial Cells or Monocytes
              </a>
            </td>
          <td>
            Mehreen Tufail, Xiangru Lu, Stephen D Barr, Nica M. Borradaile, Qingping Feng
          </td>
          <td>2025-10-22</td>
          <td>The FASEB Journal</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="ABSTRACT Severe COVID‐19 is an immunological disorder characterized by a hyper‐inflammatory reaction of the immune system. SARS‐CoV‐2 anti‐spike antibodies of the IgG isotype are known to strongly contribute to this hyperinflammation by overactivation of alveolar macrophages. However, while the pathogenic function of IgG has been extensively studied, very little is known about the function of IgA, the most abundant immunoglobulin isotype in the airways. Although IgA is generally considered noninflammatory, in this study, we show that anti‐spike IgA induces pronounced proinflammatory responses. We demonstrate that stimulation of macrophages with anti‐spike IgA immune complexes in combination with a viral stimulus amplifies proinflammatory cytokine production. This IgA‐induced inflammation is particularly driven by IgA2, the IgA subclass that is increased in the plasma of severely ill COVID‐19 patients. We identified that IgA2‐induced inflammation is predominantly dependent on FcαRI‐Syk signaling. Mechanistically, IgA2‐induced inflammation is linked to enhanced glycolysis and altered mitochondrial function, indicating subclass‐specific immunometabolic reprogramming. Taken together, these data indicate a pathogenic role for IgA2 in severe COVID‐19 and highlight its signaling cascades and metabolic pathways as potential druggable targets to counteract hyperinflammation in severe coronavirus infections, such as COVID‐19, SARS, MERS, and potential future outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/108f6fbe490f0df81a3f8e4a427171366e4fce33" target='_blank'>
              Anti‐SARS‐CoV‐2 Spike IgA2 Induces Inflammation by Human Macrophages
              </a>
            </td>
          <td>
            Lynn Mes, Jennifer Veth, Julie Van Coillie, J. Keijser, Elise Mantel, R. van der Mast, Theo Rispens, G. Vidarsson, M. van Egmond, J. den Dunnen, Hung-Jen Chen
          </td>
          <td>2025-10-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>53</td>
        </tr>

        <tr id="Introduction Sepsis is a life-threatening condition characterized by immune dysregulation, yet the mechanisms underlying T cell dysfunction remain poorly understood. Methods We integrated multi-omics data from public GEO datasets and prospective cohorts. Single-cell transcriptomic analysis was applied to identify core genes, followed by diagnostic and prognostic validation. Cell–cell interaction networks were constructed to investigate signaling alterations, and cross-platform validation was conducted. Results Seven core genes (LTB, CD3D, TRAF3IP3, CD3G, GZMM, HLA-DPB1, CD3E) were identified, showing strong diagnostic value (AUC ≥ 0.86) and prognostic significance (HR=4.50 for CD3E). Network analysis revealed collapse of critical signaling axes (HLA-DRA-MHCII, ITGB2-CD226) and aberrant activation of inhibitory pathways (LGALS9-CD45), leading to a “co-stimulation inhibition–checkpoint activation” imbalance. Cross-platform validation confirmed conserved downregulation of these genes in sepsis, which contributed to immune exhaustion via disrupted T cell differentiation trajectories and impaired intercellular communication. Conclusion Our findings highlight novel biomarkers and potential therapeutic targets for sepsis immunotherapy by systematically deciphering core gene networks and immune interaction collapse in T cell dysfunction.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4507e6cde0317e8b062b7f1ee229b5df2a8fe7bf" target='_blank'>
              Single-Cell Multi-Omics Deciphers Core Gene Networks and Immune Interaction Collapse in Sepsis-Associated T Cell Dysfunction
              </a>
            </td>
          <td>
            Xiang Li, Zhibin Chen, Yandong Yao, Muhu Chen, Ying Hu
          </td>
          <td>2025-09-13</td>
          <td>Infection and Drug Resistance</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fdbae78251ccd4fa8f2487fe48e2a546a3022eef" target='_blank'>
              Antiviral and Anti-inflammatory Effects of Cannabidiol in HIV/SIV Infection
              </a>
            </td>
          <td>
            AL Ellison, J. Rosado-Franco, L. Mamun, S. Knerler, M. Daniali, K. Mehta, S. Williams-McLeod, J. Alvarez, SS Joyner, R. Vandrey, Elise M. Weerts, Peter J. Gaskill, MJ Corley, LC Ndhlovu, DW Williams
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="The mechanisms by which SARS-CoV-2 infection lead to neuroinflammation and cognitive impairment in COVID-19 and Long COVID are unclear. Cerebrovascular Wnt/β-catenin pathway activity is suppressed in association with neuroinflammation and cognitive impairment in a mouse model of COVID-19. In this study, we asked whether SARS-CoV-2 (NY Iota strain) infection of astrocytes would result in cell-autonomous changes in Wnt/β-catenin pathway components. We report that induced pluripotent stem cell (hiPSC)-derived human astrocytes (iAs) are susceptible to sustained infection with SARS-CoV-2 in vitro. Real-time PCR revealed that SARS-CoV-2 infection of iAs decreased transcripts for Wnt3a, Wnt10b, and the downstream pathway effectors β-catenin and TCF3. Wnt7b was increased, as was the proinflammatory chemokine CXCL10. No changes were noted in Wnt3, Wnt7a, TCF1, TCF4, or LEF1. These data indicate that SARS-CoV-2 infection differentially influences Wnt/β-catenin pathway components in astrocytes. These data could have implications for the mechanistic basis of COVID-19 and Long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2df9142f8c924fe780ce7108a7ee825da25ea8a8" target='_blank'>
              SARS-CoV-2 Infection Influences Wnt/β-Catenin Pathway Components in Astrocytes
              </a>
            </td>
          <td>
            KaReisha F. Robinson, Avantika I. Ahiya, Justin M. Richner, Sarah E. Lutz
          </td>
          <td>2025-10-02</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/13b5c00dbed3ab3d029b169faa417a52dd2a967c" target='_blank'>
              STING activates ZBP1-mediated PANoptosis to defend against HSV-1 retinal infection.
              </a>
            </td>
          <td>
            Wei Liu, Haifeng Cui, Li Wang, Xiangyu Ge, Xingfei Zhu, Xingmiao Liang, Ziqing Chen, Yuwen Gan, , Xuebin Hu, Xiaohu Ding, Zhengjie Xu, Xiaoling Liang, Lili Gong
          </td>
          <td>2025-10-27</td>
          <td>Journal of neuroinflammation</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c3bc942541c2b74961a12f103de05cc6065fe633" target='_blank'>
              An NLRP3 Variant Protects Against Severe COVID-19: An Unexpected Contribution of Inflammasome Genetics in SARS-CoV-2 Infection.
              </a>
            </td>
          <td>
            L. M. Paulino, V. N. C. Leal, W. M. D. S. Santiago, Débora de Fátima Almeida Donanzam, Célio Roberto Siqueira Ledesma, Maria Fernanda Silva Bertelli, W. S. Fava, A. Latini, Alessandra Pontillo, James Venturini
          </td>
          <td>2025-10-27</td>
          <td>International journal of immunogenetics</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Intoduction T lymphocytes, along with cytokines and chemokines-dependent pathways are primarily responsible for regulating the immune response, controlling inflammation and eliminating viral infections. However, excessive immune activity can lead to pathological effects such as cytokine storm, which may cause severe respiratory distress syndrome and multi-organ damage in COVID-19. The aim of this study was to identify potential biomarkers of SARS-CoV-2 infection that could predict the severity of COVID-19 progression. Methods The cohort in this study included 52 hospitalized adult patients with SARS-CoV-2 infection from Warsaw, Poland admitted to the hospital during COVID-19 pandemic (February to November 2021). Based on clinical symptoms, patients were divided into two groups: (i) mild/moderate symptoms (non-severe) – 44 patients and (ii) severe respiratory failure (severe) – 8 patients. The control group consisted of 26 individuals without COVID-19. All COVID-19 patients and healthy controls underwent immunophenotyping of peripheral blood to assess the abundance of T lymphocytes and regulatory T lymphocytes, as well as measurement of selected cytokine and chemokine concentrations in corresponding serum samples. Data analysis was performed using CytoFLEX Flow Cytometer. Results and discussion Decreased percentages of total lymphocytes and T lymphocytes in peripheral blood were observed across all COVID-19 patients, with varying degrees between the non-severe and severe groups. A significant reduction was also noted in double-positive lymphocytes (CD4+CD8+), regulatory T lymphocytes ( CD4+ CD25HiCD127Lo and CD4+CD25HiCD127LoFoxP3+), as well as CD4+CD25+/-, CD4+CD45RA+/-, and CD8+CD45RA+/- subsets. Elevated levels of IL-6, IL-10, IL-17A, IFN-g, CCL2, CXCL8, and CXCL10 were observed in the non-severe and/or severe groups compared to healthy controls. Most importantly, only CXCL10 was significantly elevated in the severe group at admission compared to the non-severe group. In this study, we identified the chemokine CXCL10 as a crucial marker for distinguishing the severe course of COVID-19 from non-severe form at the time of admission. It may serve as an early indicator of diseases progression during hospitalization, potentially allowing prediction of the disease course. Moreover, elevated CXCL10 levels, in combination with decreased total lymphocytes counts and increased levels of IL-6, IL10, IFNg, CCL2 and CXCL9, may represent a more comprehensive biomarker panel suitable for predicting the severity of COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/befe135670515a1bc53405d52fd1e7cbd7111080" target='_blank'>
              Identification of blood immunological biomarkers of SARS-CoV-2 infection during pandemic in Poland
              </a>
            </td>
          <td>
            Monika Leśniak, A. Borkowska, Krzysztof Kłos, K. Aleksandrowicz, K. Porębska, Dagmara Kobza, K. Piwowarek, K. Plewka-Barcik, Marcin Niemcewicz, Anna Lutyńska, Jacek Z. Kubiak, Andrzej Chciałowski, R. Zdanowski
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2c5a6c1df254a1348f9af1511a5ed22d77b59bf3" target='_blank'>
              Virologic characteristics of SARS-CoV-2 infection across evolving omicron subvariants.
              </a>
            </td>
          <td>
            J. Boucau, Owen T. Glover, C. Marino, Gregory E. Edelstein, M. Choudhary, Yijia Li, Brooke M. Leeman, Zahra Reynolds, Karry Su, Dessie Tien, Chase B Mandell, E. Passell, Andrew Alexandrescu, Emory Abar, Mamadou Barry, Dibya Ghimire, T. Vyas, J. Vyas, Jacob E. Lemieux, Jonathan Z. Li, M. Siedner, A. Barczak
          </td>
          <td>2025-09-09</td>
          <td>JCI insight</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/61f2942696de914b8ddcd3d63d15f096d71ddb29" target='_blank'>
              Progenitor T cells drive chronic pulmonary type 2 inflammation
              </a>
            </td>
          <td>
            Radomir Kratchmarov, Xiaojiong Jia, Jun Nagai, Hiroaki Hayashi, Kinan Alhallak, Juying Lai, Chunli Feng, Jakob von Moltke, Joshua A. Boyce, Patrick J Brennan
          </td>
          <td>2025-10-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1cac498108b5305e7d2a1dde250a33c8a3e03b2" target='_blank'>
              Acute SARS-CoV-2 infection.
              </a>
            </td>
          <td>
            Amy C. Sherman, Glenda E Gray, Bin Cao, Kelvin K W To, Nadine G Rouphael, A. Henao-Restrepo, Anthony C Gordon, Lindsey Baden
          </td>
          <td>2025-10-24</td>
          <td>Nature reviews. Disease primers</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Severe systemic inflammatory reactions, including sepsis, often lead to shock, organ failure and death, in part through an acute release of cytokines that promote vascular dysfunction. However, little is known about the vascular endothelial signaling pathways regulating the transcriptional profile in failing organs. This work focuses on signaling downstream of IL-6, due to its clinical importance as a biomarker for disease severity and predictor of mortality. Here, we show that loss of endothelial expression of the IL-6 pathway inhibitor, SOCS3, promoted a type I interferon (IFNI)-like gene signature in response to endotoxemia in mouse kidneys and brains. In cultured primary human endothelial cells, IL-6 induced a transient IFNI-like gene expression in a non-canonical, interferon-independent fashion. We further show that STAT3, which we had previously shown to control IL-6-driven endothelial barrier function, was dispensable for this activity. Instead, IL-6 promoted a transient increase in cytosolic mitochondrial DNA and required STAT1, cGAS, STING, and the IRFs 1, 3, and 4. Inhibition of this pathway in endothelial-specific STING knockout mice or global STAT1 knockout mice led to reduced severity of an acute endotoxemic challenge and prevented the endotoxin-induced IFNI-like gene signature. These results suggest that permeability and DNA sensing responses are driven by parallel pathways downstream of this cytokine, provide new insights into the complex response to acute inflammatory responses, and offer the possibility of potential novel therapeutic strategies for independently controlling the intracellular responses to IL-6 in order to tailor the inflammatory response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/65780d592f30c68d4093888b1ed44863f3de2f35" target='_blank'>
              Endothelial STING and STAT1 mediate interferon-independent effects of IL-6 in an endotoxemia-induced model of shock.
              </a>
            </td>
          <td>
            Nina Martino, Erin Sanders, Ramon Bossardi Ramos, Iria Di John Portela, Fatma Awadalla, Shuhan Lu, Dareen Chuy, Neil Poddar, Mei Xing G Zuo, Uma Balasubramanian, Peter A Vincent, Pilar Alcaide, Alejandro P. Adam
          </td>
          <td>2025-09-16</td>
          <td>The Journal of clinical investigation</td>
          <td>1</td>
          <td>8</td>
        </tr>

        <tr id="Bacterial infection is a key trigger of inflammatory pathways that damage the preterm brain, even without direct bacterial brain invasion. However, the mechanisms underlying the involvement of intracranial tissues and cells in early immune responses to acute systemic inflammation in preterm infants remain unknown. Lipopolysaccharide (LPS) was administered with a single intraperitoneal injection into postnatal day (P) 7 mice. Four hours later, the leptomeningeal macrophages initiated an intracranial reaction by producing IL-1β, which set the stage for the arachnoid, pial, and perivascular fibroblasts to act. These brain fibroblasts produced CCL2, which increased the number of brain parenchymal macrophages/microglia and led to their hypertrophy. The macrophages/microglia isolated from the brains of mice with systemic inflammation showed marked transcript expression of genes including Saa3, Irg1, Lcn2, and Cxcl9. The expression level of Saa3 reached its peak 4 and 12 h after LPS administration. Saa3 expression was upregulated in the macrophages in the leptomeninges, perivascular space, and cerebellar medulla, as well as in the fibroblasts of the leptomeninges, choroid plexus stroma, and perivascular space. The leptomeningeal macrophages expressing Saa3 continued their developmental migration from the leptomeninges to the brain parenchyma. The blood-brain barrier of pups remained intact up to 72 h after LPS administration at P7. The expression levels of Irg1, Lcn2, and Cxcl9 peaked 4 and 12 h after LPS administration. The cells that prominently expressed Irg1, Lcn2, and Cxcl9 were the leptomeningeal macrophages, perivascular fibroblasts and choroid plexus epithelial cells, and leptomeningeal fibroblasts, respectively. The early enhancement of Saa3 expression played a key role in priming inflammation initiated by macrophages and fibroblasts. Early enhancement of Irg1 expression was crucial for determining the direction of the inflammatory response. The increase of Lcn2 was vital, sequestering the iron siderophore to limit bacterial growth. It was interesting to observe how the early immune responses to systemic inflammation in the postnatal mouse brain were initiated by migrating macrophages and leptomeningeal fibroblasts, leading to immediate gene upregulation to protect immature brain tissue. Supplementary Information The online version contains supplementary material available at 10.1186/s12974-025-03559-4.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f0b35f26b99383b11b5240dc52d6f9e54408658a" target='_blank'>
              Early immune responses to systemic inflammation in the postnatal mouse brain initiated by migrating macrophages and leptomeningeal fibroblasts
              </a>
            </td>
          <td>
            Rei Settsu, Aki Obara, Takehiko Tarui, S. Hasegawa-Ishii, Atsuyoshi Shimada
          </td>
          <td>2025-10-11</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e819f35bfc49ec2545e41780dc01e007f076a26d" target='_blank'>
              Immune Cell Dysfunction of SARS-CoV-2: Mathematical Modeling of the Within-Host Immune Dynamics
              </a>
            </td>
          <td>
            Pagnapech Ngoun, Nicolas Alvarez, Ayesh Awad, Hwayeon Ryu
          </td>
          <td>2025-10-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6ff39811b58af3141f8b13471490c1f390abe0d9" target='_blank'>
              Non-canonical inflammasome drives intrinsic anti-microbial responses in human Natural Killer cells
              </a>
            </td>
          <td>
            N. G. Leborgne, Jadie Acklam, Alexander J. Hogg, Zarema Albakova, Karen Hogg, K. Robinson, Grant Calder, Arnel Villamin, Callum Robson, Freya Pealing, Matthew A. Care, Monika Gonka, James M. Fox, James Iremonger, J. Hewitson, David G. Kent, Alison M. Layton, Frances E. Pearson, Max E. Noble, W. Grey, Jillian L. Barlow, Dave Boucher
          </td>
          <td>2025-10-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="Introduction Balamuthia mandrillaris infection in humans is rare and usually fatal. It is well established that B. mandrillaris can cause granulomatous amebic encephalitis (GAE). However, little is known about the factors that determine B. mandrillaris pathogenicity and its host-specific interactions. Methods In this study, we conducted a cohort study of five patients with B. mandrillaris GAE and analyzed immune pathway alterations, differentially expressed genes (DEGs), and changes in immune cell composition to delineate the immune response in this rare infectious disease using bulk transcriptome analysis. Notably, we conducted bulk and single-cell transcriptome sequencing on paired cerebrospinal fluid (CSF) and blood samples from a single patient across three distinct stages of infection. Results Analysis of seven CSF specimens revealed a total of 5,177 DEGs as the infection progressed. The most enriched pathway among the upregulated DEGs was the “PI3K-Akt signaling pathway”. Moreover, its upstream pathways, the “Toll-like receptor (TLR) signaling pathway” and “JAK/STAT signaling pathway”, were also upregulated. Among these, TLR2, TLR9, and IFN-I/III-related genes played a crucial role in activating these pathways. The single-cell transcriptome results served to validate these findings. Disscusion Overall, our study aimed to elucidate the pathogenic mechanisms underlying B. mandrillaris GAE, providing novel insights into the associated immune responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d7019a6fdd2a06a1fda2257cd2d7dbf2a6e7bcaa" target='_blank'>
              Bulk and single-cell transcriptome profiling reveals the dynamic immune response in granulomatous amebic encephalitis caused by Balamuthia mandrillaris: a cohort study
              </a>
            </td>
          <td>
            Jingjia Zhang, Xinmiao Jia, Bin Yang, Ying Ge, Wei Jiang, Yang Cong, Huanwen Wu, Huifang Liu, Jingjing Tian, YingChun Xu, Qiwen Yang
          </td>
          <td>2025-10-02</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Herpes simplex virus-1 (HSV-1) is a neurotropic virus that can infect the brain, and an uncontrolled infection can lead to severe encephalitis. NO can exert both antiviral as well as cytotoxic effects in the central nervous system (CNS) depending on its concentration and site of infection. In this study, we report that treatment of an intranasal murine HSV-1 infection with aminoguanidine (AMG) decreases both neuroinflammation and neurodegeneration markers, but its positive effect depends on the time of treatment. Specifically, early treatment with AMG impaired the activation of microglia/monocytes, leading to decreased virus-specific antiviral response and higher viral titers in the brain. However, AMG treatment during the peak of brain infection significantly improved antiviral response, reduced inflammation and improved general clinical score. We also found that treatment with AMG decreased beta amyloid levels during both primary and latent infections and protected from the accumulation of phosphorylated Tau protein during early infection. Our findings position inducible nitric oxide synthetase (iNOS) as a potential therapeutic target for mitigating virus-induced neuroinflammation and neurodegeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/58ab87cc99cc57e7e9c2f48c3edddb58f7cd0ecd" target='_blank'>
              The Role of Nitric Oxide in HSV-1 Infection: The Use of an Inducible Nitric Synthase Inhibitor Aminoguanidine to Treat Neuroinflammation
              </a>
            </td>
          <td>
            Magdalena Patrycy, Martyna Janicka, Agnieszka Kauc, Aleksandra Osińska, Małgorzata Antos-Bielska, Klaudia Bylińska, Oliwia Obuch-Woszczatyńska, Paweł Szymański, Marcin Chodkowski, Małgorzata Krzyżowska
          </td>
          <td>2025-09-23</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Pregnancy is associated with an increased risk of severe COVID-19. In addition, SARS-CoV-2 infection during gestation has been linked to adverse obstetrical outcomes and placental abnormalities. Nevertheless, the susceptibility of early trophoblast cells to SARS-CoV-2 and the potential consequences of infection on trophoblast function remain unclear. In this study, we assessed the permissiveness of first trimester trophoblast cells to SARS-CoV-2 infection and its impact on trophoblast cells fusion. To address this, we isolated primary cytotrophoblast (CTB) cells from first trimester human placentas and allow their differentiation into STB in vitro. These cells were infected with SARS-CoV-2 variants of concern, including Delta and Omicron (BA.1, BA.2, BA.5). Viral replication was assessed by RT-qPCR and immunofluorescence, while host cell responses, including expression of viral entry receptors and innate immunity genes, were measured by RT-qPCR. Trophoblast fusion was evaluated by staining and calculating the fusion index. In parallel, placental tissues from SARS-CoV-2-infected pregnancies were analyzed by immunohistochemistry to quantify syncytial knots (SK) formation in vivo. Our results demonstrate that both first trimester CTB and STB are permissive to SARS-CoV-2 infection in a variant- and donor-dependent manners, with Delta exhibiting higher replication efficiency compared to Omicron variants. In STB, viral replication did not correlate with the induction of entry receptors or type III interferon responses. However, in CTB, viral replication was significantly associated with enhanced cell fusion. In parallel, an increased number of SK was observed in infected placental areas in vivo compared to non-infected regions from the same placenta and to gestational age-matched controls. Altogether, these in vitro and in vivo results suggest that SARS-CoV-2 infection in early pregnancy may alter STB turnover, potentially contributing to placental dysfunction and adverse pregnancy outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/03d90e0557895d4de3980ce2928385b3fec5bfc2" target='_blank'>
              SARS-CoV-2 delta and omicron variants alter trophoblast cell fusion and syncytiotrophoblast dynamics: new insights into placental vulnerability
              </a>
            </td>
          <td>
            M. Essaidi-Laziosi, Catia Alvarez, Michal Yaron, Pascale Sattonnet-Roche, K. Adea, Mélanie Cornut, Christine Wuillemin, M. Bekliz, Yoann Sarmiento, Chloe Gibson, Laurent Kaiser, A. Rougemont, Isabella Eckerle, Marie-Benoîte Cohen
          </td>
          <td>2025-10-07</td>
          <td>Cell Death & Disease</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="
 The COVID-19 pandemic, caused by SARS-CoV-2, represents one of the most profound global public health challenges in modern history. While T cell immunity is crucial for viral clearance, the dynamics of the T cell receptor (TCR) repertoire during reinfection remain poorly understood. This study sought to characterize the TCR repertoire in peripheral blood T cells from healthy convalescent individuals (HC), patients with primary SARS-CoV-2 infection (PI), and reinfected individuals (RI), aiming to identify distinct TCR signatures linked to susceptibility or protection against reinfection. We enrolled 48 age- and sex-matched participants (18 PI, 18 RI, 12 HC), collecting blood samples during acute infection (PI/RI) or convalescence (HC). Deep TCRα/β sequencing was performed using the SMARTer Human TCR Profiling Kit with unique molecular identifiers (UMIs), followed by analysis of TCR repertoire diversity, clonal expansion, V(D)J gene usage, and CDR3 characteristics. Compared to HC, both PI and RI groups exhibited significantly reduced TCR diversity (
 p
 < 0.001), though no significant differences were observed between PI and RI. COVID-19 patients displayed skewed TCR repertoires dominated by expanded clones (>1%), whereas HC primarily harbored small clones (≤ 0.1%). RI patients demonstrated intermediate clonality, suggesting partial memory recall. Group-specific V(D)J pairings were identified, including TRAV27/TRAJ42 in RI, TRAV24/TRAJ42 in PI, and TRAV35/TRAJ42 in HC, while TRBV6-4/TRBD2/TRBJ2–3 was conserved across all groups. Additionally, HC-enriched and RI-exclusive CDR3 clusters were detected. Our findings indicate that SARS-CoV-2 reinfection is associated with impaired TCR diversity and distinct clonal expansion patterns, underscoring the role of T cell immunity in reinfection susceptibility. HC-enriched TCR clusters may represent protective memory responses, whereas RI-specific signatures suggest compromised immunity. These results offer valuable insights for vaccine design and risk stratification, though further functional validation of the identified TCRs is necessary.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2d977242eab98e457279671a381065b9ee003f60" target='_blank'>
              Distinct characteristics of T cell receptor repertoire associated with the SARS-CoV-2 reinfection
              </a>
            </td>
          <td>
            Liling Zeng, Li Liu, Baolin Ren, Bing Feng, Xudong Lai, Xunxi Lai, Zhimin Chen, Yihui Huang, Wenxin Hong
          </td>
          <td>2025-10-23</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9b18f5377f0017134020665026beaa2b6a3157ac" target='_blank'>
              Spatial transcriptomics of compartmentalised inflammation in a natural disease multiple sclerosis cohort
              </a>
            </td>
          <td>
            M. Naughton, R. Kee, Gerry Mullan, Guillermo Lopez Campos, Gavin McDonnell, Owain Howell, Denise C. Fitzgerald
          </td>
          <td>2025-09-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Mpox virus (MPXV), a member of the Orthopoxvirus genus in the Poxviridae family, has long been endemic in Africa. The interaction between MPXV infection and peripheral immune responses is of great significance. However, the activation of signaling pathways and molecular changes in peripheral blood mononuclear cells (PBMCs) following MPXV infection remain poorly understood. This study evaluated the transcriptomic profiles of rabbit PBMCs during the mpox acute and recovery phases. The results showed that MPXV infection significantly altered the transcriptomic profiles of PBMCs. At 6 days post-infection, pathways related to pathogenic infection and IL-1 response were enriched, while at 14 days post-infection, the T cell receptor signaling pathway was enriched. During the mpox acute phase, inflammatory cytokines in serum such as IL-1α, IL-1β, IL-8, and IL-21 were upregulated, while MMP-9 and NCAM-1 were downregulated. In rabbits and rhesus monkeys, key genes upregulated in common during the mpox acute period were associated with the interferon pathway (e.g., the ISG15, OAS, and IFIT families), while downregulated genes were related to B-cell activation and differentiation (e.g., the MS4A1 and FCRL families). Additionally, rabbits developed protective immunity against reinfection, with neutralizing antibodies effectively activated. These findings provide insights into the molecular characteristics of PBMCs changes in in vivo models of MPXV infection, and offer references for the diagnosis, vaccine development, and therapeutic research of mpox.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5a49c159e81a5446db89fd6f6f36a9c258007cfb" target='_blank'>
              Transcriptome Analysis Reveals Host Peripheral Blood Mononuclear Cells Response to Mpox Virus Infection
              </a>
            </td>
          <td>
            Chaode Gu, Caiyun Wang, Chenlu Zhang, Jie Ni, Yun Xia, Hongwei Wang
          </td>
          <td>2025-09-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c9787242fbe0347f543399f29d0f5edf0d405908" target='_blank'>
              Efficacy and potential human and economic impact of a broadly protective betacoronavirus vaccine
              </a>
            </td>
          <td>
            George William Carnell, Robert Vendramelli, Charles Whittaker, Jonathan Holbrook, Srivatsan Parthasarathy, Hazel Stewart, Joey Olivier, Bryce M. Warner, Thang Truong, Charlotte L. George, Sneha B. Sujit, Sruthika K. Ashokan, Maria Suau Sans, C. Q. Huang, D. Wells, Paul Tonks, Martina Pfranger, Sebastian Einhauser, Patrick Neckermann, Diego Cantoni, A. Chan, Laura O’Rei lly, Luis Ohlendorf, Isaac Unwins, S. P. Rautenbach, Matteo Ferrari, A. E. Firth, Johannes Geiger, Christian Dohmen, Verena Mummert, Anne Rosalind Samuel, C. Plank, Joanne Marie, M. Rosario, Nigel J. Temperton, B. Asbach, S. Frost, R. Kinsley, Sneha Vishwanath, S. Fedosyuk, Ralf Wagner, D. Kobasa, J. Heeney
          </td>
          <td>2025-10-19</td>
          <td>None</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d6db7c438373e1be32f3e8f8962c7eb002d2e0ff" target='_blank'>
              Single-cell profiling reveals that dynamic lung immune responses distinguish protection from susceptibility to tuberculosis
              </a>
            </td>
          <td>
            Fergal J. Duffy, M. L. Neal, Courtney R. Plumlee, Sarah Cohen, B. Gern, A. Diercks, Michael Y Gerner, K. Urdahl, J. Aitchison
          </td>
          <td>2025-10-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="


 COVID-19, including its post-acute sequelae (Long COVID), is increasingly recognized as involving persistent immune dysregulation and chronic inflammation. Severe and prolonged disease states are often accompanied by sustained cytokine release, immune cell exhaustion, and ongoing cell-cell communication that shapes the inflammatory milieu. Among immune subsets, CD8
 +
 T cells play a central role in antiviral defense, yet the molecular mechanisms linking their dysfunction to prolonged inflammation remain incompletely understood.




 We analyzed 73,110 peripheral blood mononuclear cells (PBMCs) from individuals across four disease states (Healthy, Exposed, Infected, and Hospitalized) using single-cell RNA sequencing. Immune cell subsets were annotated, and T cell heterogeneity was profiled. Cytokine and inflammatory scores were calculated to assess immune activation. Differentially expressed genes (DEGs) underwent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Cell-cell communication was evaluated to map ligand-receptor networks. Additionally, nine machine learning models were trained on a bulk RNA-seq cohort, and the SHapley Additive exPlanations (SHAP) framework was applied to interpret key predictive genes.




 Progressive disease severity was associated with a decline in T cell proportions, enrichment of pro-inflammatory myeloid cells, and elevated cytokine expression, particularly IL-32. Memory CD8
 +
 T cells showed increased exhaustion and inflammatory scores while maintaining a central position in MHC-I-mediated communication networks. Persistent activation of immune and metabolic pathways, including antigen presentation and oxidative phosphorylation, was observed in prolonged disease states. Seven genes (RPS26, RPS29, RPL36, RPL39, RPS28, RPS21, and CD3E) were identified as strong predictors of chronic immune dysregulation, with the XGBoost model achieving the highest AUC. SHAP analysis confirmed their contributions to disease classification.





 This study maps the immune landscape of COVID-19 and Long COVID at single-cell resolution, revealing that persistent immune cell communication, particularly involving memory CD8
 +
 T cells, may sustain chronic inflammation beyond the acute phase. The identified molecular signatures offer potential biomarkers and therapeutic targets for mitigating post-viral inflammatory syndromes.

">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/536000d345ef1e6f7663efc28145b0e979e70e7b" target='_blank'>
              Immune cell communication networks and memory CD8+ T cell signatures sustaining chronic inflammation in COVID-19 and Long COVID
              </a>
            </td>
          <td>
            Hengrui Liu, Zewen Xu, Ilayda Karsidag, Panpan Wang, Jieling Weng
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/93e0c85fbf1c44be881c2143fd5458fbd774e153" target='_blank'>
              Impaired IFNγ responsiveness of lung monocyte-derived cells limits immunity to Mycobacterium tuberculosis
              </a>
            </td>
          <td>
            Weihao Zheng, J. Limberis, Zachary P. Howard, Alexander Mohapatra, Enzo Takagi, J. Ernst
          </td>
          <td>2025-10-06</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2fef0ecf5b990a10a1f0fae7554cfa28ceb163d2" target='_blank'>
              SARS-CoV-2-induced damage to rat cortical neuronal networks ex vivo is mediated by the pro-inflammatory activation of the cGAS-STING pathway.
              </a>
            </td>
          <td>
            Pamela Martinez-Orellana, Matteo Manzati, Diletta Pozzi, Yingying Xiao, Alessio Di Clemente, Marika Mearelli, Chiara Kalebić, Valentina Perrera, Denise Ferrarini, Tea Carletti, Carmen Falcone, Michele Giugliano, Alessandro Marcello
          </td>
          <td>2025-10-25</td>
          <td>Journal of neurovirology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="ABSTRACT Mitogen‐activated protein kinase (MAPK) p38 plays a key role in driving the pathology of acute lung injury (ALI), but effective therapeutic targeting remains elusive. Atypical p38 signaling, mediated by interaction with the adaptor protein Tumor Growth Factor β Activated Kinase 1 (TAK1) Binding Protein 1 (TAB1), has so far only been observed during pathological responses, representing a selective and alternative target during pulmonary injury. However, atypical signaling has not been investigated in the context of pulmonary injury and immune responses related to the onset and progression of ALI. Here, we utilized a genetic knock‐in mouse to block influenza A‐induced lung injury mediated by atypical signaling. We report that the loss of TAB1‐p38 interaction reduces weight loss and recovery time, reduces histopathological scores associated with influenza‐induced lung injury early during infection, and prompts earlier recruitment of monocytes to the lungs following infection. These results were found to be independent of viral replication and infectivity, representing the first evidence for the roles of atypical signaling as a driver of host‐mediated pulmonary injury following influenza infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ed7170a2d99ca1c949beb048f13b4c9bf8b5ffef" target='_blank'>
              Role of Atypical MAPK p38 Signaling in the Progression of Influenza A‐Induced Acute Lung Injury
              </a>
            </td>
          <td>
            Jeremy C Burton, Denise L Fahey, Fredejah T. Royer, Yin Zhu, Kaori Sakamoto, Duo Zhang, Wendy T. Watford, Neil J. Grimsey
          </td>
          <td>2025-09-24</td>
          <td>The FASEB Journal</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Background: The COVID-19 pandemic prompted investigation into the interaction between SARS-CoV-2 infection and immune checkpoint inhibitor (ICI) therapy in lung cancer patients. Understanding this interplay is crucial for optimizing cancer immunotherapy. Methods: A retrospective analysis was conducted on lung cancer patients, characterizing changes in peripheral immune cells and plasma cytokines (including IL-10 and IL-12p70) before, during, and after SARS-CoV-2 infection. Progression-free survival (PFS) was compared between ICI-treated patients with and without COVID-19. Cytokine dynamics were further analyzed in a non-infected cohort. Results: SARS-CoV-2 infection induced a prolonged systemic cytokine storm, with elevated IL-10 and IL-12p70 levels and reduced monocyte proportions lasting up to 10 weeks post-recovery. Despite this immune perturbation, COVID-19 did not impair long-term PFS; instead, a transient improvement in disease control was observed in infected patients. In non-infected patients, sustained or increased IL-10 and IL-12p70 levels during ICI therapy were associated with longer PFS (p < 0.05). Conclusions: SARS-CoV-2 infection transiently alters the immune landscape in lung cancer patients without compromising ICI efficacy. The sustained elevation of IL-10 and IL-12p70 may contribute to short-term clinical benefits. Monitoring cytokine dynamics could serve as a prognostic tool for predicting ICI response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/751116a96b162ead6a92605da6ef16112bc11bf9" target='_blank'>
              SARS-CoV-2 Infection Alters the Immune Microenvironment in Lung Cancer Patients Undergoing Immunotherapy and Affects Treatment Outcomes
              </a>
            </td>
          <td>
            Yanjing Peng, Panjian Wei, Meng Gu, Guirong Wang, Teng Ma, Jinjing Tan
          </td>
          <td>2025-09-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e56b0f654aeb93a046a73a7a4da19670e8d180d9" target='_blank'>
              Single-cell multiomics reveals archetypal regulatory programs shared across CD4 and CD8 T cell subsets in viral infection
              </a>
            </td>
          <td>
            , J. van der Veeken, Alexander Rudensky, Yuri Pritykin
          </td>
          <td>2025-09-13</td>
          <td>bioRxiv</td>
          <td>1</td>
          <td>19</td>
        </tr>

        <tr id="Introduction Neuroinflammation is a critical factor contributing to secondary brain injury following traumatic brain injury (TBI). This process engages diverse cell types within the central nervous system (CNS), including significant infiltration of myeloid lineage cells–primarily neutrophils and macrophages–during the acute and subacute phases of TBI. These myeloid-derived cells represent a major population that critically influences the development and progression of neuroinflammation. Microglia and peripherally infiltrating macrophages exhibit polarization phenotypes that play a pivotal role in modulating inflammatory changes. Due to their functional and phenotypic similarities, their distinct contributions to the inflammatory response in TBI remain a subject of considerable debate. Lysozyme 2 (Lyz2) is a well-established marker for myeloid lineage cells (including monocytes, macrophages, and neutrophils) in mice, allowing specific targeting and depletion of these cells to dissect their functional roles in TBI. Methods In the present study, we investigated the trend of inflammatory factors during the early stage of TBI using Lyz2-IRES-DTREGFP transgenic mice, which specifically target and deplete Lyz2-positive myeloid cells. Tissue samples for RT-qPCR and flow cytometry were harvested from the perilesional cortex (within a 2-mm radius of the impact site) and the underlying hippocampus. Results and discussion Our findings revealed a considerable reduction in the expression of pro-inflammatory factors (e.g., IL-1β, iNOS, IL-6, IFN-γ) and an increase in the expression of anti-inflammatory factors (e.g., IL-4, IL-10, IL-13, Arg-1). Furthermore, we observed a shift in polarization phenotypes, characterized by a decreased proportion of M1 macrophages and an increased proportion of M2 macrophages. However, during the chronic phase, behavioral and histological analyses revealed worse outcomes. These findings demonstrate that targeted depletion of Lyz2-positive myeloid cells during acute TBI attenuates neuroinflammation. However, this early immunomodulatory shift correlates paradoxically with exacerbated chronic neurological deficits, suggesting that transient suppression of myeloid-driven inflammation may disrupt long-term reparative processes critical for functional recovery after TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f2b62a25efa9a7379563b95a2c6aaa7cdabd0939" target='_blank'>
              Dual role of Lyz2-positive myeloid cells in traumatic brain injury: acute anti-inflammatory effects vs. chronic neurological deterioration
              </a>
            </td>
          <td>
            Hua-Zheng Yan, Yi-Wan Fang, Shi-Yu Zhou, Jian-Xiong Gao, Ming-ming Bian, Yao-Mei Xu, Lin Zhang, Nan Zhang, He-Zuo Lü
          </td>
          <td>2025-10-07</td>
          <td>Frontiers in Cellular Neuroscience</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/17651de6c46a00b78395437afc40e239fdbc6f6f" target='_blank'>
              Neonatal Microglia and Their Secretome as Mediators of Brain Repair
              </a>
            </td>
          <td>
            Gabriela Lyszczarz, Eydís Sigurðardóttir Schiöth, A. Benmamar-Badel, Dominika Rusin, David Ramonet, Marco Anzalone, Thalissa Caers, Lejla Vahl Becirovic, Kirstine Nolling Jensen, S. G. Verberk, Fleur Mingneau, Martyna Makowska, Kate Lykke Lambertsen, Amy F. Lloyd, Jerome J. A. Hendriks, Agnieszka Wlodarczyk
          </td>
          <td>2025-09-22</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="ABSTRACT Host resilience to bacterial infection depends on tightly regulated immune responses, which can be shaped by metabolic cues, including the contribution from bioactive lipids. The endocannabinoid system (ECS), a lipid signaling network known for its neuromodulatory roles, also influences immunity; however, the receptor-specific contributions of cannabinoid receptor 1 (CB1R) and cannabinoid receptor 2 (CB2R) in host–pathogen interactions remain incompletely defined in this context. Using receptor-deficient mouse models, we investigated how CB1R and CB2R modify immune responses to Salmonella Typhimurium. CB1R-deficient (CB1R-KO) mice exhibited heightened systemic inflammation, impaired bacterial clearance, and reduced survival in systemic infection, associated with dysregulated macrophage polarization and diminished neutrophil recruitment. In contrast, CB2R-KO mice showed increased susceptibility in both systemic and mucosal infection models, marked by a pro-inflammatory macrophage profile, enhanced neutrophilia, and microbiota dysbiosis. Shotgun metagenomic analysis revealed a reduced abundance of specific protective commensals and altered microbial metabolic pathway profiles in CB2R-KO mice, suggesting a role for CB2R in maintaining mucosal immune–microbiota homeostasis. Collectively, these findings highlight non-redundant roles for CB1R and CB2R in regulating immune dynamics and salmonellosis disease severity, and they point to the ECS as a potential target for host-directed immunomodulatory therapies. IMPORTANCE Effective immunity against bacterial pathogens requires a delicate balance between microbial clearance and the containment of inflammatory damage encountered during many infections. The molecular pathways that regulate this equilibrium remain incompletely defined, and the involvement of bioactive lipid signaling mechanisms also needs to be better described. Here, we show that the endocannabinoid receptors CB1R and CB2R play non-redundant roles in host defense against Salmonella infection. CB1R deficiency results in exacerbated systemic inflammation, defective bacterial clearance, and dysregulated macrophage polarization. In contrast, CB2R deficiency leads post-infection to gut dysbiosis and has been found to negatively affect the outcome for the host in both systemic and mucosal infection with Salmonella. By describing cannabinoid receptor-specific contributions to immune regulation and microbiota dynamics, our findings reveal a previously underappreciated axis of host–pathogen interaction. This study broadens our understanding of lipid-mediated immune modulation and identifies CB1R and CB2R as potential targets for therapies aimed at restoring immune homeostasis and improving infectious disease outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/807bf880e53822e18dd6bce5ebaaab6c3409fd1a" target='_blank'>
              Deficiency of cannabinoid receptors enhances host susceptibility to bacterial infection
              </a>
            </td>
          <td>
            Hailey A. Barker, Saloni Bhimani, Deyaneira Tirado, Jorge J. Canas, Leandro Nascimento Lemos, Luiz F. W. Roesch, Mariola J. Ferraro
          </td>
          <td>2025-09-18</td>
          <td>mBio</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ea4b27b3abc1e2ce798ecec88b962d47ff12ed70" target='_blank'>
              Human Cytomegalovirus Infection of Primary Human Oral Keratinocytes Induces Intermediate Keratinocyte Differentiation and an Altered Innate Immune Response
              </a>
            </td>
          <td>
            Olesea Cojohari, Yuming Cao, Askar Temirbek, Manuel Garber, Andrés Colubri, Timothy Kowalik
          </td>
          <td>2025-09-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Long COVID (LC) is characterized by a wide range of symptoms, the causes of which remain unclear. We investigated associations between inflammatory and coagulation factors, adaptive immune response to SARS-CoV-2, and LC. We enrolled 196 unvaccinated individuals with SARS-CoV-2 (March–June 2020). Blood samples were collected at three (T3M) and twelve (T12M) months post infection. Plasma concentrations of coagulation factors (D-Dimer, E-Selectin, ICAM-1, VCAM-1) and inflammatory markers (IL-6, IL-8, TNF-α, IL-1β) were measured by ELISA, and SARS-CoV-2-specific T-cell response was assessed by Elispot. LC occurred in 66/196 patients (34%); 77.8% had been hospitalized. Respiratory symptoms were present in 54%, fatigue in 30%, and neuropsychological symptoms in 14%. At T3M, hospitalized patients exhibited higher levels of ICAM-1, VCAM-1, and IL-6, along with increased immunoreactivity. LC patients exhibited elevated IL-8 and TNF-α and enhanced immunoreactivity at T3M, though these differences were not observed at T12M. Inflammatory and coagulation markers were altered at three months after acute infection, with some changes persisting at one year, suggesting a long-term immunological impact of SARS-CoV-2 on the inflammatory response. A SARS-CoV-2-specific T-cell response was still detectable at T12M, albeit at a lower level than at T3M, suggesting the persistence of protective memory T-cells beyond the acute phase.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/661662040cb49d22a81b08c21000921af6c27b9d" target='_blank'>
              Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects
              </a>
            </td>
          <td>
            E. Cimini, A. Vergori, C. Cimaglia, Eleonora Tartaglia, S. Notari, F. Colavita, G. Matusali, I. Mastrorosa, V. Mazzotta, P. Chinello, P. Mencarini, M. L. Giancola, A. Abdeddaim, R. Casetti, G. Grassi, Simona Gili, Flavia Cristofanelli, F. Maggi, P. Piselli, E. Girardi, A. Antinori, M. Camici
          </td>
          <td>2025-10-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="Introduction COVID-19 has caused over 7 million deaths worldwide since its onset in 2019, and the virus remains a significant health threat. Identifying sensitive and specific biomarkers, along with elucidating immune-mediated mechanisms, is essential for improving the diagnosis, treatment, and prevention of COVID-19. To predict key molecular markers of COVID-19 using an established multi-omics framework combined with machine learning models. Methods We conducted an integrated analysis of single-cell RNA sequencing (scRNA-seq), bulk RNA sequencing, and proteomics data to identify critical biomarkers associated with COVID-19. The multi-omics approach enabled the characterization of gene expression dynamics and alterations in immune cell subsets in COVID-19 patients. Machine learning techniques and molecular docking analyses were employed to identify biomarkers and therapeutic targets within the disease’s pathophysiological network. Results Principal component analysis effectively grouped samples based on clinical characteristics. Using random forest and SVM-RFE models, we identified clinical indicators capable of accurately distinguishing COVID-19 patients. Transcriptomic analysis, including scRNA-seq, highlighted the pivotal role of CD8+ T cells, and WGCNA identified related module genes. Proteomic analysis, integrated with machine learning, revealed 36 DEPs. Further investigation identified several genes associated with monocyte proportions. Correlation analysis showed that BTD, CFL1, PIGR, and SERPINA3 were strongly linked to CD8+ T cell abundance in COVID-19 patients. ROC curve analysis demonstrated that these genes could effectively distinguish between COVID-19 patients and healthy individuals. Concordant findings from both transcriptomic and proteomic levels support BTD, CFL1, PIGR, and SERPINA3 as potential auxiliary diagnostic markers. Finally, AlphaFold-based molecular docking analysis suggested these biomarkers may also serve as candidate therapeutic targets. Discussion Preliminary findings indicate that BTD, CFL1, PIGR, and SERPINA3 are vital molecular biomarkers related of CD8+ T cell, providing new insights into the molecular mechanisms and long-term prevention of COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c267a410d7788bd337a76f2dc6c4f824689a5545" target='_blank'>
              Multi-omics and machine learning identify novel biomarkers and therapeutic targets of COVID-19
              </a>
            </td>
          <td>
            Yumei Zhou, Pengbei Fan, Haiyun Zhang, Shuai Han, Minghua Bai, Ji Wang, Qi Wang
          </td>
          <td>2025-10-02</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="The Interferon-Stimulated Gene 15 (ISG15) has a key role during viral infections, since it can modify and regulate the expression of proteins from the host and from viruses. Isg15−/− mice are more susceptible to infectious diseases. ISG15 is induced by type I Interferons (IFN-I) and apart from defense against pathogens, it can also play an important function in cancer or immune-mediated inflammatory diseases. Previous studies reported that ISG15 expression is increased in post-synaptic dendritic cells (DCs) upon interaction with CD4 + T cells. However, data regarding the role of ISG15 in DCs are scarce. The present study assesses the function of ISG15 in DCs activation, migration and ability to mediate T cell activation using bone marrow-derived DCs (BMDCs) and stimulation with lipopolysaccharide (LPS). Activation of DCs was not impaired but tended to be lower in Isg15-deficient mice, as observed by reduced CD40 induction in Isg15−/− BMDCs. Isg15−/− BMDCs induced less proliferation and Granzyme B expression in co-cultured CD8 + T cells. Interestingly, Isg15−/− BMDCs secreted reduced levels of the pro-inflammatory cytokines IL-1β and IL-12 upon LPS stimulation. Mechanistically, our data suggest that ISG15 regulates Caspase-1 activity in DCs leading to lower IL-1 β secretion. In conclusion, this study reveals an essential role for ISG15 modulating DCs inflammatory activity and raises new questions regarding the specific mechanisms of how this protein regulates innate immune responses. Supplementary Information The online version contains supplementary material available at 10.1007/s00018-025-05849-9.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/05fa00535a2acdc99ae44733e69601b7e28b4dad" target='_blank'>
              ISG15 modulates inflammatory profiles and ability to activate CD8 + T cells in bone marrow-derived dendritic cells
              </a>
            </td>
          <td>
            P. Martínez-Fleta, Clara Pertusa, Irene Fernández-Delgado, R. Izquierdo-Serrano, M. Ramírez-Huesca, Nieves Fernández-Gallego, D. Calzada-Fraile, Elena Moya-Ruiz, Raquel Castillo-González, Susana Guerra, E. Martín-Gayo, F. Sánchez-Madrid
          </td>
          <td>2025-10-24</td>
          <td>Cellular and Molecular Life Sciences: CMLS</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Background: Immunosuppressive treatment can attenuate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine-induced immune responses. Moreover, SARS-CoV-2 has neuroinvasive potential and may induce a persistent pro-inflammatory milieu following infection. Objectives: To investigate if diminished post-vaccine humoral responses can be overcome with additional vaccine doses and/or breakthrough COVID-19 infections, and if COVID-19 infection can lead to a pro-inflammatory state with neuroaxonal/neuroglial injury in the intermediate-term in patients with central nervous system (CNS) neuroimmunological diseases. Design: A prospective observational study conducted at National Neuroscience Institute, Singapore. Methods: Serum levels of SARS-CoV-2 neutralising antibodies (NAbs) were measured in patients with CNS neuroimmunological diseases following their fourth SARS-CoV-2 mRNA vaccine (V4), or after breakthrough COVID-19 infection following three prior SARS-CoV-2 mRNA vaccinations, or both. Serum levels of pro-inflammatory cytokines interleukin-6 (IL-6) and tumour necrosis factor (TNF) were evaluated post-COVID-19 infection and post-V4, compared to baseline within individuals. Serum neurofilament-light chain (NfL) and glial fibrillary acidic protein (GFAP), biomarkers of neuroaxonal and astroglial injury, respectively, were measured at baseline and post-COVID-19 infection within patients with relapsing-remitting multiple sclerosis (RRMS) and neuromyelitis optica spectrum disorder (NMOSD). Results: Sixty-one patients with various CNS neuroimmunological diseases were recruited, including 34 with MS and 19 with NMOSD. All had received at least three doses of the SARS-CoV-2 mRNA vaccine. Patients on anti-CD20/sphingosine-1-phosphate-receptor modulators (S1PRM) showed significantly reduced NAbs levels in both post-V4 and post-COVID-19 infection scenarios, compared to patients on other immunotherapies. No significant differences between baseline and post-COVID-19 infection concentrations of IL-6 and TNF were observed. Within RRMS and NMOSD patients, NfL and GFAP levels remained similar between baseline and post-COVID-19 infection. Conclusion: Anti-CD20/S1PRM treatments are associated with persistently diminished humoral responses post-V4/infection. Patients with CNS neuroimmunological diseases do not show biomarker evidence of intermediate-term pro-inflammatory states and neural injury after COVID-19 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/099886fa1a2b35fc8762cac481f4c16e28fd8a41" target='_blank'>
              Longitudinal quantification of serum SARS-CoV-2 neutralising antibodies, pro-inflammatory cytokines, NfL and GFAP before and after breakthrough COVID-19 infection in CNS neuroimmunological diseases: a prospective observational study
              </a>
            </td>
          <td>
            M. Hema Prashaad, Rachel Wan En Siew, Amelia Yun Yi Aw, Janice Hui Yi Tan, Muhammad Yaaseen Gulam Mohamed, Janis Tye Siew Noi, Kalpana Prasad, Kevin Tan, J. Kuhle, Yinxia Chao, I. Ho, Tianrong Yeo
          </td>
          <td>2025-09-09</td>
          <td>Therapeutic Advances in Infectious Disease</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/15afe5675b76ae8f25b12b76fc0894e683993e3d" target='_blank'>
              ODC1 restricts meningeal B cell age-associated-like phenotype and function in multiple sclerosis: a human and experimental study
              </a>
            </td>
          <td>
            J. Zurawski, Martin R. Profant, Alara Tuncer, Jianuo Wang, Miranda Green, Ke Cao, Simon Paris, S. Tauhid, Youmna Jalkh, Molly Quattrucci, R. Chu, Xingshan Cao, Alex Kiss, Tanuja Chitnis, Howard L. Weiner, C. Clish, Rohit Bakshi, Chao Wang
          </td>
          <td>2025-09-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="ABSTRACT In vitro studies have repeatedly showed that extracellular vimentin (eVIM) promotes the penetration of viruses by acting as an adhesion factor, suggesting that reducing eVIM density in the blood could be an effective approach to treat viral infections. However, despite solid evidence, it has not been previously investigated whether eVIM plays a pathogenic role during viral infections in vivo experiments. Here, we provide in vivo evidence that eVIM plays a critical role during viral infections. The severity of COVID-19 in Roborovski SH101 hamsters was positively correlated with blood concentrations of eVIM during the infection period. The reduction of blood eVIM in the SARS-CoV-2-infected Roborovski SH101 hamster through intravenous injection of hzVSF-v13, a humanized anti-eVIM monoclonal antibody, dramatically improved disease manifestations, such as body weight reduction, body temperature, death rate, and more. It also inhibited the formation of blood clots and systemic inflammation compared to remdesivir or a SARS-CoV-2 neutralizing antibody (6D11F2). Histological examination confirmed the significantly better therapeutic efficacy of anti-eVIM compared to remdesivir or the neutralizing antibody. Quantification of SARS-CoV-2 in the hamsters’ lungs revealed that the viral titer in the anti-eVIM-treated groups was 77% to 80% lower than that in the infection group, while remdesivir and the neutralizing antibody resulted in reductions of 41.9% and 34.7% to 44.1%, respectively. We believe that this work provides a foundation for the development of hzVSF-v13 as an antiviral drug for COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4aeac131b55b918a235c7cedc73efe1a44e4a271" target='_blank'>
              Reduction of extracellular vimentin in blood provides protection against SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Hae-Mi Kim, Mingda Wang, Chongkai Zhai, Sura Kim, Jungha Park, Seong-Tshool Hong
          </td>
          <td>2025-10-07</td>
          <td>Virulence</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e63b1279f51d73cda78726f8cc10b215549aa1ac" target='_blank'>
              NK cells undergo transcriptional and functional reprogramming following Streptococcus pneumoniae infection
              </a>
            </td>
          <td>
            Júlia Torné, Claudia Chica, Tiphaine Camarasa, Bernd Jagla, Matilde Diaz Enes, Aymeric Zellner, S. Mella, V. Libri, M. Hamon
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Background A certain degree of self-repair is initiated following spinal cord injury (SCI). Although intraneuronal regeneration and a supportive growth environment are limited, they serve as the foundation for functional recovery after SCI. Methods In this study, we conducted single-cell RNA sequencing combined with spatial transcriptomics and spatial metabolomics to reveal the spatial molecular characteristics of self-repair processes after SCI at single-cell resolution. Results We identified three cell subsets-Mic2 (a microglia subset), Mac4 (a macrophage subset), and Fib4 (a fibroblast subset)-that express markers associated with spinal cord repair. Mic2 and Mac4 exhibit clustered spatial distribution patterns, whereas Fib4 is predominantly located around the injured spinal cord. Additionally, Mic2 is predominantly distributed in the white matter, particularly in the dorsal region of the injured spinal cord, and exhibits high expression of taurine. Mac4 and Fib4 exhibit high expression of copalic acid and uridine, respectively. Conclusions In this study, we have identified three distinct cell subsets that express markers associated with wound healing and may promote regenerative processes, and we have determined their spatial transcriptional and metabolic features enriched within these regions. Our dataset represents a valuable resource that offers novel mechanistic insights into the pathobiology of spinal cord injury. Supplementary Information The online version contains supplementary material available at 10.1186/s40364-025-00845-4.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ac7f990261ab040d2dcb9732e55fa91a396956f2" target='_blank'>
              Integrating single-cell RNA sequencing and spatial multi-omics reveals the molecular signature of regeneration after spinal cord injury
              </a>
            </td>
          <td>
            Haoru Dong, Yuanqing Ding, Xingyu Chen, Xiao Xiao, Longnian Zhou, Haiyue Lin, Zezhen Zhang, Yiming Tao, Shiyi Cai, Jianlan Zhao, Xiaomu Li, Rong Xie
          </td>
          <td>2025-10-21</td>
          <td>Biomarker Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Background/Objectives: Understanding the durability of immunity induced by mRNA COVID-19 vaccines, especially in individuals with chronic health conditions, remains essential for guiding booster strategies. We conducted a longitudinal study to evaluate humoral and cellular immune responses up to 21 months after a primary two-dose BNT162b2 vaccination followed by a booster, either homologous (BNT162b2) or heterologous (mRNA-1273). Methods: Twenty-eight adults, mostly with chronic conditions, were assessed at approximately 9, 12 and 21 months post-primary vaccination. Serum anti-trimeric Spike IgG levels were quantified, and peripheral blood mononuclear cells were analyzed at 21 months for Spike-specific memory B-cell and T-cell responses by flow cytometry. Results: Participants were stratified by booster type, prior SARS-CoV-2 infection and health status. Anti-Spike IgG persisted in all participants but declined over time. The heterologous mRNA-1273 booster induced higher antibody titers at 9 months, while the homologous BNT162b2 booster led to more sustained antibody levels and higher frequencies of Spike-specific memory B cells at 21 months. Prior infection significantly enhanced antibody titers, particularly in homologous booster recipients. Surprisingly, individuals with chronic health conditions exhibited equal or higher antibody levels compared to healthy participants at all time points. At 21 months, robust Spike-specific class-switched memory B cells and polyfunctional CD4+ and CD8+ T-cell responses were detected. Conclusions: These findings demonstrate that BNT162b2 vaccination elicits durable, multi-layered immunity lasting nearly two years, even in individuals with chronic conditions, and support the use of both homologous and heterologous mRNA boosters to sustain protection in diverse populations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/89481772992766fff7568e99ee152ae890cc2530" target='_blank'>
              Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions
              </a>
            </td>
          <td>
            Chiara Orlandi, Ilaria Conti, Davide Torre, Simone Barocci, Mauro Magnani, Giuseppe Stefanetti, A. Casabianca
          </td>
          <td>2025-10-02</td>
          <td>Vaccines</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/42649e5799d217ae2a59e14c7eb9e6893e79caba" target='_blank'>
              Pathogenicity and Transcriptomic Profiling Revealed Activation of Apoptosis and Pyroptosis in Brain of Mice Infected with the Beta Variant of SARS-CoV-2.
              </a>
            </td>
          <td>
            Han Li, Bao-Ying Huang, Gao Qian Zhang, Fei Ye, Li Zhao, Wei Bang Huo, Zhong Xian Zhang, W. Wang, W. Wang, Xiao Ling Shen, Chang Cheng Wu, Wen Jie Tan
          </td>
          <td>2025-09-20</td>
          <td>Biomedical and environmental sciences : BES</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Cryptococcal meningitis is a fungal infection in patients with compromised CD4 T cell function. CD4 T cells provide killing signals to macrophages, principally IFNγ, to limit intracellular fungal replication. However, CD4 T cells may also drive inflammatory tissue damage. Yet, it is not fully understood how fungal-specific CD4 T cells infiltrate the brain and how they influence functional phenotypes of CNS-resident myeloid cells. In the current work, we develop a mouse model to track fungal-specific CD4 T cells and determine their influence on microglia. We found IFNγ+ fungal-specific CD4 T cells have limited TCR signalling and characterise a population of inflammatory microglia that upregulate MHCII and IFNγ-regulated genes during infection. Inflammatory microglia have poor fungicidal capacity and significantly expand during infection, a process that depends on CD4 T cell infiltration. Taken together, these data identify the early inflammatory consequences of fungal-specific CD4 T cell infiltration and identify proliferating microglia as important drivers of brain inflammation during infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/37f4633c141c3226368499b170bc53f8df43b779" target='_blank'>
              Brain-infiltrating CD4 T cells drive inflammatory microglia proliferation during cryptococcal meningitis in mice
              </a>
            </td>
          <td>
            Sofia Hain, Man Shun Fu, Lucy Wigg, Lorna S. George, D. Lecky, Alexander J Whitehead, Erin Clipston, Ko Sato, Masahiro Ono, Marcel Wuthrich, Bruce Klein, Kazuyoshi Kawakami, J. Rayes, D. Bending, Rebecca A. Drummond
          </td>
          <td>2025-10-09</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="Human immunodeficiency virus (HIV) persists in infected individuals despite effective antiretroviral therapy due to the rapid establishment of latent reservoirs, mainly composed of quiescent memory CD4+ T cells. The mechanisms governing latent reservoir formation remain poorly understood. Here, using single-cell RNA-seq and functional studies in human primary CD4+ T cell models, we show that HIV infection with reporter constructs and laboratory and patient-derived strains triggers transcriptomic remodelling, activating the p53 pathway and a quiescence programme mediated by Krüppel-like factor 2 (KLF2), a key quiescence regulator. Loss- and gain-of-function studies, including unbiased shRNA screens and confirmatory studies in CD4+ T cells from HIV+ donors, demonstrate that HIV infection drives KLF2 and p53 signalling, which downregulate MYC and proliferation pathways, resulting in proviral transcriptional silencing. This enhances latent reservoir formation in T cells, ensuring viral persistence. These findings present a mechanism for forming the latent HIV reservoir and broaden the repertoire of strategies through which viruses control host cells to their advantage.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/71ad439106244ffe6aee4ff6226965f5c2bc48f8" target='_blank'>
              HIV infection reprogrammes CD4+ T cells for quiescence and entry into proviral latency
              </a>
            </td>
          <td>
            Leah M Plasek Hegde, L. Gunawardane, F. Niazi, Uri Mbonye, K. Leskov, Gani Perez, C. Dobrowolski, Meenakshi Shukla, W.S. Nutt, Jonathan Karn, S. Valadkhan
          </td>
          <td>2025-09-26</td>
          <td>Nature Microbiology</td>
          <td>1</td>
          <td>23</td>
        </tr>

        <tr id="Abstract Atherosclerosis is a chronic inflammatory disease characterized by lipid accumulation and immune dysregulation, including expansion of pro-inflammatory monocytes and effector T cells, alongside reduced regulatory T cells (Tregs). Bacillus subtilis natto, a spore-forming probiotic, has shown anti-atherosclerotic effects, though its systemic immunomodulatory mechanisms remain unclear. In this study, we employed an AAV-mPCSK9-induced murine atherosclerotic model to investigate the effects of daily B. subtilis natto NTU-18 administration over 16 weeks. High-dimensional flow cytometry using two 13-marker panels enabled longitudinal profiling of 18 peripheral immune cell subsets across lymphoid and myeloid compartments. While no significant changes in serum cholesterol and mild decrease of body weight were observed, B. subtilis natto NTU-18-treated mice presented a significant reduction in aortic lesion area compared to PBS-treated controls. Immune profiling revealed a transient expansion of peripheral myeloid cells and CD44⁺ trained CD8⁺ T cells, followed by increased frequencies of naïve CD8⁺ T cells and reduced central/effector memory subsets at longer time point treatment. In the CD4⁺ T cell compartment, a transient increase in trained cells was accompanied by a sustained enrichment of CD25⁺CD4⁺ Tregs throughout the daily B. subtilis natto NTU-18 treatment. In contrast, no significant differences were observed in Ly6C⁻ or Ly6C⁺ monocytes, neutrophils, or eosinophils. These findings suggest that B. subtilis natto NTU-18 attenuates atherosclerosis progression not through lipid lowering or broad myeloid modulation, but via targeted reprogramming of peripheral T cell responses. This work provides mechanistic insight into the immunotherapeutic potential of B. subtilis natto NTU-18 in atherosclerosis prevention and treatment. Key points • B. subtilis natto NTU-18 significantly reduces aortic plaque burden in atherosclerotic mice without affecting serum cholesterol levels. • B. subtilis natto NTU-18 induces transient immune remodeling, marked by early expansion of trained CD8⁺ and CD4⁺ T cells, followed by increased naïve and regulatory T cells. • The atheroprotective effect is primarily mediated through adaptive immunity as myeloid subsets remain unchanged throughout B. subtilis natto NTU-18 treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/45dd339de260cb5a70cef21d3c450ab6682f7820" target='_blank'>
              Bacillus subtilis natto NTU-18 attenuates atherosclerosis progression by modulating peripheral immune cell alterations
              </a>
            </td>
          <td>
            Jian-Da Lin, Yu-Zhen Ye, Sin-Ren Wang, Wen-Yi Kao, Kung-Ta Lee
          </td>
          <td>2025-10-17</td>
          <td>Applied Microbiology and Biotechnology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Acute respiratory distress syndrome (ARDS) is a critical condition characterized by diffuse alveolar damage and intense inflammatory responses. During the COVID‐19 pandemic, its incidence and mortality have remained persistently high. Conventional approaches have struggled to uncover the complex cellular heterogeneity and dynamic inflammatory networks underlying ARDS. The advent of single‐cell sequencing technologies has revolutionized our ability to dissect the molecular mechanisms of ARDS. This review systematically summarizes recent advances in the application of single‐cell sequencing in studying pulmonary inflammation in ARDS, with a focus on its strengths in elucidating immune cell heterogeneity, reconstructing intercellular communication networks, and identifying potential therapeutic targets. Furthermore, we discuss current technical limitations and translational challenges, aiming to provide a theoretical foundation and future direction for translating mechanistic insights into precision medicine for ARDS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b7061390b06d4776270be5e5161ae41668426e25" target='_blank'>
              Single‐Cell Sequencing Redefines Immune Heterogeneity and Communication Networks in ARDS: Toward Precision Therapeutics
              </a>
            </td>
          <td>
            Han-Bing Chen, Anmin Xu, , Jie Chao, Songyun Zhao
          </td>
          <td>2025-01-01</td>
          <td>International Journal of Genomics</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f1c595bb04b33b2110b0229671f4eef2af24032e" target='_blank'>
              Genome-wide screen in Mycobacterium tuberculosis infected macrophages reveals innate regulation of antibacterial mediators by IRF2
              </a>
            </td>
          <td>
            A. W. Roberts, Linda N. Del Cid, , Jeffery S. Cox
          </td>
          <td>2025-09-29</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Background Spinal cord injury (SCI) is a devastating disorder featuring serious motor dysfunction and proprioceptive deficits due to central nervous system (CNS) damage. During its progression, macrophage-microglia (MM) cells are rapidly activated and play pivotal roles in the inflammatory response through various mechanisms. However, limited research has investigated the differential gene expression between the two groups before and after injury, and these important genes may therefore serve as potential biological diagnostic markers. Methods Our study utilized the Gene Expression Omnibus (GEO) data for SCI-related MDEG identification. Key hub genes were screened using multiple machine learning(ML) algorithms. Their predictive potential was subsequently validated using independent datasets, and their association with immune cell infiltration was assessed. An in vitro model of SCI was established, and quantitative polymerase chain reaction (qPCR) experiments were conducted to verify our findings. Results Single-cell RNA sequencing identified 16 distinct cellular subpopulations, among which MM cells were split into four subsets according to functional characteristics. Enrichment analyses, including KEGG, GO, and GSEA, revealed that the MDEGs were closely linked to key biological processes in SCI. From 200 genes associated with critical WGCNA modules, three hub genes, including EMP3, GNGT2, and SGPL1, were identified through four ML algorithms as differentially expressed before and after injury. Predictive models based on these genes demonstrated strong performance in both internal training and external validation cohorts. Preliminary analysis of immune infiltration and gene-immune cell correlation suggests an association with M2 macrophages. Furthermore, in vitro modeling of post-injury inflammation confirmed the elevated expression of EMP3, GNGT2, and SGPL1. Conclusion Our study identifies EMP3, GNGT2, and SGPL1 as potential diagnostic biomarkers associated with MM cells in SCI. The foregoing findings lay a theoretical basis for elucidating their biological roles and formulating future treatment strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/162ab9799b7715c0473f4aa2c8f97bf79f30cf43" target='_blank'>
              Novel diagnostic biomarkers associated with macrophage-microglia in spinal cord injury
              </a>
            </td>
          <td>
            Manyi Zheng, Yunduo Jiang, Fangyu Liu, Yansong Wang
          </td>
          <td>2025-09-10</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="ABSTRACT Human cytomegalovirus (HCMV) is a prolific human herpesvirus that infects most individuals by adulthood. While typically asymptomatic in adults, congenital infection can induce serious neurological symptoms, including hearing loss, visual deficits, cognitive impairment, and microcephaly in 10%–15% of cases. HCMV has been shown to infect most neural cells, with our group recently demonstrating this capacity in stem cell-derived forebrain neurons. Infection of neurons induces deleterious effects on calcium dynamics and electrophysiological function paired with gross restructuring of neuronal morphology. Here, we utilize an induced pluripotent stem cell-derived model of the human forebrain to demonstrate how HCMV infection induces syncytia, drives neurite retraction, and remodels microtubule networks to promote viral production and release. We establish that HCMV downregulates microtubule-associated proteins while largely sparing other cytoskeletal elements. Furthermore, we pharmacologically modulate microtubule dynamics using paclitaxel (stabilize) and colchicine (destabilize) to examine the effects on neurite structure, syncytial morphology, and viral release. With paclitaxel, we found improvement of neurite outgrowth, but neither paclitaxel nor colchicine impacted viral titers. Together, these data suggest that HCMV infection-induced disruption of microtubules in human cortical neurons can be partially mitigated with microtubule stabilization, suggesting a potential avenue for future neuroprotective strategies. IMPORTANCE Infection by human cytomegalovirus (HCMV) continues to cause significant damage to human health. In the absence of a vaccine, vertical transmission from mother to fetus can result in profound neurological damage impacting quality of life. These studies focus on understanding the impact of HCMV infection on forebrain cortical neurons derived from induced pluripotent stem cells (iPSCs). We show that infection results in loss of neurite extension accompanied by cell-to-cell fusion. These pathogenic changes involve HCMV infection-mediated disruption of the microtubule network in iPSCs from different patient backgrounds. The microtubule stabilization agent paclitaxel partially protected neurite length and altered syncytia morphology without impacting viral replication. This work is part of our continued efforts to define putative strategies to limit HCMV-induced neurological damage. Infection by human cytomegalovirus (HCMV) continues to cause significant damage to human health. In the absence of a vaccine, vertical transmission from mother to fetus can result in profound neurological damage impacting quality of life. These studies focus on understanding the impact of HCMV infection on forebrain cortical neurons derived from induced pluripotent stem cells (iPSCs). We show that infection results in loss of neurite extension accompanied by cell-to-cell fusion. These pathogenic changes involve HCMV infection-mediated disruption of the microtubule network in iPSCs from different patient backgrounds. The microtubule stabilization agent paclitaxel partially protected neurite length and altered syncytia morphology without impacting viral replication. This work is part of our continued efforts to define putative strategies to limit HCMV-induced neurological damage.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/43ff406a50f0e094bdc2efb44261948bcae00376" target='_blank'>
              HCMV infection of terminally differentiated neurons disrupts microtubule organization, resulting in neurite retraction
              </a>
            </td>
          <td>
            Jacob W. Adelman, Andrew T Sukowaty, Kaitlyn J Partridge, Jessica E. Gawrys, Allison Akins, S. Terhune, Allison D. Ebert
          </td>
          <td>2025-10-08</td>
          <td>Microbiology Spectrum</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Background PDLIM2, a PDZ-LIM domain-containing protein expressed highest in the lung and immune cells, serves as a unique tumor suppressor and immune modulator, mainly by turning off the activation of the master transcription factors NF-ΚB and STAT3. While its role in cancer is established, the involvement of PDLIM2 in viral infection remains unclear. Results Here, we analyzed public gene expression data of blood leukocytes, bronchoalveolar lavage cells, and lung tissues from uninfected healthy humans and those infected with the respiratory virus SARS-CoV-2 or influenza. We found that PDLIM2 expression was repressed by viral infection, and notably, this repression correlated with the severity of infectious diseases. Consistently, the expression level of PDLIM2 was negatively associated with NF-ΚB and STAT3 activity across a diverse range of cell types, such as macrophages, monocytes, neutrophils, T cells, alveolar type 1 and 2 epithelial cells, airway epithelial cells, and fibroblasts. Accordingly, cells with low PDLIM2 expression exhibited aberrant activation of signaling pathways essential for cellular functions and immune responses. Conclusions These findings highlight PDLIM2 repression as a common mechanism underlying human viral infectious diseases and suggest PDLIM2 as a potential biomarker and therapeutic target for disease prognosis, prevention, and treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/528f6601512aa6e797b7f0747ef8e893f248a31f" target='_blank'>
              PDLIM2 Repression: A Common Mechanism in Viral Lung Infection
              </a>
            </td>
          <td>
            Feng Gao, Yongzheng W. Chen, Steven D. Shapiro, Gutian Xiao, Z. Qu
          </td>
          <td>2025-09-15</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c48ccb41d3f252f85b5277e853ac6cb2ae72c91e" target='_blank'>
              Human immune response to primary cryptosporidiosis parallels murine infection models
              </a>
            </td>
          <td>
            Dana M. Van Fossen, Haroldo J. Rodriguez, Farha Naz, Carol A. Gilchrist, Justin J. Taylor, W. A. Petri, Audrey C. Brown
          </td>
          <td>2025-10-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="The Coronavirus disease 2019 (COVID-19) pandemic had a profound global impact, yet children exhibited distinct clinical and epidemiological patterns compared to adults. Pediatric cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were generally characterized by milder disease, lower hospitalization rates, and few long-term sequelae. However, a subset of children developed severe complications such as multisystem inflammatory syndrome in children (MIS-C), highlighting the heterogeneity in disease presentation. Differences in immune system maturity and comorbidities likely contribute to the age-dependent manifestation of SARS-CoV-2 and other respiratory viruses. Persistent SARS-CoV-2 infection, particularly in immunocompromised individuals, has been implicated in the emergence of new viral variants with immune escape characteristics due to ongoing viral replication in the presence of selective pressure. While SARS-CoV-2 evolution in persistently infected adults has been well-documented, it is less clear how the virus evolves during persistent infection in the pediatric population. To address this question, we performed viral whole genome sequencing of longitudinal specimens collected from immunocompetent and immunocompromised pediatric COVID-19 patients. Similarly to what has been observed in adult cohorts, mutations associated with enhanced viral fitness and immune escape arose intra-host over time. Intra-host diversity accumulated at similar rates in immunocompetent and immunocompromised children, though more mutations overall were observed in the immunocompromised cohort due to the longer infection time courses. Overall, we identified similar viral evolutionary trends over the course of infection despite clinical differences in pediatric COVID-19 manifestation and severity. This similarity suggests that persistent infection in children may be an additional, but not unique, source of ongoing viral diversification.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4ffe2a38114a8ac606db5b1f233ceadfdc7d62ca" target='_blank'>
              Intra-Host Evolution of SARS-CoV-2 During Persistent Infection of Pediatric COVID-19 Patients
              </a>
            </td>
          <td>
            Charlie R. Boyle, Tien Doan, Estefany Rios-Guzman, Jessica Maciuch, Lacy M. Simons, Dulce S. Garcia, David B. Williams, A. Alisoltani, E. Ozer, R. Lorenzo-Redondo, J. Hultquist
          </td>
          <td>2025-09-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1dcea1129884a6752fad911c44fd25ab0079c405" target='_blank'>
              Parsing the Functions of Immediate Early Proteins in HCMV Infection Outcome
              </a>
            </td>
          <td>
            Yaarit Kitsberg, A. Nachshon, Noam Stern-Ginossar, Michal Schwartz
          </td>
          <td>2025-09-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>42</td>
        </tr>

        <tr id="Oropouche virus (OROV) historically caused a self-limiting disease, yet recent strains are associated with congenital infection and neurodevelopmental disruption. These cases highlight a need to study OROV as a congenital pathogen and determine the impact of infection on neurodevelopment. Here, we show that OROV is vertically transmitted and induces a microcephaly-like phenotype in human forebrain organoids. We found OROV robustly infects human neural progenitor cells in organoids. In contrast to ZIKV, OROV had a heightened capacity for infection and organoid pathology. We show this increased pathogenesis is partially attributable to OROV antagonism of innate immune signaling. We further demonstrate that OROV is vertically transmitted and infects the fetal tissues in a murine model of congenital infection. Our results demonstrate that OROV can be vertically transmitted and has heightened capacity for neurodevelopmental disruption. These findings underscore need for monitoring OROV as a re-emerging virus capable of inducing microcephaly in infected fetuses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e3f81652c74fd20d01cd9807f8e62f3f7baa9a2d" target='_blank'>
              Oropouche virus disrupts neurodevelopment and is vertically transmitted
              </a>
            </td>
          <td>
            K. Jurado, Carl D. Bannerman, Drake Philip, Taylor Miller-Ensminger, Elizabeth Kennedy, Stephanie Liu, Kristen Walsh, Guo-li Ming
          </td>
          <td>2025-09-09</td>
          <td>Research Square</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e4a5d524256ca24b7d9653ca688695b9cdf80bc2" target='_blank'>
              Selective S1P Receptor Modulation in Multiple Sclerosis Alters CXCL13:CXCR5-Associated Immune Activities Without Impacting Anti-SARS-CoV-2 Immunity.
              </a>
            </td>
          <td>
            A. Harrer, RF Radlberger, Beate Buchegger, Brooke Slade, Thomas Haybaeck, Hannes Oberkofler, Konstantin E Thiel, Ferdinand Otto, Tobias Moser, P. Wipfler
          </td>
          <td>2025-10-08</td>
          <td>Neurology and therapy</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/49cdf4d2b06dc0c77173ce97caf0d6a3fa0e9a28" target='_blank'>
              Single-Cell Immune Profiling Reveals Non-classical Monocyte-Driven Immunodepression in Tuberculosis Treatment Non-Responders
              </a>
            </td>
          <td>
            Yang Che, Yiqun Xiong, Dongliang Zhang, Yahong Qu, Hao Shen, Weixin Wang, Junshun Gao, ZhenBo Wang, Yi Chen, Zhihong Shen
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="To investigate relevant biomarkers that might aid in the diagnosis and monitoring of long COVID (LC), an analysis of IFN-α, IFN-β, ISG15, and ISG56 transcripts was performed by Real-Time PCR among people of working age who had been infected with SARS-CoV-2 one year prior to the study [LC and non-long COVID (NLC)]. Despite no differences in the transcript levels of IFN-α, IFN-β, ISG15, and ISG56 between LC and NLC, higher IFN-β mRNA levels were observed among LC compared to NLC individuals who were hospitalized for more than 10 days during acute SARS-CoV-2 infection. Moreover, previously SARS-CoV-2 infected participants that did not require respiratory support and developed LC exhibited higher levels of IFN-α and IFN-β compared to NLC with the same clinical characteristics. These results highlight that SARS-CoV-2 infection leads to changes in peripheral innate immune pathways, which could have implications for the development of LC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f03dce13a960828a5cadacfe53978386574cb65f" target='_blank'>
              Long COVID and Type I IFN Signature in Working-Age Adults: A Cross-Sectional Study
              </a>
            </td>
          <td>
            Letizia Santinelli, E. Gentilini Cacciola, L. Bortolani, M. Ridolfi, L. Maddaloni, Federica Frasca, M. Fracella, Ginevra Bugani, G. d’Ettorre, Claudio M Mastroianni, Giancarlo Ceccarelli, G. d'Ettorre
          </td>
          <td>2025-09-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="Epigenetic scarring of terminally dysfunctional (TDysf) CD8+ T cells hinders long-term protection and response to immune checkpoint blockade during chronic infections and cancer. We developed a faithful in vitro model for CD8+ T cell terminal dysfunction as a platform to advance T cell immunotherapy. Using TCR-transgenic CD8+ T cells, we found that 1-week peptide stimulation, mimicking conditions in previous models, failed to induce a stable exhaustion program. In contrast, prolonged stimulation for 2–3 weeks induced T cell dysfunction but triggered activation-induced cell death, precluding long-term investigation of exhaustion programs. To better mimic in vivo exhaustion, we provided post-effector, chronic TGF-β1 signals, enabling survival of chronically stimulated CD8+ T cells for over 3 weeks. These conditions induced a state of terminal dysfunction, marked by a stable loss of effector, cytotoxicity, and memory programs, along with mitochondrial stress and impaired protein translation. Importantly, transcriptomic and epigenetic analyses verified the development of terminal exhaustion-specific signatures in TDysf cells. Adoptive transfer of TDysf cells revealed their inability to recall effector functions or proliferate after acute lymphocytic choriomeningitis virus rechallenge. This tractable model system enables investigation of molecular pathways driving T cell terminal dysfunction and discovery of therapeutic targets for cancer or chronic infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cc4dbe9ec01dc079f493706a4c9a1123f839c591" target='_blank'>
              Faithful modeling of terminal CD8+T cell dysfunction and epigenetic stabilization in vitro
              </a>
            </td>
          <td>
            Amira Yousif, Abbey A. Saadey, Ava Lowin, Asmaa M. Yousif, Ankita Saini, Madeline R. Allison, Kelley Ptak, Eugene M Oltz, Hazem E. Ghoneim
          </td>
          <td>2025-10-08</td>
          <td>JCI Insight</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Interferon-gamma (IFN-γ) decreases infections in chronic granulomatous disease (CGD) with variably incomplete restoration of the fundamental CGD defect, converting oxygen to microbicidal oxidants during phagocytosis. We sought to understand other IFN-γ effects that could contribute to protection of CGD patients. We measured neutrophil function, gene expression, and biochemical parameters in nine CGD patients off IFN-γ and 10–12 hours after the first (1st) and fourth (4th) IFN-γ injection. Non-directed motility and bactericidal activity increased after IFN-γ administration; ingestion remained unchanged. Stimulated release of superoxide anion (O2-) was minimally changed. Treatment decreased expression of 483 genes and increased 386. Expression of eleven genes associated with neutrophil activity was upregulated. Genes not routinely associated with neutrophil function also demonstrated increased expression, including MHCI & II proteins, guanylate-binding proteins, and an enzyme synthesizing a nitric-oxide (NO) synthetase cofactor. CD11b expression, F-actin assembly, and CD 274 antigen were increased after treatment as was NO in neutrophil lysates. Formation of neutrophil extracellular traps after ingestion of staphylococci was increased off IFN-γ compared with controls but moved toward normal after IFN-γ administration. IFN-γ protects against infection in CGD by several mechanisms that could potentially support others with compromised host defense. Trial registration ClinicalTrials.gov NCT03548818">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f8cb75832b232cce6cf4390f3a132ef6fdcb77a9" target='_blank'>
              Interferon-gamma 1b-induced gene expression alters neutrophil function in patients with chronic granulomatous disease
              </a>
            </td>
          <td>
            Daniel R. Ambruso, Natalie J. Briones, Alexander D. Tran, Bridget Sanford, Christine Childs, Ben Z Katz, Michael Ellison, Richard B. Johnston, Kenneth L Jones
          </td>
          <td>2025-09-08</td>
          <td>PLOS One</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b73ba8336580ec9e7f5e7539d0fbcc48e4944d3b" target='_blank'>
              AAV-mediated delivery of a proliferation inducing ligand (APRIL) to cortical neurons limits inflammation and demyelination in the corpus callosum of the cuprizone mouse model
              </a>
            </td>
          <td>
            Leonardo Ricciardi, Federica Di Marco, Marion Decrop, Julia Di Stefano, Tejaswini Kakunuri, Joëlle van Rijswijk, N. Vidas-Guscic, Yousra El Ouaamari, Alexandro A. Bufi, Ignace Van Spilbeeck, Johan van Audekerke, Carole Faghel, Esther Bartholomeus, Eva Lion, Nathalie Cools, Steven Van Laere, I. Cicalini, Vincenzo de Laurenzi, Una Fitzgerald, D. Pieragostino, B. Huard, P. Del Boccio, Peter Ponsaerts, M. Verhoye
          </td>
          <td>2025-10-27</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dc9320984fb7ca80afa8b2d49d724dd86390a378" target='_blank'>
              Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy
              </a>
            </td>
          <td>
            Erika Ciervo, Francesco Ceccarelli, A. D. Di Giacomo, Piera Grisolia, A. Covre, Z. M. Besharat, Antonio De Falco, F. Caruso, Luigi Laezza, Luigi Ferraro, Gloria Mas Martin, M. F. Lofiego, Tommaso Sani, E. Ferretti, Yan Guo, Sean B. Holden, R. Mortarini, A. Anichini, M. Maio, T. Noviello, M. Ceccarelli
          </td>
          <td>2025-10-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>60</td>
        </tr>

        <tr id="ABSTRACT Since the COVID-19 pandemic, there has been a notable resurgence of Mycoplasma pneumoniae pneumonia (MPP) in children, with a concerning rise in the severity of cases. Although changes in post-pandemic respiratory infection patterns have been documented, the reasons behind the increased severity of MPP, especially concerning shifts in the respiratory microbiota, are not well understood. This study aims to explore how pandemic-associated disruptions in respiratory microbiota contribute to MPP severity. Through analysis of multiple independent cohorts, we found that the depletion of protective respiratory microbiota exacerbates MPP severity by reducing colonization resistance against M. pneumoniae. We identified two antagonistic microbiota modules with distinct metabolic features and community structures that regulate pathogen colonization and disease severity. Using a Susceptible-Infected-Recovered (SIR) model, we simulated M. pneumoniae infection dynamics across different microbiota states. Additionally, a machine-learning model based on eight key microbes effectively distinguished between cases and controls and predicted infection severity, offering insights into post-pandemic respiratory infections. This study underscores the essential role of the respiratory microbiota in influencing the severity of M. pneumoniae infections. Our findings offer a framework for managing respiratory infections in the post-pandemic era, highlighting the significance of understanding microbial community dynamics in determining disease outcomes. These insights could guide the development of therapeutic strategies focused on restoring or enhancing the protective microbiota, which may offer an effective strategy for the management of MPP and other respiratory infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5135993eab74980ff7611c3603fc5faaf64d3e01" target='_blank'>
              Post-COVID-19 disruption of the respiratory microbiome modulates Mycoplasma pneumoniae: a multi-center retrospective investigation study
              </a>
            </td>
          <td>
            Shiyu Huang, Shengkai Li, Ruike Zhao, Huajiang Yang, Yina Liu, Xinyi Wang, Jiaqi Zhang, Chen Shen, Feina Li, Hua Xu, Changyuan Guo, Xin Ni, Heng Li, Qing Cao, Zhemin Zhou
          </td>
          <td>2025-09-15</td>
          <td>Emerging Microbes & Infections</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="ABSTRACT Developing therapeutics that target the host kinome is a promising strategy to support current treatments for viral infections. While multiple direct‐acting antivirals (DAAs) potentially clear Hepatitis C virus (HCV) infection in most individuals, ~2.4 million individuals are unresponsive to the current DAAs or have secondary infections/complications that impact their treatment potential. Recent studies have demonstrated that atypical p38 activity is crucial for HCV replication and may have broader implications in regulating other viruses. Despite the multifaceted roles of p38 in regulating viral pathogenesis, the molecular mechanisms that underlie atypical p38 activation by viruses remain a critical gap in our understanding of viral physiology. Here, we characterized two atypical p38 allosteric modulators (NC compounds) during HCV infection. We compared the effects of these compounds to current DAAs for HCV and Herpesvirus, respectively. Our data show that treatment of either NC compound rapidly attenuates HCV‐induced p38 activation, blocking HCV protein expression and HCV RNA replication. Interestingly, while both NC compounds can successfully attenuate HCV infection, we also found that they displayed the capacity to inhibit the betaherpesvirus, Human Cytomegalovirus (HCMV), and the alpha herpesvirus, Herpes Simplex Virus‐1 (HSV‐1). Our study is the first to assess the potential of atypical p38 selective modulators to block viral replication. While the current examples are likely not clinically viable, the concept represents an exciting opportunity to support or complement current treatment strategies, shedding light on the importance that host factors play during viral physiology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/49bfb473a32832b3a4a9f825ba36bd2d59f13818" target='_blank'>
              Small Molecule Targeting of Atypical p38 Protects Against Viral Infection
              </a>
            </td>
          <td>
            Fredejah T. Royer, Jeremy C Burton, Johnathan Burns, Megan G Lloyd, R. Onwe, J. Moffat, Neil J. Grimsey
          </td>
          <td>2025-10-13</td>
          <td>The FASEB Journal</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Zika virus (ZIKV) is a neurotropic flavivirus capable of infecting the adult brain, however its impact on hypothalamic function and metabolic regulation remains unclear. Here, we show that ZIKV invades the hypothalamus of immunocompetent adult mice, where it replicates and persists, leading to sustained insulin resistance. Following infection, ZIKV RNA and negative strand were detected in the hypothalamus of mice and immunostaining confirmed viral proteins in neurons, especially POMC-positive cells. At 6 dpi, ZIKV induced hypothalamic neuroinflammation, as shown by the upregulation of TNF-α, IL-6, IFN-β, and ISG-15, as well as microglial activation. These inflammatory responses were associated with impaired insulin signaling, characterized by reduced phosphorylation of IRS-1 and S6K, downregulation of insulin receptor mRNA, and decreased anorexigenic response following intracerebral insulin administration. Our data also showed that, despite viral clearance and resolution of hypothalamic inflammation at 30 dpi, reduction in insulin receptor protein levels and hypothalamic insulin resistance persisted. These findings demonstrate that ZIKV replicates in the hypothalamus of immunocompetent adult mice, leading to long-lasting disruption of central insulin signaling. Our study identifies hypothalamic insulin resistance as a novel consequence of ZIKV central nervous system invasion and suggests that viral infections may contribute to long-term metabolic dysfunction, highlighting the need to investigate persistent hypothalamic and metabolic alterations in ZIKV infection-recovered individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/deff0518eb16d110cb9b78adc5fc218285716fcf" target='_blank'>
              Central Zika virus infection causes hypothalamic inflammation and persistent insulin resistance in adult mice
              </a>
            </td>
          <td>
            E. V. de Lima, Clara O Nogueira, R. R. Christoff, Emylle Costa-Bartuli, Tathiany Igreja-Silva, M. D. da Silva, Daniel Gavino-Leopoldino, Maria Luiza Móra Santos, F. S. Lemos, Jaderson C. da Costa, G. Venturin, I. Assunção-Miranda, João M. N. Duarte, Claudia P. Figueiredo, G. F. Passos, Julia R Clarke
          </td>
          <td>2025-10-13</td>
          <td>Cell Death & Disease</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="HIV-associated neurocognitive impairment (HIV-NCI), a comorbidity of human immunodeficiency virus (HIV) infection, affects up to 50% of people with HIV (PWH). HIV-infected monocytes that transmigrate across the blood–brain barrier and mature into macrophages establish a central nervous system (CNS) viral reservoir that activates and infects parenchymal cells, contributing to neuronal damage that characterizes HIV-NCI. Methamphetamine (meth) use is prevalent in PWH and further impairs cognitive functioning. To examine whether meth-mediated dysregulation of macrophage functions may contribute to increased HIV-NCI, we characterized differential gene expression in primary human HIV-infected macrophages treated daily with meth for five days by RNA-sequencing. We identified increases in multiple gene isoforms of metallothionein 1 (MT1), a heavy metal binding protein involved in protective mechanisms against metal toxicity and oxidative stress. Nuclear localization of MT1 protein was previously shown to either positively or negatively affect nuclear factor κB (NF-κB) activity in a cell type specific manner, with nuclear MT1 contributing to LPS-induced TNF-α and IL-6 in macrophages. We found that daily meth treatment for one to five days increased nuclear localization of MT1 in macrophages acutely infected with HIV which was associated with increased LPS-induced CXCL8 and CCL8, and a trend towards increased basal and/or LPS-induced expression of other cytokines/chemokines, including TNF-α and IL-6, that was donor specific. Reactive oxygen species (ROS) levels were not changed with meth treatment although there was a donor specific trend towards increased ROS with multiple days of meth treatment. These data indicate that repeated exposure of macrophages to meth in the context of HIV increases nuclear MT1 localization, which is associated with increased inflammatory mediator production, and therefore may be a mechanism that contributes to meth-mediated exacerbation of HIV-NCI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f9329bb1c83ed1fd2d8eb8fde23d750ee8b8e128" target='_blank'>
              Methamphetamine Induces Metallothionein 1 Expression and an Inflammatory Phenotype in Primary Human HIV-Infected Macrophages
              </a>
            </td>
          <td>
            Jessica Weiselberg, Meng Niu, Cristian A. Hernandez, Howard S. Fox, T. Calderon, Joan W. Berman
          </td>
          <td>2025-09-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>1</td>
          <td>29</td>
        </tr>

        <tr id="Degeneration of myelinating oligodendrocytes and the resulting breakdown of the myelin sheath are key drivers of neurodegeneration and disability across numerous central nervous system pathologies. Thus, a compelling strategy to preserve neuronal function is to promote endogenous myelin repair by oligodendrocyte precursor cells (OPCs). Extracellular vesicles (EVs) secreted by pro-regenerative microglia have been shown to enhance OPC maturation and remyelination across different experimental models. Yet, the mechanisms by which microglia-derived EVs exert their beneficial effects on OPCs are not fully understood. In this study, we performed transcriptomic profiling of primary murine OPCs treated during differentiation with EVs obtained from donor microglia following stimulation with pro-inflammatory cytokines (i-EVs), interleukin-4 (IL4-EVs), or mesenchymal stem cells in the presence of the inflammatory cocktail (MSC-EVs; GEO accession number: GSE304130). Compared to controls, IL4-EVs and MSC-EVs induced robust changes in gene expression, whereas i-EVs elicited far fewer alterations. Using bioinformatic analyses, we identified the molecular pathways significantly modulated by microglial EVs, revealing a large overlap between IL4-EV and MSC-EV targets. Notably, many of these shared pathways centered on mitochondrial function and bioenergetic metabolism. Upstream regulatory network inference further pinpointed candidate transcription factors and kinases that may drive EV-induced transcriptional reprogramming in OPCs. Hence, our findings indicate that rewiring mitochondria-associated pathways is a core mechanism underlying the pro-differentiation effects of microglial EVs on OPCs. Elucidating these intracellular circuits will open new avenues for developing EV-based or mitochondria-targeted remyelinating therapies. Graphical abstract Transcriptional effects of microglia-derived extracellular vesicles on oligodendrocyte maturation. Transcriptomics profiling revealed that extracellular vesicles derived from pro-regenerative microglia (IL4-EVs and MSC-EVs) reprogram oligodendrocyte precursor cells (OPCs) by modulating mitochondrial and bioenergetic pathways, promoting their maturation. In contrast, pro-inflammatory i-EVs induce minimal transcriptional changes and have a limited impact on OPC differentiation Supplementary Information The online version contains supplementary material available at 10.1007/s10571-025-01612-7.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1b95243ad26d133386a4eadb6ee422c452782bc0" target='_blank'>
              Microglia-Derived Extracellular Vesicles Enhance Oligodendrocyte Maturation by Transcriptionally Regulating Mitochondrial Molecular Pathways
              </a>
            </td>
          <td>
            S. Raffaele, Marta Lombardi, Davide Marangon, M. Abbracchio, D. Lecca, C. Verderio, Marta Fumagalli
          </td>
          <td>2025-10-21</td>
          <td>Cellular and Molecular Neurobiology</td>
          <td>0</td>
          <td>66</td>
        </tr>

        <tr id="Sepsis, due to dysregulated host responses to infection, demands early intervention. Nevertheless, it is challenging to identify immune changes in the transition from high-risk states to sepsis, which remains unclear. Here, we profiled the single-cell transcriptome of peripheral blood immune cells in healthy controls, high-risk individuals, and clinical sepsis patients to characterize the transcriptomic reprogramming featured by the monocyte and platelet activation across sepsis progression. Particularly, a core gene set (S100A8, S100A9, IFITM2, IFITM3) showed significant upregulation in monocytes in both the high-risk stage and clinical sepsis. Moreover, platelets also exhibited early activation of coagulation and inflammatory pathways, notably sharing this core gene set upregulation. We further analyzed Single-cell RNA Sequencing (scRNA-seq) data from independent cohorts of very preterm infants with sepsis and elderly patients with diabetes. The consistent, early, and persistent upregulation of the S100A8/A9 and IFITM2/3 monocyte signature was strikingly observed across these diverse, high-risk populations. This study provides novel single-cell insights into immune dysregulation during sepsis onset, pinpointing specific transcriptomic signatures in monocytes and platelets emerging during the high-risk phase. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-025-17078-y.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/762ecf8be789dd05f23d4604ee048954d159d87d" target='_blank'>
              Single-Cell transcriptomic profiles of peripheral blood immune cells reveal early monocyte and platelet activation in the transition from high-risk states to clinical sepsis
              </a>
            </td>
          <td>
            Lanlan Sun, Peng Zhang, Haikun Zhang, Hailang Fan, Yansheng Li, Yaqian Zhao, Mengtong Wang, Yingdi Huang, Mingyang Liu, Dake Zhang, Xin Zhang
          </td>
          <td>2025-09-25</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Zika virus (ZIKV) is a mosquito‐borne flavivirus causing a major epidemic in the Americas in 2015. Dendritic cells (DCs) are leukocytes with key antiviral functions, but their role in ZIKV infection remains under investigation. While most studies have focused on the monocyte‐derived subtype of DCs, less is known about conventional dendritic cells (cDCs), essential for the orchestration of antiviral adaptive immunity. This study investigates the mechanisms by which cDCs respond to ZIKV for antiviral cytokine production. Here, using murine cultures, we demonstrate that ZIKV infection and not detection of ZIKV‐infected dead cells activates cDCs by inducing type I interferons (IFN‐I) and proinflammatory cytokines. Furthermore, ZIKV‐infected cDCs markedly activated the IRE1/XBP1s axis of the unfolded protein response (UPR). Flow cytometry analysis indicates that among cDCs, type 1 cDCs (cDC1s) are responsible for ZIKV detection. Functionally, genetic loss of XBP1s curtailed expression of the costimulatory molecule CD86 and the production of IFN‐I and proinflammatory cytokines by cDCs, without exhibiting increased susceptibility to ZIKV infection. These effects are attributable to perturbations in the IRE1/XBP1s axis and not due to overcompensation of PERK or IRE1 kinase signaling. Finally, tissue resident cDCs also exhibit susceptibility to infection, potentially establishing these cells as ZIKV targets in vivo. These findings underscore a critical role for the IRE1/XBP1s pathway in fine‐tuning cDC activation to ZIKV, linking viral recognition to cDC functional maturation and opening new avenues for exploring UPR pathways targeting cDCs in the context of flavivirus infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6dd1b3a248725abc54ccc25e9710b056d70c579d" target='_blank'>
              The IRE1/XBP1s Axis Regulates Innate Immune Responses in Conventional Dendritic Cells During ZIKV Infection
              </a>
            </td>
          <td>
            Mónica Guzmán-Rodríguez, Tomás Hernández-Díaz, Paula Lisboa, Javier López-Schettini, Sofia Sanhueza, Lisette Leyton, Takao Iwawaki, R. Soto-Rifo, Fabiola Osorio
          </td>
          <td>2025-09-08</td>
          <td>The FASEB Journal</td>
          <td>1</td>
          <td>25</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/183f309102020194c23f7f4fa2e0b4a0bcc44a55" target='_blank'>
              Whole-genome DNA methylation profiling in COVID-19 positive patients reveals alterations in pathways linked to neurological dysfunction
              </a>
            </td>
          <td>
            S. Zameer, Ehraz Anis, Qiang Sha, Martha L. Escobar Galvis, Sanam Khan, Jennifer A. Steiner, M. Milčiūtė, Ieva Kerševičiūtė, Migle Gabrielaite, Juozas Gordevičius, Andrew Pospisilik, Nazia Saiyed, Stewart F. Graham, Patrik Brundin, L. Brundin
          </td>
          <td>2025-09-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Introduction Despite SARS-CoV-2 pandemic has subsided, vaccine response profiling in patients with cancer remains critical. Methods We longitudinally assessed humoral and cellular immunity in adults with solid tumours treated with chemotherapy (ChT) or non-ChT regimens after two mRNA vaccine doses plus booster, compared with vaccinated cancer-free controls, naturally infected (convalescent) subjects including both patients with cancer and cancer-free individuals, and unvaccinated/uninfected individuals with or without cancer as a baseline reference. Results Anti-Spike IgG titres matched cancer-free controls, but anti-RBD titres and neutralising activity were consistently lower in cancer post-vaccination, most markedly with ChT, and declined faster over 4-6 months. Boosters restored IgG, yet gains were smaller in ChT recipients. Cellular analyses revealed sustained and booster-enhanced Spike-specific B cells in all groups; however, ChT exposure was associated with reduced CD27 expression on these cells, suggesting impaired activation and memory maturation. Discussion These findings support tailored immune monitoring and vaccination strategies in oncology and identify CD27 downregulation as a novel B-cell dysfunction detected by high-dimensional immunophenotyping.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ece73c2c90429ae4c877fe3e324050afd6b55d35" target='_blank'>
              Impact of chemotherapy on humoral and cellular immune responses to COVID-19 vaccination in patients with solid tumors
              </a>
            </td>
          <td>
            Andrea Favalli, Giorgio Patelli, P. Gruarin, A. Gobbini, E. Pesce, Sara Mariano, M. Bombaci, Francesca Vincenti, L. Donnici, Silvia Marchese, D. Piscazzi, A. Amatu, F. Tosi, Silvia Ghezzi, Arianna Pani, Silvia Principato, Andrea Lombardi, Alessandra Bandera, S. Abrignani, S. Siena, A. Sartore-Bianchi, Renata Grifantini, Kristin Renkema, Huang Huang, P. Favalli, Grifantini. This
          </td>
          <td>2025-09-25</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>65</td>
        </tr>

        <tr id="As the pediatric COVID-19 landscape evolves, it is essential to evaluate whether SARS-CoV-2 infection predisposes children to allergic disorders. This narrative review synthesizes current epidemiological and immunological evidence linking pediatric COVID-19 with new-onset atopy. Epidemiological data remain heterogeneous: large Korean and multinational cohorts report increased risks of asthma and allergic rhinitis following COVID-19, whereas U.S. cohorts show neutral or protective associations, highlighting geographic and methodological variability. Mechanistic insights provide biological plausibility: epithelial injury and the release of alarmin cytokines (IL-33, IL-25, TSLP) promote Th2 polarization and ILC2 expansion, while epigenetic “scars” (e.g., LMAN2 methylation changes) and hematopoietic stem cell reprogramming may sustain long-term Th2 bias. Cytokine memory involving IL-7 and IL-15 contributes to altered T- and B-cell homeostasis, whereas disrupted regulatory T-cell function may reduce tolerance thresholds. Paradoxical trade-offs exist, such as ACE2 downregulation in allergic airways, which may lower viral entry but simultaneously amplify type-2 inflammation. Together, these processes suggest that SARS-CoV-2 infection could foster a pro-allergic milieu in susceptible children. Although current evidence is inconclusive, integrating epidemiological surveillance with mechanistic studies is crucial for predicting and alleviating post-COVID allergic outcomes. Longitudinal pediatric cohorts and interventions targeting epithelial alarmins or microbiome restoration may hold promise for prevention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/915e70de93eed337c1055b8bcb1c32ceec3aa48b" target='_blank'>
              Immunological Mechanisms Underlying Allergy Predisposition After SARS-CoV-2 Infection in Children
              </a>
            </td>
          <td>
            Filippos Filippatos, Dimitra-Ifigeneia Matara, Athanasios Michos, K. Kakleas
          </td>
          <td>2025-09-28</td>
          <td>Cells</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Coronavirus disease 2019 (COVID-19) patients have a 1.7-fold higher arrhythmia risk with rates of cardiac complications ranging from 2% non-ICU patients to 59% in non-survivors. Atrial fibrillation (AF), the most common arrhythmia, is a frequent complication of acute and long COVID-19. The high expression of ACE2 in the heart suggested that infectious virus may underlie cardiac complications. However, we recently reported in human cardiac tissue from fatal COVID-19 cases perivascular spike protein, elevated pro-inflammatory cytokines, vascular damage, and cardiac remodeling without evidence for direct infection of cardiac cells by SARS-CoV2. Mislocalization of intercalated disc (ID) components, connexin-43 (Cx43) gap junctions and NaV1.5 sodium channels, was also evident in patients’ hearts, recapitulating structural remodeling we previously identified as providing a substrate for atrial arrhythmias following an acute inflammatory insult. Therefore, we hypothesized that the inflammatory response elicited by SARS-CoV2 spike protein is sufficient to provoke atrial arrhythmias. Structural and functional assessments of WT murine hearts were performed five days following a single bolus intravenous injection of the viral spike protein. In vivo ECGs demonstrated increased atrial arrhythmia burden in spike-injected mice vs. control. Immunohistochemistry studies revealed elevated expression of inflammatory markers and evidence of vascular damage in these mice. Additionally, we observed disruption of ID ultrastructure and mislocalization of Cx43 and NaV1.5 in the atria of spike protein-injected mice. Our results suggest that vascular-leak inducing inflammatory insult from viral spike protein, and not direct infection by SARS-CoV2 results in the pathophysiology of cardiac dysfunction in fatal COVID-19. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-025-12807-9.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c153f00606118d9f8c8e5f0644e86dd859e1dd6c" target='_blank'>
              SARS-CoV-2 spike protein-induced inflammation underlies proarrhythmia in COVID-19
              </a>
            </td>
          <td>
            Louisa Mezache, Andrew M. Soltisz, Esmerina Tili, Gerard J. Nuovo, R. Veeraraghavan
          </td>
          <td>2025-09-30</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Since its emergence, the coronavirus (SARS-CoV-2) outbreak has been a pandemic responsible for about 7 million deaths worldwide. Numerous studies have been conducted to determine the virus’s multiorgan system involvement, particularly its relation to cancer biology. Spontaneous regression of cancer has been observed in some patients with the coronavirus, which may be attributed to the virus’s ability to trigger specific immune responses that can be oncolytic and help reduce and eliminate oncogenic cells. This study aims to explore the paradoxical effects of COVID-19 in inducing cancer regression. The paradoxical effect of SARS-CoV-2 infection has been attributed to the possibility of a heightened immune activation possibly triggered by the virus, and some of these include increased levels of cytokines such as interferon and tumor necrosis factor-alpha (TNF-α), as well as the activation of T cells and natural killer (NK) cells. COVID-19-induced cancer regression presents new perspectives on the relationship between viral infections and the immune system’s antitumor capabilities. This would help foster future research investigating specific immune pathways activated during SARS-CoV-2 and discover how these can be therapeutically harnessed to aid cancer regression. Supplementary Information The online version contains supplementary material available at 10.1186/s13027-025-00704-9.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2b70234ee10e35d21e82680c57b0003d8503d4e0" target='_blank'>
              COVID-19 infection and cancer regression: a review of current evidence, potential mechanisms, and clinical perspectives on a Paradoxical phenomenon
              </a>
            </td>
          <td>
            I. Ogieuhi, V. Ajekiigbe, C. Agbo, Chidera Stanley Anthony, Adegbesan Abiodun Christopher, Jennifer Chinaecherem Onyehalu, M. C. Agu, Sylvia Mmesomachi Mbaji, Adewunmi Akingbola, Bisharat Ahmed, Owa Ogieuhi, Olufemi Akinmeji
          </td>
          <td>2025-10-23</td>
          <td>Infectious Agents and Cancer</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="The SARS-CoV-2 pandemic had unprecedented impacts on public health and the economy. Many studies have focused on the mechanisms of SARS-CoV-2 entry into host cells, particularly the spike (S) protein mediated receptor engagement and subsequent virus-host membrane fusion dynamics. However, the mechanistic contribution of cholesterol within spike-incorporated viral envelopes to infectivity has not been well characterized. Herein, we show that targeted cholesterol depletion from the viral envelopes of SARS-CoV-2, SARS-CoV, and MERS-CoV directly impaired viral infectivity in a dose-dependent manner. Although modulation of host cell membrane cholesterol exerted relatively minor effects on viral entry, host cellular cholesterol homeostasis critically governs progeny virion infectivity by determining cholesterol content within nascent viral envelopes. Virions derived from cells with reduced plasma membrane cholesterol demonstrate significantly attenuated infectivity in SARS-CoV-2 and related coronaviruses. In addition, we detected that exogenous cholesterol replenishment restored SARS-CoV-2 entry efficiency by augmenting virus attachment. Collectively, our data demonstrate that biophysical properties of human coronavirus envelopes, particularly cholesterol stoichiometry, function as a key molecular determinant regulating host cell susceptibility. These findings position viral lipidome remodeling as a viable therapeutic target for developing host-directed broad-spectrum antivirals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2b66bac5249cf5d92ba8f485c839bbe27a7cb1e6" target='_blank'>
              Cholesterol in viral envelope determines infectivity of SARS-CoV-2 and other coronaviruses
              </a>
            </td>
          <td>
            Xiaoying Xu, Xueyan Wang, Xiafeng Zhang, Xin Jin, Yun Tan, Lin Huang, Mingqian Zhou, Chengping Wen
          </td>
          <td>2025-09-18</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1566aab3aa003f1116a60b08f46f073a5f754602" target='_blank'>
              Single-cell multi-omics show disruption of blood and airway T-cells in pulmonary long COVID
              </a>
            </td>
          <td>
            E. Guinto, I-Chih Kuo, S. Chopra, S. B. Shin, F. V.gerayeli, J.-W. Yoo, H. Y. Park, M. Messing, X. Li, C. Gilchrist, D. Yehia, R. Eddy, S. Milne, T. Stach, C. Cheung, J. S. Yang, W. Yip, T. Shaipanich, J. Leipsic, K. McNagny, J. Leung, D. Sin
          </td>
          <td>2025-09-19</td>
          <td>None</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/10d55887dd7d12323eb386296c4572af9c380d12" target='_blank'>
              The nuclear receptor NR4A1 serves as a neutrophil-intrinsic regulator mitigating stroke severity
              </a>
            </td>
          <td>
            Jan-Kolja Strecker, Yannick Schmidt, M. Liebmann, Carolin Walter, Stefan Roth, Hanna Aleth, Anna-Lena Börsch, Antje Schmidt-Pogoda, Carolin Beuker, Ayan Mohamud Yusuf, Julian Revenstorff, Collins Osei-Sarpong, Lisa Krafft, Anna-Sophie Schwarze, M. Heming, Mathis Richter, Tanja Kuhlmann, S. Hucke, Jan-Niklas Heming, Uwe Hansen, Nina Hagemann, A. Bader, Jincheng Gao, Barbara Walzog, Daniela Maier-Begandt, Raphael Chevre, E. Hanschmann, Martin Lücke, Clemens Sommer, Dirk M. Hermann, Johannes Roth, Christian Thomas, G. Meyer zu Hörste, Matthias Gunzer, Thomas Vogl, Alexander Zarbock, Frank Rosenbauer, Carlos Silvestre-Roig, Oliver Söhnlein, L. Klotz, J. Minnerup
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f8574e17dda1b09d6c703a7d3ef93ad3a9f3cdff" target='_blank'>
              Peripheral blood cellular dynamics during the progression of human tuberculosis.
              </a>
            </td>
          <td>
            , Qiuchen Dai, Kai Wang, Hanlin Yan, , Yayan Niu, Cheng Chen, Meiying Wu, , Wanjun Gu
          </td>
          <td>2025-10-27</td>
          <td>Scientific reports</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Background Toscana virus (TOSV), a sandfly-borne phlebovirus, is a frequent cause of viral meningitis and meningoencephalitis in Mediterranean countries during summer months. Clinical outcomes vary from self-limited disease to prolonged persistent infection lasting over 3 months, but the mechanisms underlying these differences remain unclear. In this study, we compared the pathobiological features of two clinical TOSV strains, SI-1812 (associated with self-limited disease) and INMI (associated with persistent infection), using human neural models. Methods Three human neural systems, DBTRG.05MG glioblastoma cells, embryonic stem cell-derived neurons, and human brain organoids (hBOs), were infected with the two TOSV strains. Viral replication, cytopathic effect, innate immune response, and viral protein expression were assessed. Furthermore, whole-genome sequencing was performed to identify strain-specific differences. Results The INMI strain showed reduced replication and cytopathic effect compared to SI-1812, supporting persistent infection in hBOs for up to 21 days. SI-1812 infection triggered a strong interferon-β response even at early stages of infection and low viral titers, whereas INMI induced a modest innate immune response in the early stages of infection, likely supporting its persistence in hBOs. The timing of viral NSs protein expression differred between the two viral strains suggesting distinct mechanisms in RIG-I activation and inflammatory response modulation. Conclusions Distinct host-pathogen interactions underlie the divergent clinical courses of TOSV strains. The findings provide insights into mechanisms of viral persistence in the human brain and may guide future therapeutic strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/de54b8e867a33dfd2d1bf9fa6cd128497a0c4755" target='_blank'>
              Phenotypic characterization of two neuroinvasive Toscana virus strains clinically associated with self-limited and persistent infections in human neural cells and brain organoids
              </a>
            </td>
          <td>
            Stefania Vogiatzis, Gianni Gori Savellini, C. Terrosi, M. Trevisan, Gabriele Anichini, Letizia Rizzo, Giulia Alessandri, Emanuela Dal Molin, Camilla Lucca, Luisa Barzon, M. Cusi
          </td>
          <td>2025-09-25</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Ending of COVID-19 pandemic does not exclude subsequent breakthrough infections caused by SARS-CoV-2 mutant strains. The rate of SARS-CoV-2 mutations increased with emerging omicron strain and exceeds those of the influenza virus. It remains unclear what IgG antibody levels are able to protect against new mutant SARS-CoV-2 strains, and how long the immune protection will last. The objective of this study was to monitor the maintenance of humoral and cellular immunity to SARS-CoV-2 viral antigens over 4 years after the infection. Thirty-two adult reconvalescents after COVID-19 were annually examined for humoral and cellular immunity markers to the SARS-CoV-2 S protein. Humoral immunity was assessed by ELISA; cellular immunity was evaluated by expression of CD107a on CD8hi lymphocytes after recognition of S protein antigens. A four-year observation of a group of patients who recovered from COVID-19 in 2020 (SARS-CoV-2, Wuhan strain) and were in contact with a novel, freely circulating mutant VoCs showed that, 1 year later, all subjects retained the IgG antibodies to S protein, mainly the IgG1 subclass, but the antibody avidity index barely exceeded 50%. After a breakthrough infection caused by the omicron strain, the level of IgG antibodies to S protein increased significantly, along with sufficient increase of antibody avidity. The IgG2, IgG3, and IgG4 antibodies to S protein occured in the spectrum of subclasses. The level of specific IgA decreased 1 year after the disease against their level after the primary disease. However, it was significantly increased to 4-5 PR after breakthrough infections. Cellular immunity to the SARS-CoV-2 S protein was detected in all subjects at 1 year after the primary disease. After repeated infection with the omicron strain, it increased significantly and remained at this level for the next year. By 4 years, it decreased to the level that was a year after the disease. Hence, humoral and cellular immunity to S protein does not fade away, but continues to persist, maturate, being maintained at a sufficient level. Upon exposure to a new VoC, it allows to endure such a meeting either asymptomatically, or as a mild clinical infection. In view of frequent mutations in the S protein, the role of T-cell responses in anti-infectious protection seems to increase significantly. When developing new vaccines, one should rely on development of cellular immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e639b1e50968635421ab873cef8a370649bdc963" target='_blank'>
              Immunological memory to SARS-CoV-2 S protein persists 4 years after the disease
              </a>
            </td>
          <td>
            Z. Afridonova, A. Toptygina, E. Semikina
          </td>
          <td>2025-09-28</td>
          <td>Russian Journal of Immunology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/461722f90e682345662c6276a91b4383ad6356c7" target='_blank'>
              Convergent evolution and host-limiting impacts of SARS-CoV-2 revealed by cellular experiments.
              </a>
            </td>
          <td>
            Ting Zhang, Ren-Rong Tian, Fengyi Li, Xiaolu Tang, Wenbin He, , Lin Zhuo, Jian Lu, Xuemei Lu, 
          </td>
          <td>2025-10-28</td>
          <td>Molecular biology and evolution</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Introduction: Coronavirus Disease-2019 (COVID-19) vaccines are a crucial tool in controlling and ultimately ending the pandemic, complementing other preventive measures. India launched its vaccination campaign on January 16, 2021, initially using two vaccines that received emergency authorisation: Covaxin (BBV152) and Covishield (ChAdOx1 nCoV-19). The vaccination effort began with elderly individuals (60+ years) and frontline workers, eventually expanding to include various age groups. During this period, India faced a severe second wave of COVID19, marked by a notable rise in postvaccination breakthrough infections throughout 2021, driven by more transmissible and potentially more immune-evasive variants. To date, no study is available that details the rate of these breakthrough infections and the variants responsible in our region.

Aim: To determine the rate of breakthrough infections in our region and identify which Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants are responsible for these infections.

Materials and Methods: This cross-sectional study was conducted in a tertiary care hospital in Northern India over one year, from January 2021 to December 2021. Nasopharyngeal swabs from suspected COVID-19 patients were collected and subjected to Ribonucleic acid (RNA) extraction, followed by Reverse Transcription-Polymerase Chain Reaction (RTPCR) testing. The breakthrough infection rate was defined as infections occurring in individuals who were fully vaccinated with two standard doses of the AZD1222/Covishield vaccine. Genome sequencing was performed to identify the SARSCoV-2 variants responsible for postvaccination breakthrough infections. Data analysis was conducted using Microsoft Excel Software 16.

Results: Between January 2021 and December 2021, 513,197 nasopharyngeal swabs were analysed, with a total of 32,952 (6.42%) samples testing positive for SARS-CoV-2 by RT-PCR. Out of these, 2,043 (6.2%) samples were from cases in which individuals had been vaccinated with two doses of the vaccine. Genome sequencing of 11 such samples revealed that eight of the patients were infected with the Delta variant (Pango Lineage: B.1.617.2). One sample showed the Eta variant (Lineage B.1.575) with the E484K mutation. Unfortunately, two samples could not be processed due to inadequate quality.

Conclusion: A breakthrough infection rate of 6.2% was recorded, with the Delta variant (Pango Lineage: B.1.617.2) of SARS-CoV-2 being commonly associated with these infections. This study underscores the need for continued and rigorous genomic surveillance of emerging SARS-CoV-2 variants to assess their potential to evade immune responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9617ab2261eefa4c2c31fffa2776bf01b2e125fa" target='_blank'>
              Genomic Insights into Vaccine Evasion: A Cross-sectional Study from a Tertiary Care Hospital of Northern India
              </a>
            </td>
          <td>
            Uksim Qadri, B. Fomda, Shaista Nazir, Yawar B. Mir, Mehvish Saleem, M. Bhat
          </td>
          <td>2025-11-01</td>
          <td>JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Abstract Background Survivors of COVID-19 frequently report psychiatric and cognitive sequelae. The origin of such sequelae has not been determined, as it has been a challenge to resolve whether these symptoms have a viral origin or are related to the contextual stressors associated with the pandemic. Using a mouse model of post-acute sequelae of SARS-CoV-2 infection (PASC), we examined neurobiological mechanisms underlying these effects without the confounding influence of contextual factors. Results SARS-CoV-2 infection induced cognitive, but not anxiety- or depression-like, behavioral deficits. Cognitive impairments correlated with severity of the acute disease. Infected mice showed significant alterations in brain cytokine levels, as well as in kynurenine pathway (KP) metabolites, both of which were associated with acute disease severity. Microbiome taxonomic profiling revealed group-specific differences, indicating that certain bacterial species may contribute to PASC development. Conclusions Our findings suggest that SARS-CoV-2 infection causes cognitive deficits in PASC, modulated by acute disease severity, while anxiety- and depression-like behaviors appear unrelated to the viral infection itself. This supports the idea that such psychiatric symptoms may stem from pandemic-related stressors rather than infection. Altered cytokine signaling and KP metabolism may play key roles in the pathophysiology of PASC, identifying potential biomarkers and therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0fb3ed4fe779a93447277b5e14c32a1a056c5b57" target='_blank'>
              Neuropsychiatric- and cognitive post-acute sequelae of SARS-CoV-2 infection – evidence from K18-hACE C57BL/6 J mice
              </a>
            </td>
          <td>
            Marco Maria Santi, Eleonora Genovese, T. Schou, Matheus da Silva, Sophie Erhardt, L. Schwieler, Jacob Ahlberg Weidenfors, Giorgia Marino, S. R. Paludan, Sâmia Joca, G. Wegener, L. Reinert, C. Bay-Richter
          </td>
          <td>2025-09-30</td>
          <td>International Journal of Neuropsychopharmacology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c621268191d1ab1062fdde91b864e8d04c3a542c" target='_blank'>
              Induced pluripotent stem cell-derived macrophages as a model for human inflammasome signaling
              </a>
            </td>
          <td>
            Chloe M. McKee, Melanie Cranston, Emma C. McKay, Mohammad Arefian, T. Mawhinney, Ben C. Collins, Rebecca C. Coll
          </td>
          <td>2025-09-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Abstract Multiple sclerosis (MS) is a chronic, autoimmune, demyelinating disease of the central nervous system (CNS) in which macrophages play a pivotal and multifaceted role. These highly plastic immune cells are key effectors in the immunopathology of MS, contributing to both inflammatory-driven demyelination and subsequent tissue repair. Historically, macrophage function was viewed through the binary lens of pro-inflammatory M1 and anti-inflammatory M2 polarization. However, recent research reveals a far more complex spectrum of activation states within the dynamic microenvironment of MS lesions. Understanding the intricate signals and molecular pathways that govern macrophage polarization in the CNS represents a critical frontier for therapeutic innovation. Interventions aimed at rebalancing macrophage phenotypes have yielded encouraging results in preclinical models, and some therapeutic agents are now advancing into clinical trials. Future investigations are focused on the diverse functions of macrophages in MS pathogenesis, including their involvement in oxidative stress, antigen presentation, and myelin debris clearance. A particularly innovative approach involves harnessing macrophages as cellular vehicles for targeted drug delivery across the blood-brain barrier, offering a potential solution to one of the most significant challenges in CNS therapeutics. The primary challenge now lies in the safe and effective clinical translation of these macrophage-centered therapies. Successfully navigating this transition from bench to bedside holds the potential to deliver transformative treatments that can halt disease progression and restore neurological function for individuals living with this debilitating disease.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aad33ff0adee236c1c773c1750932b0d5634824d" target='_blank'>
              Emerging Insights into the Role of Macrophages in Multiple Sclerosis: Pathogenesis and Potential Therapeutic Strategies
              </a>
            </td>
          <td>
            Jundong Yang, Ziyue Fu, Qiyuan Zou, Zhaoyinqian Li, Yuhan Xing
          </td>
          <td>2025-10-01</td>
          <td>Journal of Inflammation Research</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0911d60365dedd3cca17fdc7bda0117b0a42dd1a" target='_blank'>
              Senescent-like border-associated macrophages regulate cognitive aging via migrasome-mediated induction of paracrine senescence in microglia.
              </a>
            </td>
          <td>
            M. Hu, Xinmei Kang, Zhiruo Liu, Shisi Wang, Sanxin Liu, Chunyi Li, Danli Lu, Qin Qin, Yuxin Liu, Haotong Yi, Liling Yuan, Quentin Liu, Zhengqi Lu, W. Cai
          </td>
          <td>2025-09-10</td>
          <td>Nature aging</td>
          <td>1</td>
          <td>19</td>
        </tr>

        <tr id="ABSTRACT Activating immune receptors provides mechanisms for phagocytes to elicit important effector functions that promote the killing of microbes. Leukocyte immunoglobulin‐like receptor A5 (LILRA5), an orphan immune receptor expressed by human phagocytes and co‐localising with FcRγ, remains poorly characterised. To address this, we developed a highly specific anti‐LILRA5 monoclonal antibody that has agonistic properties. We show LILRA5 expression on naïve monocytes and neutrophils, and that ligation of LILRA5 stimulates ROS production. While increased LILRA5 transcripts have been associated with sepsis, we also observed increased levels in patients with systemic infection but without sepsis complications. Ex vivo bacterial infection of whole blood did not alter surface LILRA5 expression, but LPS stimulation changed expression levels, indicating that surface LILRA5 expression is dynamic and likely regulated post‐transcriptionally, changing responses to different stimuli or over time. Soluble (s)LILRA5 was enhanced in sera from sepsis patients and in supernatants of monocytes that were LPS‐stimulated, indicating that shedding of LILRA5 from cell surfaces or that expression of sLILRA5 isoforms provides a mechanism to regulate surface LILRA5 expression levels. Finally, we show that altered surface LILRA5 expression influences LILRA5‐induced ROS production capacity. Thus, LILRA5 is a dynamically regulated activating receptor expressed on phagocytes that stimulates ROS production.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e622c651c7e7739946e6713271f95711e4f0f55e" target='_blank'>
              LILRA5 Functions to Induce ROS Production on Innate Immune Cells
              </a>
            </td>
          <td>
            Zuyi Fu, Matevž Rumpret, Irina Kube-Golovin, M. Lyndin, Vera Solntceva, Yuxi Zhao, Anastasia Konieva, Na Liu, A. Press, Stefanie B Flohé, Michael Bauer, Gunther Wennemuth, Bernhard Singer, Alex J. McCarthy
          </td>
          <td>2025-10-01</td>
          <td>European Journal of Immunology</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a chronic, immune-mediated autoimmune disease characterized by the infiltration of autoreactive T cells and other inflammatory immune cells from the periphery into the central nervous system. Currently, there is no cure for MS, and treatment consists of disease-modifying therapies (DMTs), most of which modify or delete specific immune cell populations. These populations express crucial MS treatment-associated receptors, which may be differentially expressed in each patient, and thus each drug may affect individuals differently. Here, we developed the first comprehensive 24-parameter flow cytometry immunophenotyping panel to evaluate treatment-associated receptor expression on the major MS-associated immune cells in whole blood. Analyzing whole blood samples from treatment-naïve individuals with MS using this panel, we demonstrated that expression levels of these receptors vary between individuals. Response to the chosen DMT treatment also differed across participants. When monitoring the receptor expression during the course of treatment, we detected an increased response to treatment when receptor expression was elevated at the start of treatment. This panel reliably detects these receptors in MS treatment-naïve participants and enables monitoring of their expression throughout treatment. This tool will enable deep interrogation of the immune receptors targeted by MS therapies and highlights that treatment-associated receptor expression levels might be used to predict or correlate with treatment response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/019f2dcb4e902228e625f81330b78afadd2958ea" target='_blank'>
              Monitoring Treatment-Associated Receptor Expression in Multiple Sclerosis Using a Newly Developed Panel for Spectral Flow Cytometry.
              </a>
            </td>
          <td>
            Katharina Robichon, Jennifer Taylor, Imogen Milner, Kathryn E Hally, A. L. La Flamme
          </td>
          <td>2025-09-23</td>
          <td>Cytometry. Part A : the journal of the International Society for Analytical Cytology</td>
          <td>1</td>
          <td>27</td>
        </tr>

        <tr id="ABSTRACT The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in 2020 led to the immediate development of vaccines to combat SARS-CoV-2 infections and coronavirus disease 2019 (COVID-19). First-generation (2020–2021) COVID-19 vaccines demonstrated high immunogenicity and efficacy, successfully reducing hospitalization, disease severity and COVID-19 related deaths. However, the initial clinical trials for these vaccines focused on overall healthy individuals, and generally excluded high risk populations, such as people with cancer. The SARS-CoV-2 VaccinE Response, Immunological eFfects and safetY in patients with Cancer (VERIFY-C) study formed a unique cohort in early 2021, to capture the initial immune response to BNT162b2 mRNA (Pfizer) vaccination in people with cancer, with or without ongoing/recent exposure to systemic cancer treatment. Fifty-three participants diagnosed with cancer were enrolled. Majority were non-Hispanic, Caucasian females. Patients under cancer treatment had significantly lower antibody responses than those without treatment at pre-second dose and 1-month post-second dose. The levels at 6-months post-second dose were similar between both groups. Patients under treatment had a significantly lower immune response 1-month post-second dose, with an increased immune response at 6-months post-second dose, suggesting a delayed immune response. Further investigations are needed to understand antibody functionality post-vaccination in these individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e45420f0ba45dea4c651f1e55f885e82dbe1ff7e" target='_blank'>
              Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatment
              </a>
            </td>
          <td>
            Christine M Dang, Troy J. Kemp, Nancy V. Roche, Katarzyna Haynesworth, Sarah A Loftus, Benjamin J Borski, Ziad El Bakouny, C. Labaki, Gwo-Shou Mary Lee, Rachel Trowbridge, Sarah Strauss, Melissa E Hughes, Nancy U Lin, T. Choueiri, Ligia A. Pinto
          </td>
          <td>2025-10-14</td>
          <td>Human Vaccines & Immunotherapeutics</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Leprosy is a chronic infectious disease that targets the peripheral nervous system, leading to peripheral neuropathy. Mycobacterium leprae primarily infects Schwann cells, adipocytes, and macrophages, altering their metabolism and gene expression. This study investigates the metabolic interaction between M. leprae and Schwann cells, with a focus on indoleamine 2,3-dioxygenase (IDO), a key enzyme in tryptophan catabolism via the kynurenine pathway. We found that M. leprae induces IDO expression in Schwann cells, suggesting a role in immune modulation and neuropathy. Inhibition of IDO with 1-methyl-L-tryptophan (1-MT) reduced Schwann cell viability and metabolic activity in response to M. leprae. After 24 h of infection, M. leprae impaired mitochondrial membrane potential, although no significant changes in autophagy or mitochondrial ultrastructure were observed by electron microscopy. Interestingly, IDO1 inhibition upregulated the expression of antioxidant genes, including GPX4, NFE2L2, and HMOX1. In conclusion, these findings highlight a central role for IDO in shaping the metabolic and immunological response of Schwann cells to M. leprae infection. IDO induction contributes to immune regulation and cellular stress, while its inhibition disrupts cell viability and promotes antioxidant gene expression. These results position IDO as a potential therapeutic target for modulating host–pathogen interactions and mitigating nerve damage in leprosy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/abb3610626dbc037a9c11480f7a7205f2b79ea22" target='_blank'>
              IDO-Mediated Immune and Metabolic Dysregulation in Schwann Cells Exposed to Mycobacterium leprae
              </a>
            </td>
          <td>
            Atta Ur Rahman, Raíssa Couto Santana, Mylena Masseno de Pinho Pereira, Claudia Luciana dos Santos Moura, Débora Santos da Silva, Otto Castro Araujo, Thyago Leal-Calvo, Isabela Espasandin, Tatiana Pereira da Silva, E. Sarno, Bruno J. de Andrade Silva, R. Menna-Barreto, M. M. Jardim, C. S. de Macedo, F. A. Lara, Roberta Olmo Pinheiro
          </td>
          <td>2025-10-01</td>
          <td>Cells</td>
          <td>0</td>
          <td>52</td>
        </tr>

        <tr id="We performed a large-scale immunogenomic analysis of ∼13,000 transcriptomic profiles from 10 autoimmune diseases, integrating publicly available datasets from both blood and tissue. Using meta-analysis, we identified core immune mechanisms underlying autoimmunity, including strong interferon responses, inflammation, and adaptive immune suppression, alongside disease-specific signatures. To enhance biological interpretability, we derived higher-order immune features - such as cell type proportions, cytokine levels, pathway activity, transcription factor regulation, and miRNA activity - and organized them into 15 coherent immune modules. These modules enabled systematic cross-disease comparisons, revealing shared and distinct immunopathological patterns. The inflammation module, in particular, was associated with disease severity and predicted treatment response across multiple conditions. This modular framework offers a powerful tool for understanding immune dysregulation and advancing precision medicine in autoimmune diseases. To support reproducibility and enable others to build upon this work, we developed an interactive app to explore and download the complete dataset and associated results.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33657b128cad4b7bef3c91009696d7561897ed33" target='_blank'>
              The Integrated Cellular and Molecular Landscape of Autoimmunity
              </a>
            </td>
          <td>
            R. Appierdo, G. Pepe, M. Helmer-Citterich, Marina Sirota, Francesco Vallania, P. Gherardini
          </td>
          <td>2025-09-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Extracellular vesicles (EVs) are rapidly gaining recognition as critical mediators of inter-cellular communication during viral infections. To contribute to fill the gap in knowledge regarding the role of EVs in adenovirus infection, we used human adenovirus type 4 of species Mastadenovirus exoticum (HAdV-E4), a prevalent respiratory and ocular pathogen, and characterized the cargo and biological properties of EVs released by HAdV-E4-infected A549 lung epithelial cells at a pre-lytic stage of infection. Using immunocapture-based isolation and multi-omics approaches, we found that infection profoundly alters the EV uploaded proteome and small non-coding RNA repertoire. Mass spectrometry identified 268 proteins unique to EVs purified from infected cells (AdV-EVs), with enrichment in pathways supporting vesicle trafficking and viral protein translation, and importantly also a few virus-encoded proteins. Small RNA transcriptome analysis showed differential uploading in AdV-EVs of various small non-coding RNAs, including snoRNAs, as well as the presence of virus associated RNAs I and II. Notably, AdV-EVs contained viral genomic DNA and were capable of initiating productive infection upon delivery to naïve cells in the absence of detectable viral particles. Our data suggest that EVs released during HAdV-E4 infection may serve as vehicles for non-lytic viral dissemination and highlight their possible role in intra-host dissemination.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2099efee27dc1f09a50509011e989cc86d99ff60" target='_blank'>
              Cargo and biological properties of extracellular vesicles released from human adenovirus type 4-infected lung epithelial cells
              </a>
            </td>
          <td>
            Alessio Noghero, Stephanie Byrum, C. Okeoma, A. Kajon
          </td>
          <td>2025-08-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/01d23f6e4d0fadd94bb32dc65cae50f988969ac5" target='_blank'>
              Re-shaping the immune response to influenza vaccination in a host with immune memory from influenza
              </a>
            </td>
          <td>
            Chantelle L. White, Lara Mengu, Siva K. Gandhapudi, K. Richards, A. J. Sant
          </td>
          <td>2025-10-01</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="The SARS-CoV-2 pandemic presents a broad clinical spectrum from asymptomatic cases to severe respiratory failure with high mortality. Severe COVID-19 is characterized by immune dysregulation, including lymphopenia and alterations in the counts of T, B, and NK cells in peripheral blood. Due to the limited data on long-term outcomes related to immune dysregulation, we aimed to analyze immunologic features at baseline in severe and mild COVID-19 cases and assess follow-up characteristics associated with later mortality and long-COVID signs. We included adult patients consecutively hospitalized with COVID-19 between June and November 2020 at the University Hospital in Kraków, corresponding to the first and second waves of COVID-19 in Poland. We enrolled only those who had been thoroughly assessed in terms of clinic and laboratory data, including immunological workups, and survived the acute phase of the disease. In 2025, between February and April (median time of follow-up: 54 months), we conducted a telephone questionnaire on long-COVID symptoms among survivors who had given their consent. Statistical analyses were performed to compare groups with severe and mild disease in terms of dysregulation in lymphocyte subpopulations and the follow-up outcomes. The study included 103 COVID-19 patients, comprising 53 severe (based on the need for at least high-flow nasal oxygen therapy) and 50 mild cases, with no differences in age, sex, and body mass index. Severe COVID-19 patients compared to mild cases had lower CD3+ T cells (count and percentage), CD4+ T cells (count and percentage), CD8+ T cells (count), and NK cells (count), but higher CD19+ B cells (percentage) at baseline (p < 0.05, all). At the time of follow-up, we evaluated 80 patients (77.7% of the baseline participants), with 23 (22.3%) patients lost to follow-up. Among patients analyzed in the follow-up, 23 (28.8%) had died, and 29 of the 57 survivors (50.9%) reported persistent long-COVID symptoms. Patients who died had significantly lower baseline counts of CD3+ T cells (377 vs. 655 cells/µL), CD4+ T cells (224 vs. 372 cells/µL), CD8+ T cells (113 vs. 188 cells/µL), and NK cells (118 vs. 157 cells/µL) compared to survivors (p < 0.05, all). Notably, the percentage of CD19+ B cells was higher in deceased individuals (19.2% vs. 13.5%; p = 0.049). In contrast, we did not document differences in baseline immunological data among survivors with and without long-COVID signs. Our study suggests that dysregulation in lymphocyte subpopulations during the COVID-19 acute phase may be associated with increased late mortality, but not with the persistence of long-COVID symptoms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/de8b75924f0ad1abad27efe7fa8b5e02ab64f1f4" target='_blank'>
              Baseline Dysregulation in B, T, and NK Cells in COVID-19 Predicts Increased Late Mortality but Not Long-COVID Symptoms: Results from a Single-Center Observational Study
              </a>
            </td>
          <td>
            Aleksandra Matyja-Bednarczyk, Radosław Dziedzic, Anna Drynda, Ada Gradzikiewicz, Monika Bociąga-Jasik, Krzysztof Wójcik, Sabina Lichołai, K. Górka, N. Celejewska-Wójcik, Tomasz Stachura, K. Polok, L. Zarȩba, Teresa Iwaniec, Krzysztof Sładek, S. Bazan-Socha
          </td>
          <td>2025-10-21</td>
          <td>Viruses</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0e2cd0bbb1e59a38e076fba7a9569f36e691a9aa" target='_blank'>
              SARS-CoV-2 infection induced alterations in ADAR editing patterns differ between patients who developed critical compared to non-critical COVID-19
              </a>
            </td>
          <td>
            A. M. Nair, H. Piontkivska
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>30</td>
        </tr>

        <tr id="Japanese encephalitis virus (JEV) infection causes encephalitis in humans and animals. Following intradermal infection, JEV crosses the blood-brain barrier (BBB) and reaches target cells in the brain parenchyma. However, the cellular dynamics and pathological niches involved in JEV neuroinvasion remain poorly understood. In this study, we investigated the early stages of JEV infection in the mouse brain employing a highly multiplexed spatial transcriptomics platform to map viral RNA and host gene expressions in intact brain sections at a single-cell resolution. Although JEV RNA was undetectable in brain sections at 1-day postinfection (dpi), innate immune responses were transiently activated across the brain. At 4 dpi, we detected limited viral RNA and mapped its spatial distribution, identifying glial cells surrounding microvessels as early targets of brain infection. We further characterized transcriptional changes in infected and surrounding bystander cells, revealing cell-type-specific antiviral responses. Notably, JEV neuroinvasion led to the downregulation of endothelial tight junction genes, indicative of an early event that precedes BBB impairment during subsequent disease progression. Our spatial transcriptomic analysis provides insights into cell-type- and region-specific responses to JEV infection, and highlights the early role of glial cells in shaping the immune response landscape of the brain. These findings greatly improve our understanding of JEV pathogenesis before the onset of clinical encephalitis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/20b652e6d4a5af18c629cdfab49fb2adcd9dcec8" target='_blank'>
              Spatial gene expression analysis reveals pathological niches in Japanese encephalitis virus neuroinvasion.
              </a>
            </td>
          <td>
            Y. Orba, Y. Kashima, Koshiro Tabata, Yukari Itakura, Takuma Ariizumi, William W Hall, Hirofumi Sawa, Yutaka Suzuki, M. Sasaki
          </td>
          <td>2025-10-23</td>
          <td>Proceedings of the National Academy of Sciences of the United States of America</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3659e67328ffa6a7afc24383c34110e1246de0a3" target='_blank'>
              Single-Cell Atlas of CD4+ T-Helper 2 Cells Reveals Distinct Cytokine Functions Across Diseases
              </a>
            </td>
          <td>
            Son Vo, Maria Suprun, Han Do, My Ngo, Rajesh Rao, Saurabh Vishnu Laddha, Marta E Polak, Calixte Monast, Son Pham
          </td>
          <td>2025-09-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Progressive multiple sclerosis (PMS) represents a distinct clinical and biological entity characterized by compartmentalized neuroinflammation, chronic glial activation, and resistance to conventional immunotherapies. Unlike relapsing MS, PMS is sustained by resident CNS immune networks, where activated microglia and astrocytes orchestrate persistent cytokine signaling—particularly involving TNF-α, IL-1β, and IL-6—through self-amplifying feedback loops. In this narrative review, we explore how these cytokines interact with oxidative stress, iron accumulation, mitochondrial dysfunction, and impaired autophagy to drive neurodegeneration. Human-based evidence is integrated with insights from experimental models to clarify translational mechanisms. We also highlight fluid biomarkers (e.g., GFAP, NfL) and imaging modalities (e.g., TSPO-PET, QSM) that reflect glial activity and disease progression in vivo. Age, sex hormones, and immunosenescence are discussed as modulators of cytokine expression. Finally, we review emerging therapeutic strategies that target glial metabolism and cytokine networks rather than peripheral immune cells, offering a systems-based framework for future PMS interventions and personalized disease monitoring.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b95aee20640777431b2cd302ca1ff620ae824601" target='_blank'>
              Glial Cytokine and Metabolic Networks in Progressive Multiple Sclerosis: From Pathophysiology to Biomarkers and Therapeutic Strategies
              </a>
            </td>
          <td>
            Henry Leonard Hohm, Rasmus Schuster, Victor-Bogdan Buciu, D. Șerban, Sebastian Ciurescu, A. Cornea, Abhinav Sharma, D. Nistor, N. Kundnani
          </td>
          <td>2025-09-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e5941ecec7872e6e7a4fe85dc2f11895a3625725" target='_blank'>
              PD-1 signaling is essential for the early accumulation of HBV-specific CD8+ T cells during HBV infection
              </a>
            </td>
          <td>
            Xiaoqing Zeng, Wen Pan, Ziwei Li, Zhaoli Liu, Hongming Huang, Xuecheng Yang, K. Sutter, Mengji Lu, Ulf Dittmer, Gennadiy Zelinskyy, Xin Zheng, Dongliang Yang, P. Kennedy, Yanqin Du, Jia Liu
          </td>
          <td>2025-09-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="INTRODUCTION
Cytokine storm can result from uncontrolled proinflammatory cytokines released in SARS-CoV-2 infection that cause damage to several organs. Il-6 is one of the major mediators of cytokine storm. IFN-α2 has been reported to have anti-viral potential and the pre-infection levels of proinflammatory cytokines have been suggested to drive the fate of the disease. There is a paucity of information on how anti-viral cytokines at the onset of infection affect the disease progression. This study aims to profile IL-2, IL-6, IL-10, and IFN-α2 expression levels for 44 days post-diagnosis and their effects on recovery.


METHODS
Peripheral venous blood was collected from 38 SARS-CoV-2 infected participants who came for diagnosis at the Center for Research on Emerging and Reemerging Diseases. IL-2, IL-6, IL-10, and IFN-α2 levels were measured using a Luminex panel.


RESULTS
Males had higher SARS-CoV-2 viral load than females, although the difference was not statistically significant (p=0.08). Age-related variation was also observed, with individuals aged 40-60 showing significantly higher viral load than those over 60 (p=0.045). Cytokines analysis revealed that males had significantly higher levels of IFNα-2, IL-2, and IL-6 (p=0.0031, p=0.009, and p=0.022 respectively) than females upon diagnosis, with cytokines levels decreasing over time in males but increasing in females. Cytokine levels trended higher in symptomatic individuals, although differences were not significant.


CONCLUSION
These findings highlight the influence of sex, clinical status, and viral load on cytokine dynamics in COVID-19, with potential implications for understanding disease severity and immune response.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a96153529dbc58b976dae603414f6f5491296d91" target='_blank'>
              Cytokines dynamics and biological sex differences in SARS-CoV-2 infected people in Cameroon.
              </a>
            </td>
          <td>
            Hillary Tene, Romuald Ngamaleu, R. Djounda, Rachel Minomo, Sabine Ngale, Micheal Besong, Honore Awanakam, Krystelle Nganou Makamdop, Rene Essomba, Jude Bigoga, Daniel C. Douek, L. Esemu
          </td>
          <td>2025-09-22</td>
          <td>Clinical and experimental immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Parrots, valued companion animals with a concerning conservation status, can act as reservoirs for zoonotic diseases. During various infections, systemic inflammation significantly impairs host health. However, the regulation of inflammatory responses in birds, particularly in cognitively advanced parrots, remains poorly understood. Here, we examine parrot systemic inflammation in response to virus-mimicking stimulation. In budgerigars (Melopsittacus undulatus), a novel model for neuroinflammation research, we induced sterile inflammation with synthetic poly(I:C) RNA and analysed dose-, time- and tissue-dependent gene expression patterns of key markers, including TLR3, NLRP3, CASP1, IL1B and IL6, during acute immune response. We report a significant relationship between cytokine expression (IL1B, IL6) in the intestine (local response) and brain (systemic response) that has not yet been described after viral stimulation in parrots. Peripheral IL6 expression was upregulated at 3–6 h after stimulation with poly(I:C). In the brain, multiple genes (TLR3, IL1B and IL6) showed activation early during the immune response. These findings highlight the susceptibility of parrots to neuroinflammation following viral infections, having specific relevance for basic research in neurobiology, immunology and behavioural science, and also veterinary research in psittacine birds. Our study provides a foundation for future comparative research on avian neuro-immune crosstalk and neuroinflammation-related behavioural disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b23dca0d96ff356c079d40ec7845a15398f0ccf4" target='_blank'>
              The neuro-immune crosstalk between periphery and central nervous system during acute immune response to virus-mimicking RNA in parrots
              </a>
            </td>
          <td>
            Balraj Melepat, Daniel Divín, Kateřina Marková, Tao Li, Nithya Kuttiyarthu Veetil, Eleni Voukali, Lucie Schmiedová, Martin Těšický, Michal Vinkler
          </td>
          <td>2025-10-01</td>
          <td>Royal Society Open Science</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Zika virus (ZIKV) can infect and replicate in the endoplasmic reticulum (ER) of different human cell types, including neural progenitor cells, radial glial cells, astrocytes, and microglia in the brain. ZIKV infection of microglia is expected to trigger both ER stress and the induction of an antiviral response through production of type-I interferons and pro-inflammatory cytokines, contributing to neuroinflammation during infection. Despite their critical role in ZIKV pathogenesis, the interplay between ER stress and the antiviral response during infection has not been fully characterized in human microglia. In this work, we show that infection of a human microglia cell line with ZIKV triggers the induction of an antiviral response and the activation of the endonuclease activity of the unfolded protein response sensor IRE1. Interestingly, we observed that both IRE1 and XBP1 were sequestered to the viral replication sites during infection. Moreover, pharmacological inhibition or hyperactivation of the endonuclease activity of IRE1 resulted in reduced viral titers. As such, while inhibition of IRE1 resulted in an increased type-I interferon response, hyperactivation led to a decrease in ZIKV RNA levels and the appearance of ER-derived cytoplasmic structures containing NS3, IRE1, and XBP1. Together, our data indicate that regulation of the endonuclease activity of IRE1 is critical for both ZIKV replication and immune activation, highlighting the potential of the ER stress sensor as a target for the development of antivirals to treat ZIKV infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c49266713c41489835395ed05f1e9648bda8bc34" target='_blank'>
              Activation of IRE1 Endonuclease Activity Regulates Zika Virus Replication and Antiviral Response During Infection in Human Microglia
              </a>
            </td>
          <td>
            Tomás Hernández-Díaz, A. Oyarzún-Arrau, Aracelly Gaete-Argel, Delia López-Palma, Javier López-Schettini, Dominique Fernández, F. Valiente-Echeverría, Fabiola Osorio, R. Soto-Rifo
          </td>
          <td>2025-09-24</td>
          <td>Viruses</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="Although the COVID-19 pandemic is no longer a global health emergency, many patients still suffer from long-term effects, known as post-acute sequelae of COVID-19 (PASC) or long COVID. Understanding its complex pathophysiology requires animal models replicating the post-acute phase, which may aid in developing, the urgently needed, therapeutics. Our review assessed and summarized 81 studies from 1979 manuscripts. In addition, a second table summarizing the imaging findings of 26 studies related to this topic was added, based on a separate literature search of 797 manuscripts. In humans a SARS-CoV-2 infection, the sequelae and possible development of PASC is heterogenic. The same holds true for experimental animal models. While several models are suitable to address different research questions, no single model can fully replicate all aspects of PASC. Imaging plays a crucial role in visualizing these aspects, especially since questionnaires, the primary diagnostic tool in humans, cannot be used in animals. Thus, imaging allows the investigation of pathophysiology in a controlled setting, offering valuable insights. This review summarizes the available animal models and imaging modalities used in PASC research. Our aim is to provide researchers with guidance on selecting the most appropriate model and imaging technique to address their specific research questions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/31d97a980102a7066ecfd8960908cbcbefc27537" target='_blank'>
              Post Pandemic Problem, is there an animal model suitable to investigate PASC
              </a>
            </td>
          <td>
            Julia van der Bie, Anthony Coleon, Denise Visser, Willy M. Bogers, Jeroen den Dunnen, Henri M H Spronk, J. A. M. Langermans, H.L.D.M. Willemen, G. D. de Melo, J. Middeldorp, M. Stammes
          </td>
          <td>2025-09-15</td>
          <td>npj Imaging</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Age is a critical factor in immune responses to infection. In malaria, severe disease risk increases with age in non-immune individuals. Malaria severity is in part driven by inflammation, but mechanisms contributing to age-dependent disease risk are incompletely understood. We assessed inflammatory cytokines during malaria in non-immune children and adults, and innate cell responses in vitro to malaria parasites in naive children and adults. We show during malaria age is associated with increased inflammatory chemokines CCL2, CCL3, CXCL8, CXCL9, along with CRP, and IDO, which associate with symptoms. In naive individuals, classical monocyte and Vδ2+ γδ T cells from adults have higher inflammatory cytokine production, and transcriptional activation following stimulation with parasites. Classical monocyte responses in adults are dominated by CCL2, while in children increased IL10 and enrichment of IL10 signaling pathways is detected. Findings identify age-dependent cellular mechanisms that play crucial roles in driving inflammatory responses in malaria.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/08d5c0c81051d13694cfc33dd1cf3b4215156753" target='_blank'>
              Age is an intrinsic driver of inflammatory responses to malaria
              </a>
            </td>
          <td>
            Jessica R. Loughland, Nicholas L Dooley, Zuleima Pava, Arya SheelaNair, D. Andrew, Peta E. Tipping, Peter Bourke, C. Engwerda, J. A. Lopez, Kim A. Piera, Timothy William, Bridget E. Barber, M. Grigg, N. Anstey, Gabriela Minigo, Michelle J. Boyle
          </td>
          <td>2025-09-30</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Pneumococcal infection of the leptomeninges triggers a strong inflammatory response, contributing to tissue damage and adverse outcome in meningitis. While border-associated macrophages (BAM) are thought to initiate immune responses against pathogens, their exact role in pneumococcal meningitis (PM) - especially at later stages - remains unclear. This study examined the impact of BAM depletion on disease progression. Mice received intracisternal injections of clodronate liposomes (CL) to deplete BAM, followed three days later by intracisternal infection with Streptococcus pneumoniae. At 18 h post-infection, CL-treated mice exhibited clinical signs similar to controls treated with phosphate-buffered saline liposomes (PBSL). However, CL-treated mice had lower cerebrospinal fluid leukocyte counts, increased expression of brain immune mediators, and elevated plasma levels of neuronal damage (NEFL) and astrocyte activation (S100B) markers. Over a 42-h observation period - during which ceftriaxone therapy was started 18 h post-infection - CL-treated mice showed significantly worse outcomes: 9 of 12 reached termination criteria versus 1 of 9 PBSL-treated mice. This correlated with more severe neuropathology, higher bacterial loads, and persistent inflammation. Notably, infection with a pneumolysin-deficient mutant conferred strong protection against disease aggravation caused by macrophage depletion, whereas caspase-1 inhibition - despite its known immunosuppressive effects in experimental PM - did not. These findings underscore a critical immunoregulatory role for BAM in PM, particularly in resolving rather than initiating inflammation. Their absence exacerbates disease severity, mainly due to increased bacterial proliferation and elevated levels of bacterial toxins. Supplementary Information The online version contains supplementary material available at 10.1186/s40478-025-02126-5.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6563837df86067b2d0826abdc0bf8ed3eb50df5b" target='_blank'>
              Pharmacologic depletion of border-associated macrophages worsens disease in a mouse model of meningitis
              </a>
            </td>
          <td>
            Susanne Dyckhoff-Shen, I. Masouris, H. Pfister, Stefanie Völk, Sven Hammerschmidt, Matthias Klein, U. Koedel
          </td>
          <td>2025-09-23</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>55</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/077c5f7bdc46a2e19cbd2c688cbd2d3576c8d469" target='_blank'>
              Transcriptomic Analysis Reveals Key Regulatory Genes and Pathways Involved in Macrophage Inflammation Induced by Hypervirulent Klebsiella pneumoniae Infection.
              </a>
            </td>
          <td>
            Jinli Bi, Xin Huang, Liqin Meng, Jinghan Li, Yu He, Jing Jin, Taijie Li
          </td>
          <td>2025-09-05</td>
          <td>Current microbiology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Virus-specific CD4+ T cells typically undergo T helper (Th) 1 differentiation and contribute to a type 1 immune response in infection with lymphocytic choriomeningitis virus (LCMV). Using this model pathogen, we performed an in-depth analysis of the quantitative expression stability of the Th1 key transcription factor T-bet. Previously, it was shown that virus-specific Th1 cells arising in acute infections expressed T-bet at distinct intensities and maintained their T-bet expression differences after viral clearance as memory cells for weeks in the steady state. However, it was unclear whether differential T-bet expression was associated with heterogeneity inside the Th1 population and if the quantitative T-bet memory, particularly of those cells expressing T-bet at low levels, could withhold the strong and continuous stimulation present during chronic infection. Using T-bet-ZsGreen reporter mice, virus-specific Th1 cells were characterized phenotypically at protein, RNA, and DNA/chromatin accessibility levels. The Th1 cells arising during acute LCMV Armstrong infection showed a continuous spectrum of T-bet expression, ranging from cells with very high T-bet to cells with low T-bet. Even though the cells with low T-bet expression clearly possessed Th1 characteristics, they additionally showed certain Tfh-like features at protein and RNA level. When virus-specific Th1 cells were sorted according to T-bet-ZsGreen reporter expression intensity, adoptively transferred, and rechallenged by infecting the host animals with the chronic Clone 13 strain of LCMV, they maintained quantitative differences in T-bet reporter and IFN-γ expression levels. A subpopulation of the progeny of the former T-betlow cells still showed a mild Tfh-associated phenotype. Independent of their past and present T-bet expression level, all virus-reactive CD4+ T cells acquired phenotypic signs of exhaustion as characterized by upregulation of PD-1, LAG3, and TOX and vast absence of effector cytokine co-expression in the chronic infection environment. Collectively, our findings highlight the heterogeneity of T-bet+ antiviral CD4+ T cells and the stability of quantitative differences in individual virus-specific CD4+ T cells during chronic viral challenge infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bc9e88d2fafc16f74c1bf59bb61267ab8fcd6cb4" target='_blank'>
              Stable characteristics of intrapopulation heterogeneity in virus-specific Th1 cells during chronic viral challenge infection
              </a>
            </td>
          <td>
            V. Plajer, A. Madrigal-Avilés, Maria Dzamukova, Nayar Durán-Hernández, Philippe Saikali, Vivien Holecska, Isabel Panse, Katrin Lehmann, Jinfang Zhu, Mir-Farzin Mashreghi, Ahmed N. Hegazy, Caroline Peine, M. Löhning
          </td>
          <td>2025-09-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Acute lower respiratory infections are the primary cause of global mortality in post-neonatal children. Most respiratory viruses primarily involve upper airway infection and inflammation, yet nasal responses are poorly characterized. Using a mouse model of human metapneumovirus (HMPV), we found viral burden was higher in nasal airways and exhibited delayed clearance. Despite high burden, there was low nasal expression of type I and III interferon (IFN). Single-cell RNA-sequencing (scRNA-seq) from HMPV-infected mice showed lower nasal interferon-stimulated gene (ISG) expression and nasal enrichment of genes negatively regulating IFN. scRNA-seq of COVID-19 patients confirmed lower ISG expression in upper airways. HMPV infection downregulated nasal expression of interferon regulatory factor-3, suggesting a mechanism for limited response. To rescue the quiescent environment, we administered type I or III IFN to upper airways early post-infection, leading to lower nasal HMPV titer and virus-specific CD8+ T-cell upregulation. Intranasal immunization adjuvanted with type I or III IFN improved immune response, reduced clinical disease, and enhanced viral clearance in HMPV and influenza infection. IFN adjuvant increased recruitment of dendritic cells, resident-memory T-cells, and neutralizing antibodies. These findings reveal locally suppressed IFN production contributes to a quiescent nasal immune landscape that delays viral clearance and impairs mucosal vaccine responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5293ad91066dc2e4c751ceac69a474e1697f9ed9" target='_blank'>
              Limited nasal interferon production contributes to delayed respiratory virus clearance and suboptimal vaccine responses.
              </a>
            </td>
          <td>
            Jorna Sojati, Olivia B. Parks, Taylor Eddens, J. Lan, Monika Johnson, John V. Williams
          </td>
          <td>2025-09-16</td>
          <td>JCI insight</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Chronic lymphocytic leukemia (CLL) is associated with immune dysfunction, but how disease-intrinsic mechanisms in treatment-naive patients influence the coordination of adaptive responses to novel antigens remains unclear. Here, we assessed SARS-CoV-2-specific antibody and T cell immunity in 38 treatment-naive CLL patients and 13 healthy controls (HCs) following vaccination. Despite significantly reduced total immunoglobulin levels compared to HCs, 94.7% of CLL patients developed SARS-CoV-2-specific IgG, and 89.5% mounted IgA responses, with serum titers comparable to those of HCs. Virus-specific T cell responses, measured by IFN-γ release following antigen stimulation, were detected in 78.9% of patients. CLL patients had significantly more circulating CD4+ T follicular helper (Tfh) and T follicular regulatory (Tfr) cells than HCs. These expansions correlated with B cell abundance, which, in untreated CLL, predominantly reflects malignant B cells. Notably, Tfh cell frequencies and absolute counts were highest in patients lacking a SARS-CoV-2-specific T cell response, indicating a decoupling between Tfh expansion and functional antiviral immunity. Overall, these findings demonstrate that while SARS-CoV-2-specific immune responses are largely preserved in treatment-naive CLL patients, disease-driven alterations in T cell composition may compromise the coordination and quality of antigen-specific T cell-mediated immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380a2444f13a61f76a9c9706f853d8210212d10f" target='_blank'>
              Attenuated SARS-CoV-2-Specific T Cell Responses Are Associated with T Follicular Helper Cell Expansion in Treatment-Naive Chronic Lymphocytic Leukemia Patients
              </a>
            </td>
          <td>
            B. Šlisere, R. Kārkliņš, A. Rivkina, Sandra Lejniece, K. Oļeiņika
          </td>
          <td>2025-09-01</td>
          <td>Pathogens</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="INTRODUCTION
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants that emerged shortly after the coronavirus disease 2019 (COVID-19) pandemic began have altered epidemiological and clinical findings; and these variants changed the course of this health crisis.


METHODOLOGY
Whole-genome sequencing was performed on SARS-CoV-2 strains isolated from 21 patients with COVID-19. The frequency of structural changes in the virus and their effects on clinical findings of the disease were analyzed.


RESULTS
The spike Q493R mutation was detected more frequently in patients who had received four or more doses of a COVID-19 vaccine (p = 0.043). The clinical effect of the spike R346K and A263T mutations (reported in Türkiye for the first time) detected in a patient who had received four doses of the vaccine in the 3 months prior to being infected with COVID-19 could be related to escape from the antibody response. The spike R21T mutation may increase the virus's entry into intestinal cells; and, as a result it may be responsible for severe clinical course and gastrointestinal symptoms. The patient infected with the Omicron BA.2 subvariant with the spike L452M mutation exhibited a significant increase in inflammatory parameters; suggesting that this mutation may trigger an excessive immune response and hyperinflammation.


CONCLUSIONS
This is the first study based in Türkiye that evaluated the clinical impact of variations in the sequences of SARS-CoV-2 variants. There is a need for further investigation into the clinical impact of these results in a larger population spread over more centers, and more sequencing studies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f9038ab2f87898403bd45b31ad5eff4904f2f429" target='_blank'>
              Whole genome sequencing and analysis of the clinical implications of SARS-CoV-2 strains.
              </a>
            </td>
          <td>
            Firuze Soyak, Tugba Sari, O. Tokgun, Ahmet Çalışkan, Hüseyin Turgut
          </td>
          <td>2025-09-30</td>
          <td>Journal of infection in developing countries</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Fever, a universal host defense in infection and inflammation, paradoxically contributes to neurological complications in malaria. While febrile temperatures enhance the expression of parasite virulence proteins that mediate vascular adhesion and disease severity, its effects in the endothelium remain elusive. Here we present a 3D fever-on-a-chip model that recapitulates human brain and lung microvessels under febrile conditions. Short febrile episodes at 40 °C, common in treated cerebral malaria patients, rapidly enhanced iRBC and immune cell binding under flow. Mechanistically, we demonstrated that this phenotype was driven by endothelial glycocalyx shedding, which exposed endothelial receptors EPCR and ICAM-1. Preserving glycocalyx integrity with a broad MMP inhibitor prevented the temperature-induced rise in cytoadhesion. These findings identify fever as a host-specific amplifier of vascular pathology in malaria and highlight endothelial-protective or antipyretic interventions as important strategies to mitigate febrile microvascular pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d47b3eee29354cca13ac834e2304230b2e377991" target='_blank'>
              Febrile temperature enhances Plasmodium falciparum cytoadhesion by disrupting the endothelial glycocalyx
              </a>
            </td>
          <td>
            Viola Introini, Rory K. M. Long, O. Oyerinde, Silvia Sanz Sender, Frank Stein, Gyu Min Hwang, Borja Lopez Gutierrez, Karl Boynton Seydel, Gretchen Birbeck, Maria Bernabeu
          </td>
          <td>2025-09-08</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="ABSTRACT: It has been five years since the first COVID-19 cases emerged in China. The infection spread extensively around the world, impacting millions and presenting a significant risk to public health, leading to the breakdown of healthcare systems in various countries. The COVID-19 is caused by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and is a recent emergent virus that belongs to the beta (β)-coronaviruses. The presence of comorbidities significantly influenced the mortality rate among patients infected with COVID-19. For a while, it was believed that the transmission of SARS-CoV-2 was limited to respiratory tract invasion; however, more research indicated that the infection may also affect the central and peripheral neurological systems, among many other organs and systems. Encephalopathy, encephalitis, meningitis, ischemic and hemorrhagic stroke, and cerebral venous sinus thrombosis are among the neurological side effects linked to the SARS-CoV-2 infection. Since the pandemic began, COVID-19 treatment has advanced swiftly, mostly emphasizing antiviral and immunomodulatory medications. Remdesivir and nirmatrelvir-ritonavir are examples of antivirals that have been observed to be most effective when used initially in an illness (for instance, as outpatient treatment) and in instances of milder disease. When treating serious disease or critical illness, immunomodulatory treatments like dexamethasone, Janus kinase inhibitors, or interleukin-6 are most beneficial. Mass vaccination campaigns as a preventative measure are the most effective means of preventing this pandemic. In order to mitigate or lower the rates of COVID-19 infections, hospitalizations, and fatalities, several vaccine platforms, such as vaccines based on nucleic acids (DNA and mRNA vaccines), adenovirus-vectored vaccines, inactivated vaccines, and protein-based subunit vaccines, have been created and developed. This article mainly emphasizes the taxonomy and structural virology with the probable viral immuno-pathogenesis mechanism of SARS CoV-2. It also outlines the correlation between comorbidities and neurological complications, and lastly, it mentions the prophylaxis and vaccines used for treating COVID-19 patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0a70a2923de6b03b5ba5d2f9d44e636f97663886" target='_blank'>
              An All-Inclusive Overview of COVID-19 (SARS-COV-2): Emphasising Immuno-Pathogenesis, Correlation with Comorbidities, Neurological Consequences, and Therapeutic Objectives
              </a>
            </td>
          <td>
            Joy Biswas
          </td>
          <td>2025-09-30</td>
          <td>Biosciences Biotechnology Research Asia</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Introduction American cutaneous leishmaniasis (ACL) constitutes a neglected skin disease that causes severe disability and significant social stigma for millions of people each year. This parasitic infection is caused by several species of the protozoan Leishmania, including Leishmania amazonensis. There is therefore an urgent need to develop effective new tools to control ACL, primarily due to the limitations of current prophylactic and therapeutic strategies, which are exacerbated by the growing burden of the disease and its social impact. In recent years, scientific research has focused on extracellular vesicles (EVs), which are lipid-enclosed rounded nanostructures that carry macromolecules to recipient cells and are part of eukaryotic biology. The role of Leishmania-derived EVs in host pathogenesis has attracted considerable attention among researchers, with studies suggesting that EVs may play a key role in modulating the host immune response. Therefore, this study examined the immunogenicity and protein cargo of EVs shed by L. amazonensis, exploring their effect on immune activation in the murine macrophages (MΦs) lineage. Methods Nanoparticle tracking analysis, microscopy, proteomic methodologies, colorimetric assays, serological immune methods, PCR, and multiparametric flow cytometry were employed. Results EVs derived from L. amazonensis cultured promastigotes contain key components, such as the 63 kDa surface glycoprotein, intracellular heat shock protein 70, and α-type proteasome subunit, which may be involved in parasite survival. Moreover, EVs are recognized by mouse- and human-specific antibodies, indicating that they have the potential to elicit humoral immune responses and can be inactivated by host-specific antibodies. Depending on the concentration, EVs can drive MΦs to express MHC molecules that are essential for antigen presentation to T lymphocytes, thereby being able to promote a cellular immune response. EVs favor IL-1β+MΦs contraction, and low nitric oxide production, and activate the arginase pathway to produce urea along with the generation of proinflammatory cytokines. This MΦs modulation may support parasite control through the specific activation of T cells while preserving skin homeostasis, thereby reducing the pathology associated with L. amazonensis infection, which causes ACL and leads to the development of chronic disease. Discussion Thus, this study’s findings suggest that although L. amazonensis-derived EVs can trigger MΦs activation, favoring a pro-inflammatory immune response, they also have the potential to ensure parasite survival while limiting host pathogenesis. This can be advantageous for parasite transmission and essential for completing the parasite life cycle.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79f613bb205b5bc2151b97424d0dce4df5f3b5dd" target='_blank'>
              Unleashing the immune modulatory potential of Leishmania amazonensis-derived extracellular vesicles in American cutaneous leishmaniasis
              </a>
            </td>
          <td>
            Bruna Eugênia de Freitas, A. Rodrigues, Joana Palma-Marques, Juliana Inês Weber, A. Valério-Bolas, Rodrigo Pedro Soares, A. Torrecilhas, Micheli Ferla, Munira Muhammad Abdel Baqui, Raul Alexander Gonzales Cordova, G. Alexandre-Pires, I. Pereira da Fonseca, H. M. de Andrade, G. Santos-Gomes
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Molecular Biosciences</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="BackgroundMicroglia are central mediators of neuroinflammation in Alzheimer's disease (AD), contributing significantly to disease pathogenesis. Understanding microglial heterogeneity and their regulatory mechanisms is critical for identifying potential therapeutic targets.ObjectiveThis study aimed to investigate the diversity of microglial subpopulations in AD and uncover key transcriptional regulators driving their pathogenic activity.MethodsWe integrated bulk RNA sequencing data from AD patients and 5×FAD mouse models with single-cell RNA sequencing (scRNA-seq) to profile microglial heterogeneity. Differential gene expression, pathway enrichment, pseudotime trajectory, and SCENIC analyses were used to identify functionally distinct subsets and regulatory networks. Experimental validation was conducted through in vivo assays in 5×FAD mice and in vitro inhibition studies targeting HIF-1α.ResultsA unique microglial subpopulation, termed microglia_2, was identified with an inflammatory-angiogenic transcriptional signature that was enriched during AD progression. This subset showed significant activation of inflammatory pathways. Pseudotime and SCENIC analyses revealed HIF-1α as a master regulator of microglia_2. In 5×FAD mice, cognitive decline was accompanied by increased expression of HIF-1α and Apoe, as well as microglial activation in the prefrontal cortex. In vitro inhibition of HIF-1α significantly reduced microglial inflammation.ConclusionsOur study demonstrates that a specific microglial subpopulation characterized by elevated HIF-1α expression may contribute to AD-associated neuroinflammation. By integrating transcriptomic analyses and experimental validation, we provide cell type-specific insights into disease mechanisms, offering potential insights for future mechanistic studies and therapeutic exploration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e93c7b3dbe189816e022a4a45715e584784e4e7e" target='_blank'>
              HIF-1α-induced microglia-mediated neuroinflammation is involved in Alzheimer's disease: Evidence from single-cell transcriptomic analysis.
              </a>
            </td>
          <td>
            Manyu Dong, Yilun Qian, Yao Geng, Ruiyu Wang, Yu Wang, Jili Cai, Xihui Wang, Ying Huang, Yan Liu, Wentao Liu, Qi Wu, Ying Shen
          </td>
          <td>2025-09-19</td>
          <td>Journal of Alzheimer's disease : JAD</td>
          <td>1</td>
          <td>3</td>
        </tr>

        <tr id="Introduction Microglial energy metabolism has gained attention for the treatment of neurodegenerative diseases. In vitro methods provide important insights; however, it remains unclear whether the metabolism of highly motile microglia is preserved outside their regular environment. Therefore, we directly compared the microglial glucose uptake in vivo and in vitro in mice. Methods Microglia and astrocytes were isolated from the brain using immunomagnetic cell sorting following [18F]FDG injection in living mice, followed by gamma and single-cell radiotracing (scRadiotracing). Enriched cell fractions were incubated with excess [18F]FDG (50,000-fold) in vivo, washed, and measured equivalently. For all fractions, radioactivity per cell was normalized to the injected or incubated radioactivity, and ratios of microglialuptake were calculated relative to astrocytes and the microglia/astrocyte-negative fraction. The experiment was repeated using a glucose-free buffer and validated by in vitro incubation without prior in vivo [18F]FDG injection to exclude the influence of fasting and glucose injection. Results scRadiotracing results were compared against cell culture [18F]-FDG incubation. The in vivo glucose uptake of microglia was higher when compared to astrocytes (50.4-fold, p < 0.0001) and non-microglia/ non-astrocyte cells (10.6-fold, p < 0.0001). Microglia still exhibited the highest glucose uptake in vitro, but with a distinct reduction in microglia-to-astrocyte (5.7-fold, p < 0.0015) and microglia-to-microglia/astrocyte-negative ratios (1.7 fold, p < 0.0001). Fasting and in vitro incubation were used to validate the results. Cell culture indicated low microglial uptake compared to that in neurons (1:100) or astrocytes (1:10). Discussion Compared to astrocytes and other cells, microglia show a distinct reduction in uptake in vitro compared to in vivo uptake. Our results emphasize that in vitro experiments should be interpreted with caution when studying microglial energy metabolism.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b66d8ac3f158ce5aeca5c55db0447f0befdb24cc" target='_blank'>
              Distinct reduction in relative microglial glucose uptake compared to astrocytes and neurons upon isolation from the brain environment
              </a>
            </td>
          <td>
            Sebastian T Kunte, Johannes S Gnörich, Philipp Beumers, L. Bartos, Stephan Wagner, K. Wind-Mark, A. Holzgreve, D. Pötter, Rudolf A. Werner, S. Ziegler, Nathalie L Albert, Alessio Colombo, Sabina Tahirovic, Matthias Brendel
          </td>
          <td>2025-09-15</td>
          <td>Frontiers in Cellular Neuroscience</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Malaria, an infectious disease caused by Plasmodium, is primarily characterized by anemia and splenomegaly. CD8 ⁺ T cells are known to play a key role in anti-malaria immunity. Lymphocyte Activation Gene 3 (LAG3), a critical immune checkpoint molecule, is pivotal in CD8 ⁺ T cell-mediated anti-tumor responses. However, the role of LAG3 ⁺ CD8 ⁺ T cells in anti-malarial immunity and the regulatory factors governing LAG3 expression in CD8 ⁺ T cells remain unclear. In this study, C57BL/6 mice were subcutaneously infected with Plasmodium yoelii NSM. Splenic lymphocytes were isolated and analyzed using flow cytometry (FACs) and single-cell RNA sequencing (scRNA-seq). Results showed a significant upregulation of LAG3 expression in splenic CD8 ⁺ T cells post-infection. These LAG3 ⁺ CD8 ⁺ T cells displayed enhanced activation, responsiveness, proliferative capacity, and cytokine production. Additionally, activated nuclear factor of activated T cells 1 (NFATc1) was found to co-express with LAG3 in splenic CD8 ⁺ T cells from infected mice. Dual-fluorescence reporter gene assays in 293T cells identified NFATc1 as a key transcription factor that binds to the LAG3 promoter sequence. Knockdown of NFATc1 via small interfering RNA (siRNA) reduced LAG3 expression. In conclusion, our findings suggest that splenic LAG3 ⁺ CD8 ⁺ T cells in Plasmodium yoelii NSM-infected C57BL/6 mice display enhanced functionality and imply that NFATc1 could positively regulate LAG3 expression.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/701cb5eebc64fee04dae0516c62ef93e3f03170b" target='_blank'>
              NFATc1 regulates LAG3+CD8+ T cells in the spleen of mice infected with Plasmodium yoelii NSM
              </a>
            </td>
          <td>
            Xingfei Pan, Feng Mo, Li Pan, Wei Xiao, G. Liang, Xiongyu Xie, Haiwen Yuan, Haixia Wei, Shan Zhao, Lu Li, Lei Jia, Hongyan Xie, Jun Huang
          </td>
          <td>2025-10-01</td>
          <td>PLOS Neglected Tropical Diseases</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/142b5f26c2f76fb27e002bd4d17b50dbd3ea1a15" target='_blank'>
              Structural insights into TLR4 activation by SARS-CoV-2 spike protein: implications for inflammatory response modulation.
              </a>
            </td>
          <td>
            Priya Prakasam, Thripthi Nagesh Shenoy, Abdul Ajees Abdul Salam, Syed Ibrahim Basheer Ahamed
          </td>
          <td>2025-09-13</td>
          <td>Molecular diversity</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1d8a754f463ab7baffd2a9daeb1d70ff841b56ea" target='_blank'>
              Fibroblast orchestration of inflammaging via NF-kB activation
              </a>
            </td>
          <td>
            Nancy C. Allen, Christian Ringler, Jin Young Lee, Nabora S. Reyes, Ritusree Biswas, Sofia E Caryotakis, M. Magnen, Pedro Ruivo, V. Auyeung, M. Looney, Averil Ma, Ari B. Molofsky, Tien Peng
          </td>
          <td>2025-10-01</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="Type 1 diabetes (T1D) risk has been associated with enteroviral infections, particularly coxsackieviruses B (CVB). Cellular host factors contributing to virus-induced islet autoimmunity remain unclear. We show that the Hippo pathway effector Yes-associated Protein (YAP) is markedly upregulated in the exocrine and endocrine pancreas of T1D and at-risk autoantibody-positive (AAb+) donors, along with its target CTGF. YAP expression correlates with CVB RNA presence, often in or near infected cells. YAP overexpression enhances CVB replication, islet inflammation, and β-cell apoptosis, whereas its inhibition halts viral replication in primary and immortalized pancreatic cells. In exocrine-islet co-cultures, CVB triggers YAP and target gene expression. In mice, chronic β-cell YAP expression impairs glucose tolerance, abolishes insulin secretion, and promotes β-cell dedifferentiation. Mechanistically, YAP, in complex with its transcription factor TEAD, induces its own negative regulator MST1. MST1 inhibition boosts viral replication and reduces β-cell apoptosis, constituting a negative feedback loop in which the reciprocal antagonism between YAP and MST1 balances viral replication and β-cell death during CVB infections. YAP is thus an important host factor for enteroviral amplification, offering a potential antiviral target in T1D.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/46a8c22841dec45ad83eda3f4933a10a838e2d8e" target='_blank'>
              The Hippo terminal effector YAP boosts enterovirus replication in type 1 diabetes
              </a>
            </td>
          <td>
            Shirin Geravandi, Huan Liu, Heena Pahwa, Murali Krishna Madduri, Farah Atawneh, Adib Miraki Feriz, Sahar Rafizadeh, Annabelle Elisabeth Kruf, Mona Khazaei, Pouria Bahrami, David Gotti, Mohamed Elawour, R. Elgamal, Ausilia Maria Grasso, David Bund, Blaz Lupse, Zahra Azizi, Omar Zabad, Karim Bouzakri, Marc Horwitz, A. Pugliese, Kathrin Maedler, A. Ardestani
          </td>
          <td>2025-10-06</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e074c56d374fdaac1cf557896d7c71f80862340a" target='_blank'>
              Viral infections shape inter-individual immune variability
              </a>
            </td>
          <td>
            Chad Hogan, Zafiirah Baurhoo, Nathália Beller, Ernest Turro, S. Asgari
          </td>
          <td>2025-09-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="With the unprecedented surge of severe COVID-19 cases in early 2020, researchers and medical professionals worked actively to identify effective viral infection treatments based on a scientific understanding of viruses. Over the past few years, an enormous amount of research has investigated the viral infection and replication processes following the first SARS-CoV-2 case. With this knowledge, many drugs have been explicitly created to inhibit viral replication or decrease the severity of the immune response. Additionally, scientists have utilized decades of research and techniques to expedite SARS-CoV-2 vaccine development. SARS-CoV-2, a positive-strand RNA virus, belongs to the Sarbecovirus subgroup of Betacoronaviruses. Its emergence is not unique; previous outbreaks like SARS and MERS have shaped our understanding of coronavirus-related diseases. Molecular clock analysis suggests that the ancestor of all current coronaviruses existed over 10,000 years ago, with subsequent evolution occurring around 3300–2400 BC. Researchers have explored synthetic and natural treatments alongside other antiviral therapies, corticosteroids, and immunotherapies. Additionally, using artificial intelligence and nano-based technologies enriched SARS-CoV-2 diagnosis and management. In this comprehensive review, we provide recent literature on COVID-19, exploring its evolving etiology, pathogenicity, and pathophysiology, alongside developments in synthetic and natural therapeutic strategies, vaccines, artificial intelligence in diagnosis, and nano-based technologies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/87c8a723eadbbda2af3f16a95b70dc7eb21c41db" target='_blank'>
              Comprehensive review on COVID-19: etiology, pathogenicity, and treatment
              </a>
            </td>
          <td>
            Amr El Zawily, Sarah Eckert, Reed Adajar, Nardin Wagih, Abeer H. Elmaidomy, Abdelrahman M. Helmy, Mazen Mustafa, Mazhar Elshorbagi, Erin Ghali, Rehab G. Fadl, Jochen Bodem, U. Abdelmohsen, Marco Y. W. Zaki
          </td>
          <td>2025-09-23</td>
          <td>Frontiers in Medicine</td>
          <td>0</td>
          <td>41</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b0e23bb57efc4221ce814fa2c8dc4db1256ec5ee" target='_blank'>
              Spatiotemporal dynamics of alphaherpesviral latency and reactivation in the murine central nervous system
              </a>
            </td>
          <td>
            Viktoria Korff, Issam El-Debs, B. Klupp, Jens P. Teifke, T. Mettenleiter, Julia Sehl-Ewert
          </td>
          <td>2025-09-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>94</td>
        </tr>

        <tr id="Herpes simplex virus type 2 (HSV-2) is a globally prevalent sexually transmitted infection, affecting an estimated 491 million people worldwide. The virus establishes lifelong latency in the sensory nervous system, particularly the sacral dorsal root ganglia, and periodically reactivates to cause recurrent genital lesions, asymptomatic viral shedding, and considerable psychological distress. HSV-2 infection also facilitates HIV acquisition by disrupting mucosal barriers and enhancing the recruitment of HIV target cells, contributing significantly to the global HIV burden. Despite the widespread use of antiviral agents such as acyclovir and valacyclovir, current therapies only manage symptoms and reduce shedding without eliminating the latent viral reservoir. Although numerous vaccine candidates—including subunit, viral vector, and mRNA-based platforms—have shown promise in animal studies, they have failed to demonstrate consistent and durable protection in human trials. This review synthesizes current knowledge on HSV-2 immunobiology, including the roles of innate immunity, adaptive T cell responses, and tissue-resident memory T cells in controlling viral infection. It also highlights the challenges posed by viral immune evasion strategies and evaluates emerging approaches such as CRISPR/Cas9 gene editing, latency-reversing agents, and T cell receptor (TCR) profiling. A deeper understanding of these mechanisms is essential for the development of effective, long-lasting HSV-2 interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/170980b09bcdb8f8fa5bddb1295d152193b7196f" target='_blank'>
              Immunological Insights and Translational Advances in HSV-2 Infection and Vaccine Development
              </a>
            </td>
          <td>
            Yumin Min
          </td>
          <td>2025-10-11</td>
          <td>Transactions on Materials, Biotechnology and Life Sciences</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Pyroptosis is a mode of inflammatory cell death, characterized by cell membrane rupture and the release of pro-inflammatory cytokines and damage-associated molecular patterns (DAMPs). Pyroptosis is a critical part of the innate immune response and acts as a defense mechanism against different types of pathogens, including viruses. Several respiratory viruses, including influenza virus, respiratory syncytial virus (RSV), human metapneumovirus, and SARS-CoV-2, have been shown to trigger pyroptosis through distinct mechanisms. While pyroptosis is beneficial to the host by controlling virus replication and eliminating infected cells, the exaggerated induction of pyroptosis can be harmful and cause significant tissue damage, such as that to the lung tissue during infection with respiratory viruses. Therefore, understanding the mechanisms and the role pyroptosis plays during respiratory virus infections could lead to the development of novel therapeutic approaches to reduce the morbidity caused by these infections. In this review, we discuss the recent knowledge obtained on the pathophysiological role of pyroptosis during different respiratory viral infections as well as some experimental approaches to regulating its detrimental effects to the host.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cefe2eccc974211f9771f04bc4c3513a27ae2c60" target='_blank'>
              Pyroptosis in Respiratory Virus Infections: A Narrative Review of Mechanisms, Pathophysiology, and Potential Therapeutic Interventions
              </a>
            </td>
          <td>
            Runqi Lin, Barbara N. Porto
          </td>
          <td>2025-09-01</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Natural killer (NK) cells represent a critical component of antiviral immunity, demonstrating remarkable adaptability during infections such as human cytomegalovirus (hCMV) and SARS-CoV-2. Recent advances in single-cell transcriptomics have revealed the clonally expanding NK cell populations with distinct functional profiles, blurring the traditional boundaries between innate and adaptive immunity. However, the functional heterogeneity and immunological significance of these clones remain incompletely understood. Our aim was to dissect clonal NK cell heterogeneity using published scRNA-seq datasets from hCMV-seropositive, seronegative, and COVID-19 patients, focusing on cluster-specific gene expression patterns. Our computational pipeline employed Seurat-based integration and high-resolution clustering of datasets from hCMV-seropositive (n = 5) and seronegative (n = 2) donors, along with COVID-19 patients (n = 2). We analyzed datasets using Seurat 5 in R. Quality-controlled data were normalized (SCTransform), integrated (batch-corrected), and clustered (UMAP). Differential gene expression (Wilcoxon test, log2FC 0.25, p-adj 0.05) and annotation were performed. In hCMV-seropositive individuals, we identified 12 transcriptionally distinct NK cell clusters exhibiting KLRC2 (NKG2C)-dependent organization, with specific clones showing either enhanced cytotoxic potential (marked by GZMB/GZMA upregulation), or unique inhibitory receptor profiles (variable KIR expression patterns). The hCMV-seronegative cohort displayed a simpler clonal structure with 9 clusters showing reduced KIR diversity but maintained distinct effector gene signatures. Analysis of COVID-19 patients revealed divergent clonal patterns: one patient showed reduced KLRC2 variability with prominent KLRC1 (NKG2A) expression, while another exhibited KIR heterogeneity without KLRC2 variation. Our analysis reveals distinct clonal NK cell populations in hCMV and COVID-19 contexts, characterized by divergent expression of activating and inhibitory receptors. These findings demonstrate infection-specific dynamics of clonal NK cell populations, highlighting their adaptive potential through differential receptor expression in antiviral responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c8710e10cb35d236dca302d2bde6c2f6638a39e8" target='_blank'>
              Analysis of clonal NK cell populations using single-cell transcriptomics data
              </a>
            </td>
          <td>
            M. O. Ustiuzhanina, E. Kovalenko
          </td>
          <td>2025-09-28</td>
          <td>Russian Journal of Immunology</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7c6680175abb418a05b168b252653ec024e4fd0b" target='_blank'>
              Activation of Toll and IMD pathways in the Drosophila brain following local and systemic bacterial infection
              </a>
            </td>
          <td>
            Sameekshya Mainali, Isaac Toles, Paige Magid, Jordan Grammer, Lauren Harper, Elizabeth Kitchens, Kaitlin Davis, Stanislava Chtarbanova
          </td>
          <td>2025-10-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="ABSTRACT Streptococcus pneumoniae (pneumococcus) is an opportunistic pathogen that remains the leading cause of bacterial meningitis worldwide. For meningitis to occur, pneumococcus must breach the blood-brain barrier (BBB), a highly specialized network of brain endothelial cells that comprise the microvasculature of the brain. Here, we report the use of human induced pluripotent stem cell-derived brain-like endothelial cells (iBECs) to model the BBB during pneumococcal infection. iBECs were infected with the S. pneumoniae strain TIGR4. Adherence assays showed that pneumococcal adherence to iBECs was a saturable process. Moreover, deletion of two pneumococcal adhesins resulted in an adherence defect, supporting a receptor-mediated interaction between pneumococcus and iBECs. Next, the integrity of several tight junction components was assessed via western blot and RT-qPCR, revealing the loss of abundance and expression in iBECs during infection with pneumococcus. Simultaneously, the expression of VEGFA and the tight junction repressor SNAI1 was upregulated. Semi-automated analysis of junction images also demonstrated a loss of ZO-1 and occludin continuity during pneumococcal infection. Consistent with these findings, the loss of TEER and the increase in barrier permeability were observed in pneumococcus-infected iBECs. The toxin pneumolysin (Ply) was important for this disruption, as the loss of Ply in pneumococcus partially arrested the reduction of TEER and the increase in permeability. Finally, RT-qPCR showed that pneumococcus was sufficient to upregulate a panel of inflammatory cytokines in iBECs. Taken together, these findings show that pneumococcus interacts with and disrupts iBECs during infection, supporting iBECs as an important model for studying pneumococcus-BBB interactions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7b4da273ff50172679dc524578b58f9068453a41" target='_blank'>
              Stem cell-derived brain-like endothelial cells to interrogate Streptococcus pneumoniae interaction with brain endothelium
              </a>
            </td>
          <td>
            Henry D Mauser, Taryn E. Keyzer, Jessica M Surma, Natalie G Alexander, William D Cutts, Sarah F. Hathcock, Kimberly H Lackey, Daryl W. Lam, Justin A Thornton, Nadine Vollmuth, Brandon J. Kim
          </td>
          <td>2025-10-03</td>
          <td>Virulence</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Significance We identify goblet cells as regulators of viral infections at mucosal surfaces. Goblet cell-derived mucus effectively shields nasal and intestinal epithelia from swine influenza virus (SIV) and porcine epidemic diarrhea virus (PEDV), with virus-driven modulation of mucus secretion determining infection containment or dissemination. Remarkably, PEDV not only suppresses mucus secretion but also rapidly induces goblet cell-associated antigen passages (GAPs) through an acetylcholine–cholinergic receptor muscarinic 3 neuro-epithelial axis. GAPs enable luminal bacteria to cross the intact epithelial barrier during the initial infection phase, triggering an acute inflammatory cascade that significantly exacerbates mucosal damage. Our findings reveal goblet cells and their neuronal signaling circuits as key determinants of viral mucosal pathogenesis and promising targets for developing broad-spectrum antiviral interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/890992aa0c43464d9330c6c8d499c8354fe42288" target='_blank'>
              Goblet cells dictate viral tropism and pathogenesis in nasal and intestinal mucosae
              </a>
            </td>
          <td>
            Wenqian Wang, Wenwen Chao, Hui Zeng, Rongfeng Tang, Ruiling Liu, Chengcheng Wang, Xuan Wu, Jiaxin Qi, Yunlei Cao, Yuchen Li, Qian Yang
          </td>
          <td>2025-10-08</td>
          <td>Proceedings of the National Academy of Sciences of the United States of America</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="In response to an infection, the host T cell compartment develops immunological memory to ensure rapid responses upon re-infection with the same pathogen. However, these memory responses can also modulate immune reactions to unrelated pathogens through bystander activation. Herein, T cells are activated in an antigen-independent manner, often triggered by innate cytokines or Toll-like receptor ligands. To uncover new strategies for modulating immune responses, it is essential to deepen our understanding of this alternative mechanism of T cell activation, particularly in humans. Therefore, we studied the response of human CD8+ T cells to innate bystander stimuli in vitro. Thereby, we measured the induction of activation markers and proliferation using flow cytometry, and depleted or blocked several potential modulatory components to identify mediators of bystander CD8+ T-cell responses. Our study demonstrates that CD8+ T cells can be activated as bystander cells in response to innate stimuli present during a viral infection, including IL-15, IFN-α, and TLR7/8 and 9 agonists (R848 and CpG). Depletion experiments demonstrated that these bystander responses are dependent on monocytes and CD4+ T cells. In addition, we revealed that the bystander responses to the innate stimuli are highly reliant on IL-2 signaling. Altogether, our study underscores the pivotal role of IL-2 in mediating bystander responses of CD8+ T cells to innate stimuli, revealing a novel mechanism of immune response modulation during viral infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fc56083194a00b756c976473122860d219d86c29" target='_blank'>
              IL-2 mediates human bystander CD8+ T-cell responses to innate immune signals.
              </a>
            </td>
          <td>
            Tamara Johanna Cornelia Schenk, Martijn Vos, Yannick van Sleen, Jeroen Hoeboer, Debbie van Baarle, T. Guichelaar
          </td>
          <td>2025-09-22</td>
          <td>Journal of immunology</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b5151f90f811e456ad4218b04e57c27b24b53bb8" target='_blank'>
              Glucose-Fueled Histone Modifications Drive HIV-1 Latency Reversal at Hypoxia
              </a>
            </td>
          <td>
            Yetunde I Kayode, Deanna C. Clemmer, A. A. Owolabi, Abdulkareem A Alshaheeb, E. K. McMahon, Anna Tangiyan, Lauren Clark, Glenn E Simmons, Alberto Bosque, Melanie R. McReynolds, Harry E. Taylor
          </td>
          <td>2025-09-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Traumatic brain injury (TBI) initiates a prolonged and complex immune response that critically shapes both secondary injury and long-term recovery. Among adaptive immune cells, CD4⁺ T cells have emerged as central regulators of neuroinflammatory processes, acting as a double-edged sword that can be either neuroprotective or neurotoxic. This review focuses on the roles of major CD4⁺ T cell subsets-Th1, Th2, Th17, and Tregs-in modulating the immune landscape following TBI, with an emphasis on their temporal dynamics, phenotypic plasticity, and therapeutic potential. We examine how blood-brain barrier disruption and innate immune activation facilitate T cell infiltration into the central nervous system, and outline the cytokine networks and signaling pathways that orchestrate CD4⁺ T cell differentiation and functional polarization. Advances in single-cell RNA sequencing (scRNA-seq) have provided new insights into the transcriptional heterogeneity of CD4⁺ T cells post-TBI, offering novel angles for therapeutic targeting. In addition, we assess current strategies for targeting CD4⁺ T cells therapeutically and examine translational challenges, particularly the translational gap between animal models and human disease. To provide a focused synthesis, this review does not delve into all immune cell types or other aspects of neuroinflammation that may also play significant roles in TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5bb08683dbcd2c252e04f0b54a89e13ce83a8999" target='_blank'>
              The immunological paradox of CD4⁺ T cells in traumatic brain injury (Review Article).
              </a>
            </td>
          <td>
            Qian Zhao, Bo-Ao Chen, Wen-Qing Ai, Nadezhda Brazhe, Dan Liu, Ling-Qiang Zhu, Ming Wen
          </td>
          <td>2025-10-15</td>
          <td>International journal of surgery</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/75adc2fc401fe68e4fecfbc1d302e045b6cba87f" target='_blank'>
              Inflammatory reprogramming of human brain endothelial cells compromises blood–brain barrier integrity in Alzheimer’s disease
              </a>
            </td>
          <td>
            R. Pinals, Md Rezaul Islam, Oisín King, Aaron Choi, Eulim Kang, Masayuki Nakano, Anjanet Tuyéras, Maeesha Tasnim Naomi, Arthur Ngo, Al Jiang, Nhat Truong, Emre Agbas, Claudia F Lozano Cruz, Colin Staab, Tak Ko, David A. Bennett, Alice E. Stanton, Robert Langer, Li-Huei Tsai
          </td>
          <td>2025-09-27</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="ABSTRACT Dengue virus (DENV) is a major arthropod‐borne pathogen, endemic in over 100 countries and posing global health challenges. While innate immune responses and viral evasion mechanisms have been extensively studied in animal models and mononuclear cells, severe dengue can affect multiple tissues, including the central nervous system (CNS), leading to neurological manifestations. However, the CNS immune response remains poorly understood. This study analyzed molecules linked to innate immunity in CNS lesions from fatal dengue cases. Histopathological examination of the cerebral cortex revealed marked neuronal damage—chromatolysis, pyknotic nuclei—accompanied by microglial hyperplasia, white matter demyelination, perivascular inflammation, vascular congestion, vasogenic edema, and occasional hemorrhage or meningitis. DENV antigen was detected in endothelial cells of cortical and leptomeningeal vessels and in glial cells or macrophages. Immunohistochemistry revealed altered expression of innate immune markers: RIG‐I was sparsely expressed, STING was absent, and IFN‐α/β levels were reduced compared to controls. Notably, IRF2 expression was markedly elevated, with strong labeling in neurons, glial, and endothelial cells. These findings suggest an atypical pattern of immune activation in the CNS during severe dengue and highlight a potential role for IRF2 in modulating cerebral immune responses, offering new insights into the neuropathogenesis of dengue.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b8f7f91bd3195b66fc9031dd8d09c37a3bc65daf" target='_blank'>
              Histopathological Alterations and Dysregulation of Type I Interferon Signaling in the Human Cerebral Cortex During Severe Dengue
              </a>
            </td>
          <td>
            Leandro Mantovani de Castro, E. R. Fernandes, J. Quaresma, Carmen Lucia Penteado Lancelotti, Maria Irma Seixas Duarte, L.V. Carvalho, R. Penny, P.F.C. Vasconcelos, Evandro Sobroza de Mello, M. Sotto, C. Pagliari
          </td>
          <td>2025-10-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Introduction Rhinovirus (RV) is the leading cause of exacerbations of lung disease. A sensory neuronal model, derived from human dental pulp stem cells and differentiated into peripheral neuronal equivalents (PNEs), was used to examine RV’s effects on airway sensory nerves. We investigated whether RV can directly infect and alter PNEs or whether it exerts effects indirectly via the release of mediators from infected epithelial cells. Methods PNEs or primary bronchial epithelial cells (PBECs) were infected with the RV-A16 strain. Viral replication was confirmed by viral titration assays, immunofluorescence (IF) for the double-stranded RNA (dsRNA) replication intermediate and western blotting (WB). RNA sequencing was used to determine transcriptomic changes in PNEs, and inflammatory responses were assessed by inflammatory microarray. Calcium mobilisation assays were used to investigate the effect of interleukin-1β (IL-1β) on PNE transient receptor potential (TRP) A1 channel responses. Results Viral titrations, WB and IF confirm RV-A16 entry and replication in PNEs and PBECs. Gene signatures associated with antiviral immune responses, sensory neuropathies and N-Methyl-D-aspartic acid (NMDA) receptor activity were upregulated in RV infected PNEs. Several cytokines were increased from PNEs and PBECs following RV infection, most notably IL-1β. Treatment of PNEs with IL-1β resulted in heightened TRPA1 channel sensitivity. Conclusion We report the suitability of an airway neuronal model for the study of the direct effects of RV infection on nerves. RV-induced release of IL-1β from airway epithelium heightens neuronal TRPA1 responses suggesting a mechanism for virus-induced cough hypersensitivity. Supplementary Information The online version contains supplementary material available at 10.1007/s00408-025-00846-y.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c92f212f951f984bcc10c7c2f55a264e9802674a" target='_blank'>
              Neuroinflammatory Consequences of Rhinovirus Infection in Human Epithelial and Neuronal Models
              </a>
            </td>
          <td>
            Orla M Dunne, Nicola A M Roe, Aurélie Mousnier, S. L. Martin, Gerard P Sergeant, Imad About, I. El-Karim, Fionnuala T. Lundy, Lorcan P. A. McGarvey
          </td>
          <td>2025-09-07</td>
          <td>Lung</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Chlamydia invades multiple mucosal tissues in humans and animals. The body’s first line of defense against chlamydial infection is provided by innate immunity, whereas adaptive immunity plays a crucial role in managing the infection’s progression and preparing the immune system to combat reinfection. Host resistance to chlamydial infection necessitates a coordinated effort between innate and adaptive immune cells. Numerous cell types are capable of producing interferon gamma (IFN-γ) as a defense mechanism against chlamydial infection, thereby effectively mediating the clearance of infection. However, the distinct roles of various immune cell populations in responding to chlamydial infection, as well as their functions during infection progression, remain poorly understood. Therefore, we will discuss the various roles of IFN-γ released by different immune cells in chlamydial infection, focusing primarily on experimental animal models and a review of available data from in vivo cellular immunological studies in humans.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7c375743e3715f5e17dc641ecdc55eebdf06385f" target='_blank'>
              Role of IFN-γ from Different Immune Cells in Chlamydia Infection
              </a>
            </td>
          <td>
            Xuan Chen, Wenjing Yang, Yuchen Hu, Yang Zhou, Zhou Zhou
          </td>
          <td>2025-10-15</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Background Chronic obstructive pulmonary disease (COPD) is a significant global health concern, marked by persistent inflammation and immune dysregulation. Although it is widespread and has substantial clinical implications, the systemic immune mechanisms driving disease progression are not fully understood. Since blood contains a diverse array of immune cells and offers a non-invasive means of assessing immune homeostasis and overall physiological status, investigating immune dysregulation through blood sampling offers considerable value for both basic research and clinical application. This approach can provide novel insights into the pathogenesis of COPD. Methods This study employed high-dimensional flow cytometry and RNA sequencing to comprehensively characterize peripheral immune cells from a cohort of 69 COPD patients spanning clinical stages 1 to 4, alongside 41 healthy donors as controls. To capture granulocyte populations typically excluded from peripheral blood mononuclear cell analyses, fresh whole blood samples were analyzed directly. Results Our study revealed a marked shift in the myeloid-lymphoid balance, characterized by elevated neutrophils, eosinophils, and classical monocytes that correlated with disease severity, alongside reduced CD8+ T cells and circulating T follicular helper cells. Transcriptional profiling identified oxidative stress pathways, T cell suppression, and aberrant natural killer (NK) cell activation as hallmarks of advanced COPD. Notably, activated Nkp44+ NK cells were significantly enriched in severe stages, implicating their role in perpetuating inflammation. Smoking exacerbated immune perturbations, including upregulated complement activation and B cell pathways, though cessation partially restored transcriptional homeostasis. Conclusions This study underscores the value of peripheral immune profiling in capturing the heterogeneity of COPD. The results reveal systemic immune dysregulation-especially NK cell hyperactivity and point to potential therapeutic avenues aimed at modulating immune responses to slow disease progression.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/aae7cb72f1629c9d76e999fa034c112ee9f0561d" target='_blank'>
              Dysregulated NK cell activation and myeloid-lymphoid imbalance underpin COPD progression: insights from high-dimensional immune profiling and smoking-induced immune remodeling
              </a>
            </td>
          <td>
            Qin Qiao, Yazheng Yang, Ke Huang, H. Niu, X. Ren, Shiwei Qumu, Wei Li, Chen Dong, Ting Yang, Ling Ni
          </td>
          <td>2025-09-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="ABSTRACT Type I interferons (IFNs) play complex roles during bacterial infections. We previously found that type I IFNs were induced in Bordetella pertussis-infected adult mice but not in infant mice, a potentially relevant clinical dichotomy, since pertussis can be fatal in human infants. We investigated the role of type I IFNs and their cross-regulation with type III IFNs (IFN-λ) in B. pertussis infection across developmental stages. In contrast to global IFNAR1 knockout adult mice, in which lung inflammation was equivalent to that in wild-type mice, myeloid cell-specific deficiency of the type I IFN receptor protein IFNAR1 (LysMCreIFNAR1fl/fl) resulted in significantly reduced lung inflammation and pro-inflammatory cytokine production, despite elevated pulmonary IFN-λ levels. Mechanistically, we found that, in contrast to WT macrophages, IFNAR1-deficient macrophages produced IFN-λ in response to B. pertussis or pertussis toxin, a process dependent on the G protein-coupled receptor lysophosphatidic acid receptor 1 (LPAR1). IFNAR1 deficiency did not affect type I IFN expression or killing capacity by macrophages and neutrophils. In striking contrast to WT infant mice, which developed resistance to lethal B. pertussis infection by postnatal day 10 (P10), LysMCreIFNAR1fl/fl infant mice remained highly susceptible to lethal infection through P21, exhibiting increased lung bacterial burden and inflammation, as well as increased bacterial dissemination compared to WT infant mice. These findings reveal a critical age- and cell-specific interplay between type I and III IFNs during B. pertussis infection and highlight a novel LPAR1-dependent pathway for IFN-λ induction in the absence of type I IFN signaling.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a9c0aa3f05dcfdc1479f2b1fdad4c8a6d9041cee" target='_blank'>
              Myeloid cell-specific type I interferon signaling mediates age-dependent inflammation and protection in Bordetella pertussis infection
              </a>
            </td>
          <td>
            Amit Kumar, Alicia Bukowski, N. Carbonetti
          </td>
          <td>2025-09-22</td>
          <td>Infection and Immunity</td>
          <td>0</td>
          <td>33</td>
        </tr>

        <tr id="People living with HIV-1 (PWH) and chronically using opioids have elevated risks of developing HIV-associated neurological disorders (HAND) that are often correlated with persistent inflammation. Microglia, innate immune cells in the brain, are the principal HIV-1 reservoir in the central nervous system and regulate neuroinflammation. Our group previously showed that HIV-1 infection of induced pluripotent stem cell (iPSC)-derived microglia and viral intron-containing RNA (icRNA) expression triggers inflammatory responses. Microglia express μ opioid receptor, MOR, yet the immunomodulatory effects of opioids on HIV-1 infection in microglia are unclear. Here, we report that MOR activation impacts HIV-1 infection establishment and HIV-1-induced innate responses in microglia. Morphine pretreatment enhanced reverse transcription (RT), integration, viral transcription, and p24Gag secretion in HIV-1-infected iPSC-derived microglia, which was blocked by treatment with naloxone, a MOR antagonist. In contrast, morphine treatment did not impact HIV-1 infection in MOR-deficient monocyte-derived macrophages, although, induced exogenous expression of MOR in macrophages conferred morphine-mediated enhancement of HIV-1 infection. Interestingly, viral transcriptome analysis by digital-drop PCR revealed selective enhancement of HIV-1 icRNA expression in morphine-exposed iPSC-derived microglia, which correlated with enhanced HIV-1 icRNA-induced secretion of IP-10 in MOR+ cells. Further, PI3K inhibitor, wortmannin, blocked morphine-mediated enhancement of HIV-1 replication and HIV-1 icRNA-induced IP-10 secretion, suggesting that MOR signaling and HIV-1 icRNA expression synergistically activate the PI3K-Akt signaling pathway in microglia to exacerbate virus-induced inflammatory responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33120b856a2b6c63c61e9bfd1c234edbc64bb007" target='_blank'>
              Mu opioid receptor activation in microglia enhances HIV-1 infection and HIV-infection-induced inflammatory responses
              </a>
            </td>
          <td>
            Chelsey A. Skeete, Gabriel M. Sgambettera, Aldana D. Gojanovich, Xianbao He, Daniel Bryant, Mengwei Yang, Shreya Banerjee, Andrés A. Quiñones-Molina, H. Akiyama, Gustavo Mostoslavsky, Andrew J. Henderson, S. Gummuluru
          </td>
          <td>2025-10-06</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Type 1 interferons (T1IFNs) are typically expressed in low concentrations under homeostatic conditions, but upon pathogenic insult or perturbation of the pathway, these critical immune signaling molecules can become either protectors from or drivers of pathology. While essential for initiating antiviral defense and modulating inflammation, dysregulation of T1IFN signaling can contribute to immunopathology, making it and its associated pathways prime targets for immune evasion and disruption by pathogens. This review focuses on the changes in T1IFN signaling across the lifespan, with particular emphasis on the role of the Stimulator of Interferon Genes (STING) pathway in autoimmune and infectious disease susceptibility, especially in the context of viral infections. Aging is associated with diminished T1IFN responsiveness, partially resulting from chronic stimulation of the STING pathway, which contributes to increased susceptibility and impaired viral clearance. Conversely, neonates and young children also show increased vulnerability to certain viral infections, but whether this is driven by T1IFN differences or another mechanism remains incompletely understood. Despite growing interest in T1IFN-based immunotherapies, pediatric and elderly populations remain underrepresented in clinical trials. Here, we advocate for a deeper molecular and systems understanding of how the interferon response evolves across the human lifespan, to inform age-tailored therapeutic approaches and more inclusive study designs, thereby improving outcomes in both the youngest and oldest patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/92fe0ce0558850fa46898881223207341f832632" target='_blank'>
              What goes up must come down: dynamics of type 1 interferon signaling across the lifespan
              </a>
            </td>
          <td>
            Lucy Hartnell, P. Agudelo-Romero, S. Montgomery, R. Ben-Othman, Valerie Verhasselt, Stephen M. Stick, Tobias R. Kollmann
          </td>
          <td>2025-10-16</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="COVID-19 has caused more than 7 million deaths worldwide, and according to the World Health Organization, it continues to result in more than 1000 reported deaths per month at the time of this writing. It is crucial to understand the immune response to COVID-19 since the virus continues to persist. Natural killer (NK) cells play a critical role in the immune defense against viral infections, including COVID-19. While it is well documented that infected patients have a reduction in lymphocytes and NK cells, gaps in knowledge exist regarding the function of NK cells. To study the function of NK cells in patients hospitalized with COVID-19, peripheral blood was obtained from patients admitted to the medical (non-ICU) wards at a large tertiary hospital. We demonstrated a decrease in the mature cytotoxic subset of NK cells within the peripheral blood of patients hospitalized with COVID-19. We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. We examined the mechanisms leading to NK cell killing. We found reductions in the intracellular levels of effector molecules, the degranulation of cytotoxic granules, and the extracellular concentrations of released effector molecules. We identified dysfunctional intracellular granule trafficking required to position the granules for degranulation, which would be consistent with the reduced release of effector molecules. We found clusters of inhibitory receptors were upregulated in subsets of NK cells, in keeping with inhibition of cytotoxicity. Additionally, males with COVID-19 showed NK cell defects compared to healthy males, while no significant differences were observed in females. Our findings highlight defects in cytolytic effector molecules, granule trafficking and release, and increased expression of inhibitory receptors on NK cells in patients hospitalized with COVID-19, in addition to a sex difference in cytolytic function, which contributes to defective NK cell function in COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/01cdfabb81491ce2cba0ee7f56a0d8dd7e9e7d8a" target='_blank'>
              The effect of COVID-19 and sex differences on natural killer cell cytotoxicity
              </a>
            </td>
          <td>
            Arushi Dagar, Maria J Polyak, Adley C. H. Mok, David D Feehan, Michael Potemkin, Alain Tremblay, Christopher H. Mody
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Background People living with HIV are called immunological non-responders (INR) when their CD4+ T cell count is not restored to immunocompetent levels, despite successful viral suppression. INR have increased risk of progression to AIDS, non-AIDS related morbidity, and death. Impaired mucosal barrier function is a prevailing hypothesis for why INR among people with HIV (PWH) have persistently low CD4+ T cell counts. Objective To understand the molecular mechanisms behind incomplete immune recovery in INR, we analyzed gene regulation and protein expression in gut tissues from INR, immunological responders (IR) and healthy controls (HC). Methods The transcriptome was assessed by RNA-sequencing (RNA-seq) and the proteome was examined using shotgun proteomic mass spectrometry in mucosal biopsies from the sigmoid colon and terminal ileum. Results In INR compared to IR, we identified 3326 differentially expressed genes (DEGs) in the colon while no DEGs were observed in the ileum. Gene ontology (GO) analyses revealed that the DEGs in colon of INR, compared to IR, predominantly involved pathways related to immune response, metabolism, and cellular processes. Notably, GO analysis highlighted downregulation of genes associated with B cell-mediated immunity and adaptive responses in INR. Deconvolution analysis indicated that these transcriptomic changes were not solely due to shifts in immune cell composition. Proteomic analysis supported these findings, showing more differential protein composition between INR and IR in colon than ileum. These proteins are associated with the regulation of adaptive immune signaling and essential cellular processes, including cell signaling, tissue repair, and growth, all of which are characteristic features of inflammatory bowel disease (IBD). Conclusion Our findings suggest that incomplete immune recovery during anti-retroviral therapy in PWH is associated with specific dysregulations in the molecular environment of the sigmoid colon, which may share mechanisms with IBD. The identified macromolecules may serve as potential targets for adjuvant treatment to improve the prognosis for INR.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2c7973b900544867274ca44e59969cd94c404f9e" target='_blank'>
              Transcriptomic and proteomic profiling reveal immune and metabolic dysregulation in the colonic mucosa of people living with HIV with incomplete immune recovery
              </a>
            </td>
          <td>
            Mari Kaarbø, Mingyi Yang, Malin Holm Meyer‐Myklestad, Arvind Y M Sundaram, Mirta Mittelstedt Leal de Sousa, Animesh Sharma, A. Medhus, A. M. Dyrhol-Riise, Dag Kvale, J. R. Hov, Pål Aukrust, Magnar Bjørås, D. Reikvam
          </td>
          <td>2025-09-17</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/695c274c959b0fd1b92ee86ff6aa4f6baf9e49bd" target='_blank'>
              A multicenter spatial transcriptomics atlas of human tuberculosis and non-tuberculous mycobacterial disease
              </a>
            </td>
          <td>
            Xun Jiang, Leonard Christian, Yuesi Xi, Liang Zhou, Ahmed Alaswad, , N. V. Unen, L. Neubert, Jana Dietrich, Jan C. Kamp, Moritz Kayser, Mark Kühnel, J. Hohlfeld, Hortense Slevogt, Marius M. Hoeper, N. Kaminski, Tobias Welte, Jan Fuge, Felix C. Ringshausen, Robert J Homer, D.D. Jonigk, Chengbin Xu, Jonas C. Schupp, Yang Li
          </td>
          <td>2025-10-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="ABSTRACT Studies have shown that 129 mice generate more severe inflammatory responses than C57BL/6 (B6) mice shortly after influenza virus infection. However, the mechanisms for regulation of the magnitudes and kinetics of innate immune responses in different hosts remain to be fully understood. In this study, we found that cysteine sulfinic acid decarboxylase (CSAD), an essential enzyme in the taurine synthesis pathway, inhibits excessive inflammation after viral infection. CSAD KO mice in B6 background initiate stronger inflammatory responses and are more vulnerable to viral infections, exhibiting a phenotype resembling 129 mice. Interestingly, CSAD is differentially expressed in 129 and B6 mice; CSAD is highly expressed in B6 mice than in 129 mice. CSAD inhibits the NF-κB signaling pathway during various virus infections and stimulations. CSAD directly interacts with IKKα at the kinase domain, thus limiting the fast and strong phosphorylation of IKKα and then the downstream signaling pathway. Therefore, CSAD is a novel regulator to fine-tune the intensity of the NF-κB signaling pathway. IMPORTANCE The mechanisms by which host factors regulate the intensity of innate immune responses are important because excessive inflammatory response can be harmful to the host. CSAD, an enzyme in the taurine synthesis pathway, inhibits excessive inflammatory responses after viral infection or stimulation by interacting with IKKα of the NF-κB signaling pathway, thus limiting the downstream activation of signaling and reducing the cytokine and chemokine gene expression. Our studies reveal for the first time that CSAD plays an important role in regulating innate immune responses, adding novel regulators to the complex networks of the NF-κB signaling pathway. Furthermore, our results also help us further understand the variations in the innate immune responses among individuals and provide a novel perspective for the development of new drugs or therapies for infectious diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f1feec513b6404942fec04ebf8bb949f8b0d7fde" target='_blank'>
              CSAD inhibits excessive inflammation during viral infections through the NF-κB signaling pathway
              </a>
            </td>
          <td>
            Yufan Zhang, Xiaotian Yang, Yun Chen, Junnan Shi, Kai Zhou, Li Zhu, Jing Wang, Wei Jiang, Dahui Zhao, Lipeng Gan, Sanguo Ren, Min Fang
          </td>
          <td>2025-09-15</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Toll-like receptor 7 (TLR7) is crucial for recognizing single-stranded viral RNA and initiating type I interferon signalling, which initiates antiviral immune responses. DNA methylation and other epigenetic controls may affect TLR7 expression and play a role in immune dysregulation in post-COVID syndrome. Objectives: To assess the association between immune dysregulation in people with post-COVID syndrome and epigenetic regulation of the TLR7 gene, specifically DNA methylation patterns. Methods: Patients with post-COVID-19 symptoms (≥12 weeks’ post-infection) and age- and sex-matched recovered controls participated in a case-control study. The purpose of peripheral blood mononuclear cells (PBMCs) was to use bisulfite pyrosequencing to analyze the DNA methylation of TLR7 promoter CpG sites, to use qRT-PCR to quantify TLR7 mRNA, and to use flow cytometry to immunophenotype immune cell subsets and type I interferon (IFN-α) production. Analysis was done on statistical relationships among immune parameters, gene expression, and methylation status. Results: In comparison to controls, post-COVID patients showed notable changes in TLR7 promoter methylation patterns, with site-specific hypo- and hyper-methylation associated with corresponding changes in TLR7 expression. Anomalies in B-cell and plasmacytoid dendritic cell (pDC) profiles and dysregulated IFN-α levels were linked to aberrant expression, suggesting persistent innate immune activation. Conclusions: TLR7 epigenetic changes could be a factor in post-COVID-19 persistent immunological dysregulation. These results emphasize TLR7 methylation as a possible therapeutic target and biomarker. To confirm these correlations, more long-term research is needed.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9614460bd9b458a97ea3bceb49565b7aab8a8dcb" target='_blank'>
              Epigenetic Regulation of the TLR7 Gene and Its Correlation with Immune Dysregulation in Post-COVID Syndrome
              </a>
            </td>
          <td>
            Beenish Khalid, Saeeda Baig, Aliya Jafri, G. Farrukh, Sobia Khan Nabeel, Hina Faisal
          </td>
          <td>2025-09-30</td>
          <td>Pakistan Journal of Health Sciences</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Chronic neuroinflammation and neurodegeneration are critical but unresolved drivers of disability accumulation in progressive multiple sclerosis (MS). Chronic active white matter lesions, identifiable radiologically as paramagnetic rim lesions (PRL), indicate progression-relevant chronic neuroinflammation. Using single-cell transcriptomics (scRNAseq) and T-cell receptor sequencing (scTCR-seq), we profiled cerebrospinal fluid (CSF) and blood immune cells of 34 radiologically characterized adults with MS (17 untreated, 6 treated with B-cell-depletion) and 5 healthy controls. Coupled with proteomics, we found PRL-associated enrichment of interferon (IFN) signaling and upregulation of TCR signaling in CSF and blood. This was accompanied by clonal expansion of CD8+ T effector memory (TEM) cells, with the highly expanded clonal cells exhibiting T helper type 1 (TH1)-like and cytotoxic profiles. Validating the cytotoxic immune profile in blood using flow cytometry, we identified a cellular correlate of PRL exhibiting features of CD8+ TEMRA cells. Despite chronic B-cell depletion, PRL-associated neuroinflammation, driven by myeloid activation and CD8+ T-cell cytotoxicity, persisted. Serum and CSF proteomic networks showed PRL-pertinent signatures, including networks unaffected by B-cell depletion. CSF:serum protein ratios revealed compartmentalized myeloid activation in cases with PRL. Using in silico perturbation, we nominated therapeutic targets, including MYD88, TNF, MYC, TYK2, JAK2, and BTK, for alleviating chronic neuroinflammation in MS. Our findings highlight mechanisms of chronic neuroinflammation in MS and point to potential biomarkers for monitoring disease progression.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1fa3caa3cc29a10980dc0ec5a031cd39c41d34cf" target='_blank'>
              Maintenance of chronic neuroinflammation in multiple sclerosis via interferon signaling and CD8 T-cell-mediated cytotoxicity
              </a>
            </td>
          <td>
            D. Reich, Syed Ali Raza, Yoshimi Enose-Akahata, Anna S Blazier, Lauren M. Guerra, E. Beck, M. Gaitán, Nyater Ngouth, Jefte M. Drijvers, E. Dammer, Devan Moodley, Kory Johnson, Martina Absinta, V. Ramaglia, J. Gommerman, Timothy J. Turner, Richard M. Ransohoff, Steven Jacobson, D. Ofengeim, Ellen Cahir-McFarland
          </td>
          <td>2025-09-25</td>
          <td>Research Square</td>
          <td>0</td>
          <td>50</td>
        </tr>

        <tr id="Introduction Toll-like receptors 7 and 8(TLR7/8) recognize purine-rich single-stranded RNA from pathogens, triggering immune responses. Although TLR7/8 agonists are emerging as potential novel adjuvants, their impact on the adaptive B cell response, particularly antibody repertoire, remains unclear. Methods Six Indian rhesus macaques(IRMs) and six African green monkeys(AGMs) were stimulated with a TLR7/8 agonist. Peripheral blood samples were collected pre-stimulation and multiple timepoints within one week post-stimulation for flow cytometry and antibody repertoire sequencing. Results B cell activation was observed at 24 hours. Significant increases in antibody repertoire diversity were detected at 48 and 72 hours in both species; however, diversity remained elevated at one week in IRMs but returned to baseline in AGMs. Analysis of antibody lineage distributions revealed a marked increase in increased lineages at 48 and 72 hours, characterized by higher frequency, a greater number of antibody clonotypes, and increased mutation rates. The identified expanded lineages, induced by the TLR7/8 agonist, exhibited λ chain bias and divergent antibodies across individuals, and primarily originated from highly mutated antibodies, likely corresponding to memory/effector-like B cells. Conclusions Our findings demonstrate that the TLR7/8 agonist rapidly induces a divergent expansion of B cells, establishing an immune foundation supporting vaccine responses and offering new insights into the dynamic B cell modulation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5daef9f40e9473cb595d9f22ac1da398eeaebc35" target='_blank'>
              Toll-like receptor 7/8 agonist stimulation rapidly skews the antibody repertoire of B cells in non-human primates
              </a>
            </td>
          <td>
            Shi-Yin Wang, Michael Citron, Lihua Luo, I-Ming Wang, Xiao Liu, Wei Zhang
          </td>
          <td>2025-09-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Empirical data from survivors of Lassa fever and experimental disease modelling efforts, particularly those using mouse models, are at odds with respect to T cell-mediated pathogenesis. In mice, T cells have been shown to be imperative in disease progression and lethality, whereas in humans, an early and robust T cell responses has been associated with survival. Here, we assessed the role of CD4+ and CD8+ T cells on disease progression and severity of Lassa virus infection in a non-human primate model. Using an antibody-mediated T cell depletion strategy prior to and post-inoculation, we were able to examine Lassa virus infection in the absence of specific T cell responses. In animals depleted for either CD4+ or CD8+ T cells, Lassa virus infection remained uniformly lethal, with only a slight delay in disease progression observed in the CD4-depleted group when compared to non-depleted controls. Milder pulmonary pathology was noticed in the absence of CD4+ or CD8+ T cells. Overall, our findings suggest that T cells have a limited impact on the development of Lassa fever in non-human primates.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd5239ecbf6e602e94f9d819f5db6cb827db29fd" target='_blank'>
              CD4+ and CD8+ T-cells are not the main driver of Lassa fever pathogenesis in macaques.
              </a>
            </td>
          <td>
            Jérémie Prévost, Nikesh Tailor, G. Soule, J. Audet, Yvon Deschambault, Robert Vendramelli, Jessica Prado-Smith, Kevin Tierney, Kim Azaransky, D. Kobasa, Chad S. Clancy, H. Feldmann, K. Rosenke, David Safronetz
          </td>
          <td>2025-09-25</td>
          <td>JCI insight</td>
          <td>0</td>
          <td>33</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2024', '2025'],
    y: [2, 10],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>